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Glossary
3-APA 3-alkyl pyridinium- or 3-alkyl tetrahydropyridine alkaloid
ACN acetonitrile
ArW Arctic Water
AW Atlantic Water
BuOH n-butanol
CID collision induced dissociation
cPro cis-proline
DAD diode array detector
DCM dichloromethane, methylene chloride
DGGE denaturing gradient gel electrophoresis
DMSO dimethylsulfoxide
DNA desoxyribonucleic acid
EI electron impact ionisation
ELSD evaporative light scattering detector
ESI electrospray ionisation
EGC East Greenland Current
EIC extracted ion chromatogram
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ESC East Spitsbergen Current
EtOH ethanol
HCCA α-cyano-4-hydroxycinnamic acid
HMBC heteronuclear multiple bond correlation
HPLC high performance liquid chromatography
HRMS high resolution mass spectrometry
LCMS liquid chromatography – mass spectrometry
LCMS/MS liquid chromatography – tandem mass spectrometry
MALDI matrix-assisted laser desorption/ionisation
MeOH methanol
MS mass spectrometry
NAC North Atlantic Current, "Gulf Stream"
NMR nuclear magnetic resonance
TOF time of flight mass spectrometer
PI peak integral (given in % relative to the monoisotopic peak)
Pyr pyridine
rDNA ribosomal desoxyribonucleic acid
RP-TLC reversed phase thin layer chromatography
S salinity
SCUBA self-contained underwater breathing apparatus
T temperature
TAW Transformed Atlantic Water
TFA trifluoroacetic acid
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THP tetrahydropyridine
TLC thin layer chromatography
tPro trans-proline
WSC West Spitsbergen Current
3

1
Introduction
All living organisms produce so-called natural products, bioactive chemicals or
metabolites that are essential for the organisms’ survival. [1] The natural products
are divided into primary and secondary metabolites. [2] Primary metabolites include,
among others, amino acids, sugars, and enzymes, compounds that are needed for
the growth and reproduction of cells and whole organisms. [3] They are produced
by the same biochemical pathways in all organisms. [4] Secondary metabolites, on
the other hand, are metabolites that are not directly involved in the organism’s
survival. However, they often possess biological activity thus giving the organisms
an advantage over competitors and may therefore promote survival. They are often
species- or genus specific [5], which, together with the high biodiversity of organisms
producing secondary metabolites like plants, animals, fungi, bacteria, has lead to a
wide variety of different secondary metabolites.
The organisms that produce bioactive or otherwise interesting secondary metabo-
lites have always fascinated humans. Their use can be dated back to the hunters in
Stone Age Europe who knew e.g. about the toxicity of banewort (Atropa belladonna)
and henbane (Hyoscamus niger) and used their plant saps as arrow poison. [6] Chinese,
Indian, Egyptian and Celtic traditional medicines know treatments based on plant,
fungi or animal products that contain bioactive secondary metabolites and exact
reports about the preparation of remedies still exist today as some of the oldest
written records. [7] Also the monastery gardens that developed in Medieval Europe
are a testimony of the profound knowledge about medicinal plants and their remedy
usage which had been collected and exchanged during travels throughout the known
world. [8]
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But natural products are not only interesting for their medicinal uses. Organic
colors like indigotin (1) from the tree Indigofera tinctoria, Tyrian purple (2) obtained
from the marine snails Murex brandaris and M. trunculus, carminic acid (3, E120)
produced by the cactus-dwelling scale insect Dactylopius coccus, and crocin (4) from
the saffron flower Crocus sativus have become inherent parts of human life as fabric
dyes and food additives; natural rubber as well as the development of vulcanization
techniques and synthetic rubber as a substitute has strongly promoted the automobile
industry; insect pheromones play a role in insect attractants/repellents used in
agriculture [9] or human households [10] and, more recently, in the development of
pest-resistant genetically modified organisms. [11,12]
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Until the beginning of the 19th century however, little was known about the
active ingredients in the organisms of use. One of the early successes in natural
product research was the isolation and structure elucidation of salicin in 1828 from
the bark of the white willow (Salix alba) [13] which had been known for its pain
killing and fever reducing properties. Conversion of salicin to salicylic acid and later
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into acetylsalicylic acid (5, ASA) yielded a potent analgesic and antipyretic remedy
known under the trade name Aspirin™. Other famous natural product-derived
drugs are morphine (9), [14] quinine (7), [15] cocaine (8), [16] the penicillins (6), [17] and
cardiac glycosides like digoxin (10, digitalis). [18] But although Aspirin™ is the most
widely used analgesic and antipyretic drug in the world since 1899, the complete
process of isolation (1828) [13], characterisation (1869) [19] and the finding of its mode
of action (1975) [20] took more than 100 years. However, with the progress in the
field of chemistry, analytical methods improved in scope and sensitivity and today,
the process of isolation and structure elucidation may take less than a year while at
the same time natural resources can be preserved. [21]
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After the isolation of bioactive compounds had concentrated on terrestrial plant,
fungi and animal sources to elucidate the active component of traditional remedies,
the focus was expanded to marine sources in the 1970s. [22] This trend went along with
the development of the self-contained underwater breathing apparatus (SCUBA)
which allowed observation and directed selection of organisms from under the
water surface. Research in the marine sector concentrated on sessile organisms,
based on the theory that sessile organisms like sponges, soft corals, ascidians,
bryozoans, gorgonians etc., in contrast to mobile ones, have a stronger need to
produce bioactive compounds to defend themselves against predators since they
cannot escape or hide. [23] Many sessile marine organisms however, live in symbiosis
with other organisms like bacteria or algae, and in many cases it was shown that e.g.
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symbiotic bacteria instead of the host sponge produce the active metabolites. [24–27]
This mutualistic relationship provides a benefit for both partners; the host is
chemically protected against predators by metabolites produced by the symbiont
while the symbiont is mechanically protected by the body structure of the host.
The finding that microscopic symbionts produce secondary metabolites promoted
a new field of study, the isolation of secondary metabolites from bacteria, micro-
scopic fungi or algae. While sessile organisms cannot be exploited from natural
sources in industrially utilizable amounts and are often not suited for cultivation,
many microscopic organisms can be cultured under laboratory conditions and the
metabolites can thus be produced in the desired quantities. [28]
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In cases where cultivation in a laboratory is not
possible, synthetic preparation of the secondary
metabolites can supply material for industrial
purposes or preclinical and clinical trials. Syn-
thesis, however, is still a major challenge since
many natural products possess complex struc-
tures with often multiple stereogenic centers or
ring systems and develop the desired bioactivity
only with stereochemical specificity. This may be one of the reasons why relatively
few marine natural products have found their way into pharmaceutical use. However,
a few examples exist that have successfully passed clinical trials and have been
approved by the medical authorities; ziconitide (Prialt™, ω-conotoxin MVIIA), [29,30]
the toxin of the marine cone snail Conus magus was accepted as an analgesic in
2004, and ecteinascidine 743 (11, Yondelis™, ET-743, trabectedine), [31,32] from
the ascidian Ecteinascidia turbinata, was approved as an anti-cancer drug in 2007.
Several others are currently in clinical trials, most of them as anti-cancer drugs. [33]
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1.1 Sponges
Sponges (phylum Porifera) as a very diverse group of sessile aquatic organisms
that often live in densely inhabited environments evoked the interest of scientists
already at an early stage of marine natural products research. After nearly 40 years
of investigation, they are today thought to contain the largest diversity of marine
natural products. [34]
Sponges represent the simplest and most primitive of multicellular animals. Their
cells are specialized for different functions, such as support, feeding, or reproduction,
but they do not form complex organ structures like the cells of higher animals.
They are mostly1 filter-feeding animals that draw water into their central cavity
through numerous tiny pores (ostia, Figure 1.1) all over the body surface, and expel
it through the outlet vents (oscula), which are more obvious and fewer in number.
Constantly beating flagellated cells (choanocytes) that sit in the cavity walls create
the water current and at the same time strain fine food particles from the water
that nourish the sponge. Tiny needles (spicules) of calcite or silicate, or fibers of a
horny material (spongin) stiffen the body. [37,38] Sponges that possess calcite spicules
belong to the class Calcarea while those that contain silicate spicules belong to the
Hexactinellidae or Demospongiae; Demospongiae build the largest and most diverse
group and contain approximately 85% of the recent species. [38] They are found in
all oceans as well as in freshwater.
Sponges can defend themselves by physical or chemical means. Large or barbed
spicules effectively deter feeding action imposed on sponges e.g. by fishes and
turtles. [39] However, many sponge species do not possess apparent physical defenses
but still assert themselves well against predators. An alternative to physical defenses
are physical compensation mechanisms like high growth-, "healing-", or reproduction
rates to compensate for the loss of tissue imposed by predators. Low nutritional value
of the tissue makes some sponge species less susceptible to spongivores. [40] In addition,
sponges accumulate a large amount of potentially pathogenic microorganisms in
their body by their filter feeding activity. Since microorganisms are unaffected by
1 Exceptions from this filter-feeding life style are the carnivorous sponges that are found in deep
caves or the deep ocean. These sponges are passively captivating prey by means of filaments
covered with spicules, then engulf the entire prey with their own body and digest the organic
material. An example is Asbestopluma hypogea found in a cave in Brittany, France. [35,36]
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Excurrent Canal
Choanocyte
Ostium
Incurrent Canal
Choanocyte
Chamber
Osculum
Figure 1.1 Schematic body
plan of a sponge of the class
Demospongiae; arrows indicate
the direction of the water flow;
modified from P.R. Bergquist
(1978). [37]
physical defenses, many species produce antimicrobial or feeding deterrent secondary
metabolites to counter the risk of infection and to fortify physical defenses. [41] In
fact, sponges have been the major source of new secondary metabolites isolated from
the marine environment since the beginning of natural products research. [42] Many
of these compounds exhibit high pharmacological potential as antitumor agents,
antibiotics, anti-inflammatory agents, etc., [43] but scientists have also focused on
revealing their ecological roles. [44,45]
Since the most densely populated areas are located in the tropics, the hypothesis
has shaped that predation pressure is higher in the tropics than in temperate
areas and consequently that tropical sponges [46] as well as e.g. holothurians [47] and
algae [48,49] are chemically better defended than temperate ones. However, there
are also examples that contradict this hypothesis, [50] which indicates that defense
strategies cannot be generalized but that each species must be considered according
to its habitat and predator-prey relationship.
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1.2 Secondary metabolites as environmental markers
As a consequence, secondary metabolites may not only be appreciated for their
pharmaceutical potential but also be used as environmental markers. On one hand,
the metabolite composition of an organism is often genus- or species specific [51–53];
secondary metabolites can therefore be consulted to identify organisms to the
genus or species level given that detailed information is available on the secondary
metabolites present or absent in the species. While several studies examine the
potential of secondary metabolites as chemotaxonomic markers (e.g. the works of
Ciminiello et al. on Verongida sponges [54–62]), comparatively few studies address
the spatial and temporal variation in composition and concentration of secondary
metabolites in sponges [63] and the influence of environmental factors. [64,65] This
information however, is equally important to estimate the value of specific marker
compounds.
On the other hand, most authors discuss the presence of secondary metabolites
on the basis of biotic factors such as predator-prey relationship, competition and
antifouling [66] while there are also multiple abiotic factors to consider. Such factors
can be the light intensity, salinity, water temperature, currents that transport
nutrients and food particles, sediment load etc. which may have strong effects on
the organism’s metabolism. For example, low light intensity seems to stimulate
several sponge species to produce more toxic metabolites. [67,68] At the same time the
metabolite quantity changes with season [68] which might be linked to the reproductive
or nutrition status of the sponge. Lindquist and Hay [69] as well as McClintock and
Baker [70] report several Caribbean and Antarctic sponge larvae to be unpalatable
to fish. Since the larvae do not contain morphological defense structures they
conclude that the larvae must be chemically defended. This invites speculation on
secondary metabolites contained already in sponge eggs which would be present in
the "mother" sponge body. High sediment rates influence the pumping rate in the
sponge Aplysina lacunosa and since most of the vital activities of a sponge, such
as feeding, respiration and release of sexual products depend upon a water flow,
sediment load in the water can strongly influence the organism’s fitness and energy
available to produce secondary metabolites. [71]
If the metabolite production is influenced by environmental parameters then
the qualitative and/or quantitative metabolite composition is expected to change
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with changing environmental conditions. Therefore, the monitoring of secondary
metabolites of key species can give information about the condition of the organisms
and can be used, together with other parameters and observations, as an indicator
for change happening in the ecosystem.
The aim of this thesis is to investigate the differences in secondary metabolites of
the sponge species Haliclona viscosa between two different habitats, the Orkneys
and Spitsbergen; at the same time, the study addresses variations of the metabolites
between different years and within the year. Since taxonomic differentiation of
Haliclona species is difficult, the investigation tests various chemical, taxonomical
and biological methods to answer the question whether the populations of sponges
identified as Haliclona viscosa in the Orkneys and Spitsbergen are the same species.
The chemical analysis also involves the identification of new secondary metabolites.
12
2
Summary and Outlook
In the course of this thesis, a total of 67 Haliclona individuals assigned to four
different Haliclona groups1 from Spitsbergen and the Orkneys were subject to a
compound screening. None of the Orkney samples and only two of the Spitsbergen
specimens yielded 3-alkyl pyridinium- or 3-alkyl tetrahydropyridine alkaloids (3-
APAs). Since the identification of Haliclona individuals to the species level can be
difficult, different chemical and biological approaches tried to supplement classical
taxonomic identification of the sponges. Thin layer chromatography was a helpful
tool to identify 3-APA containing individuals in proximity to the sampling site.
Matrix assisted laser desorption/ionization mass spectrometry (MALDI-MS) also
proved to be useful to identify 3-APA containing Haliclonas by a fast and universal
crude extract screening, but both methods were unsuitable for sponges with low
abundance of secondary metabolites. In addition, structure elucidation by MALDI-
MS was hampered by the limits of the method in small molecule research and
taxonomic identification of sponges was difficult by the absence of comparative
databases. A study to overcome these difficulties is in progress. In the future, the
usage of other environmental markers such as e.g. sponge specific sterols should be
considered.
The sponge identification by biological methods concentrated on the direct phy-
logenetic relationship of the sampled sponge individuals and on the composition
of the bacterial community. This study was performed by external researchers.
1 Since the species assignment is difficult in the Haliclona sponges examined for the present thesis,
sponges were arranged in taxonomic "groups" according to important, though not necessarily
diagnostic, taxonomic characteristics.
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While the results for the direct relationship of the sponges are still in progress, DNA
studies of the Haliclona sponges from Spitsbergen yielded a relationship with other
Haliclonas sampled in cold water. Further identification was not possible due to
limited database entries. The bacterial community was found to reflect the habitat
in which the sponge lived, with predominantly sediment-associated bacteria for Hali-
clonas that had been samples in turbid water, and clearly sponge-associated bacteria
in Haliclona that lived in oceanic environments. The similarities and differences
observed for the bacterial community of the different Haliclona groups was reflected
in their chemical profiles obtained by chromatographic methods.
Investigation of the compound variation in Haliclona viscosa from Spitsbergen
between 1999 and 2009 showed a significant change in the metabolite composition
between 2001 and 2003. All H. viscosa sponges sampled before 2003 contained 3-alkyl
pyridinium compounds while the specimens collected in 2003 and 2009 almost only
contained 3-alkyl tetrahydropyridine alkaloids. The results were discussed in view of
environmental factors but could not be manifested due to lack of environmental data
from the sampling area. To extend our knowledge on the mechanisms underlying the
production of 3-APAs in Haliclona viscosa, the sampling in the Kongsfjord should
be extended over the period of the presented thesis. The aim should be on sampling
several individuals at different times within a year, e.g in early spring and later
autumn as well as the sampling of multiple 3-APA containing individuals from the
fjord. Also the monitoring of one sponge individual over several years should be
considered.
The metabolite screening of Haliclona viscosa yielded 21 3-alkyl pyridinium
alkaloids whose structure was unknown before (haliclocyclin C, haliclamine K
and J, dehydro-haliclamine J, dehydro-viscosaline E1, viscosamine D, dehydro-
viscosamine C and D) or had previously been suggested and could be refined or
confirmed (haliclocyclin F1, haliclamine E and F, dehydro-haliclamine C, D, F,
ambidehydro-haliclamine F and didehydro-haliclamine D, viscosaline B1, B2, E1 and
E2, viscosamine B). The structure identification of haliclamines based on a mass
spectrometric fragmentation study of the haliclamines that forms part of this thesis
and is enclosed in manuscript form to be published (page 183). New viscosalines
and viscosamines were identified by evaluation of the high resolution mass spectra
of a known viscosaline and viscosamine, and the observations concerning their
fragmentation behavior are described in the presented thesis. Structure elucidation
of 3-APAs that contain double bonds in the alkyl chains is in progress, as is the
14
structure elucidation of still unknown 3-APAs in the crude extract eluting before
12min and after 23min.
The identification of a number of haliclamines, one viscosaline and two viscosamines
with unsaturated alkyl chains confutes the hypothesis that Haliclona sponges in
warmer waters yield more 3-APAs with unsaturated alkyl chains. Although the
screening revealed viscosamines with longer chains than had been published from
warmer waters, the hypothesis that alkyl chains tend to be longer in cold water
Haliclonas cannot be confirmed or rejected for the lack of comparative organisms.
In the progress of developing a method that allows metabolite screening of different
sponges by MALDI-MS, the Caribbean sponge Stylissa caribica was found to
possess previously unknown compounds which were identified as the new cyclic
heptapeptides stylissamides A-D. The stylissamides are very rich in proline and
especially stylissamide B shows an interesting combination of amino acids, with three
out of four prolines being arranged consecutively. Imposed by this configuration, the
NMR signals of the stylissamides overlapped strongly but the structure elucidation
could finally be achieved by a combination of extensive NMR and MS experiments.
Zusammenfassung und Ausblick
Im Rahmen dieser Arbeit wurden 67 einzelne Haliclona Schwämme, die vier ver-
schiedenen Gruppen2 aus Spitzbergen und den Orkneys zugeordnet wurden, einem
Metabolitenscreening unterzogen. Keine der Orkney- und nur zwei der Spitzber-
genproben enthielten 3-Alkylpyridinalkaloide (3-APAs). Da die Identifizierung von
Haliclona Schwämmen bis zur Artebene schwierig sein kann, wurde die klassisch-
taxonomische Identifizierung der Schwämme durch chemische und biologische Metho-
den unterstützt. Dünnschichtchromatographie erwies sich als nützliche Methode, um
Individuen schon in der Nähe der Probennahmestelle (d.h. nicht erst im möglicher-
weise weit entfernten Analyselabor) auf das Vorhandensein von 3-APAs zu unter-
suchen. Massenspektrometrie, die Matrix-unterstützte Laser Desorption/Ionisation
als Ionisierungsmethode verwendet (MALDI-MS), zeigte sich ebenfalls als nützliche
Methode, um durch ein schnelles und universelles Screening des Rohextrakts 3-
2 Da die Artzuordnung in den untersuchten Haliclona-Schwämmen schwierig ist, wurden die
Schwämme taxonomischen "Gruppen" zugeordnet. Die Gruppenzuordnung stützte sich auf
taxonomisch wichtige, ggf. aber nicht diagnostische, Charakteristika.
15
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APA beinhaltende Organismen zu identifizieren. Beide Methoden waren jedoch
ungeeignet, Schwämme mit generell niedriger Menge an Sekundärmetaboliten zu
klassifizieren. Zusätzlich war die Strukturaufklärung mit Hilfe von MALDI-MS
erschwert, da die Methode für kleine Moleküle nicht optimal ist, und für die taxono-
mische Identifizierung von Schwämmen entsprechende Datenbanken fehlen. Eine
Studie ist in Arbeit, die die Überwindung dieser Schwierigkeiten zum Ziel hat. Für
zukünfige Studien sollte in diesem Zusammenhang auch die Verwendung anderer
Umweltindikatoren, wie zum Beispiel die Zusammensetzung schwammspezifischer
Sterole, in Betracht gezogen werden.
Die Schwammidentifizierung durch biologische Methoden konzentrierte sich auf die
direkten phylogenetischen Verwandtschaften der untersuchten Schwämme und auf
die Zusammensetzung ihrer Bakteriengemeinschaften. Dieser Teil der Studie wurde
von externen Wissenschaftlern durchgeführt. Die Ergebnisse zum gegenseitigen
Verwandtschaftsverhältnis der Schwämme sind noch in Arbeit, die DNA Studien
zeigten aber eine enge Verwandtschaft mit anderen Kaltwasser-Haliclonas. Eine
genauere Identifizierung war aufgrund fehlender Datenbankeinträge nicht möglich.
Die Bakteriengemeinschaft spiegelte den Standort wider, an dem der Schwamm lebte.
In Schwämmen, die aus schwebstoffreichem Wasser entnommen wurden, überwogen
Sediment-assoziierte Bakterien, während Schwämme, die von Stellen stammten,
die von ozeanischem Wasser geprägt waren, auch Schwamm-assoziierte Bakterien
zeigten. Die Ähnlichkeiten und Unterschiede, welche die Bakteriengemeinschaften
der verschiedenen Haliclona-Gruppen aufwiesen, wurden in den chemischen Profilen
der Rohextraktchromatogramme dieser Schwämme wiedergefunden.
Die Untersuchung der Metaboliten-Variabilität in Haliclona viscosa von Spitzber-
gen zwischen 1999 und 2009 ergab eine deutliche Veränderung der Metaboliten-
zusammensetzung zwischen 2001 und 2003. Alle vor 2003 gesammelten H. viscosa
besitzen 3-Alkylpyridinalkaloide während in den Proben aus 2003 und 2009 fast
ausschließlich 3-Alkyltetrahydropyridine zu finden sind. Diese Ergebnisse wer-
den mit Hinblick auf beeinflussende Umweltfaktoren diskutiert, eine abschließende
Klärung konnte aber wegen mangelnder Umweltdaten von den Probennahmestellen
nicht erzielt werden. Um unser Wissen über die zugrundeliegenden Mechanismen
der 3-Alkylpyridinalkaloid-Produktion in Haliclona viscosa zu vertiefen, sollte die
Beprobung von Schwämmen im Kongsfjord über den Zeitraum der vorgelegten Arbeit
ausgedehnt werden. Ziel sollte es sein, eine jährliche Probennahme durchzuführen,
bei der mehrere 3-Alkylpyridinalkaloid-enthaltende Schwämme zu mehreren Zeit-
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punkten des Jahres, z.B. im frühen Frühjahr, Sommer, und späteren Herbst beprobt
werden. Auch das Beobachten eines einzelnen Schwammindividuums über mehrere
Jahre wäre sinnvoll.
Das Metabolitenscreening in Haliclona viscosa ergab 21 3-Alkylpyridinalkaloide,
deren Struktur vormals unbekannt war (Haliclocyclin C, Haliclamine K und J,
dehydro-Haliclamin J, dehydro-Viscosalin E1, Viscosamin D, dehydro-Viscosamin C
und D), oder deren Struktur suggeriert war und nun weiterenwickelt oder bestätigt
werden konnte (Haliclocyclin F1, Haliclamine E und F, dehydro-Haliclamine C, D, F,
ambidehydro-Haliclamine F und didehydro-Haliclamine D, Viscosalin B1, B2, E1 und
E2, Viscosamin B). Die Strukturaufklärung der Haliclamine basierte auf einer Studie
zur massenspektrometrischen Fragmentierung der Haliclamine, die auch Teil dieser
Arbeit ist und in einreichbarer Manuskriptform beigelegt wird (Seite 183). Die neuen
Viscosaline und Viscosamine wurden durch die genaue Analyse von hochauflösenden
Massenspektren eines bekannten Viscosalines und Viscosamines identifiziert. Die
neuen Beobachtungen zum Fragmentierungsverhalten dieser Verbindungen sind Teil
dieser Arbeit. Die Strukturaufklärung von 3-APAs mit ungesättigten Seitenketten
ist in Arbeit, genauso wie die Aufklärung der noch unbekannten Verbindungen, die
im Rohextrakt vor 12min und nach 23min eluieren.
Die Identifizierung einer Reihe von Haliclaminen, eines Viscosalines und eines Vis-
cosamines mit ungesättigten Alkylketten widerlegte die Hypothese, dass Schwämme
in wärmeren Gewässern vermehrt 3-APAs mit ungesättigten Alkylketten produzieren.
Obwohl auch Viscosamine mit längeren Ketten als bisher bekannt und publiziert
waren, gefunden wurden, konnte die These von längeren Alkylketten in kaltem
Wasser aufgrund mangelnder Vergleichsorganismen weder belegt noch widerlegt
werden.
Während der Entwicklung einer MALDI-MS-Methode die zum Metabolitenscreen-
ing in verschiedenen Schwämmen angewandt werden kann, wurden in dem karibis-
chen Schwamm Stylissa caribica vier neue Verbindungen gefunden, die als zyklische
Heptapeptide, Stylissamide A-D, identifiziert wurden. Die Stylissamide sind sehr
reich an Prolin. Vor allem Stylissamid B zeigt eine interessante Verknüpfung der
Aminosäuren, da hier drei von vier Prolinen hintereinander angeordnet sind. Die
dadurch stark überlappenden NMR Signale gestalteten die Strukturaufklärung
schwierig; sie war aber schließlich durch vertiefende NMR und MS Experimente
erfolgreich.
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Haliclona viscosa
A bioactivity screening in sessile or slow-moving Arctic invertebrate species in the
Kongsfjord, Spitsbergen yielded a sponge, Haliclona viscosa, whose crude extract
was significantly feeding deterrent to the Arctic amphipod Anonyx nugax and the
North Sea starfish Asterias rubens [72]. It also inhibited the growth of five bacterial
strains that had been isolated from the vicinity of the sponge [73] and a number of
bacteria used in general bioactivity screening assays [74].
Haliclona viscosa belongs to the order Haplosclerida, class Demospongiae. Mem-
bers of the order Haplosclerida are widely distributed around the world and form
an important element of marine sessile shallow- as well as deep water communities.
Among taxonomists they are known to be one of the most difficult and unstable
groups of the Demospongiae. [75] Reasons for this are the few characters which are
available for taxonomic identification, their variability (and assigned taxonomic
weight), and the number of species involved. [76] This is especially true for most
species of the genus Haliclona, where growth form is highly variable while spicule
form and arrangement is highly homogeneous. [77] Therefore, most publications on
new secondary metabolites isolated from Haliclona do not identify the sponge to
the species level and instead use the paraphrase "Haliclona sp." Since the genus
comprises numerous species, this noncommittal classification complicates evaluation
of the findings in terms of ecological relevance or interspecific variation.
The identification of H. viscosa represented the first report of the species in the
Arctic. The main distribution area of H. viscosa is located around the British
Isles and the west coast of France, but some specimens were also collected on the
west coast of Portugal and in the eastern Mediterranean. [78] The occurrence of
Haliclona viscosa around the Orkneys, a much better accessible place than the
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Arctic, stimulated an examination of the Orkneys specimen’s secondary metabolites
in hope of finding more organisms with similar bioactive metabolites.
However, a comparison of the secondary metabolites of the Arctic H. viscosa
with the same species collected around the Orkneys showed large differences in the
metabolite quality and quantity (Figure 3.1). A comparison of a second Haliclona
species that was also reported from both geographic locations, Haliclona rosea, did
not yield such differences; although the main metabolites present in the Arctic
Haliclona viscosa were absent from the crude extracts of H. rosea, the crude extracts
of H. rosea from both locations were similar. In addition, the Arctic H. viscosa showed
variation of its metabolites between different sampling years while individuals from
the Orkneys and Haliclona rosea from both locations did not show such variations
(not shown). [79]
Orkneys
H. viscosa
Spitsbergen
H. viscosa
Spitsbergen
H. rosea
Orkneys
H. rosea
0 5 10 15 20 25 30 min
0 5 10 15 20 25 30 min 0 5 10 15 20 25 30 min
0 5 10 15 20 25 30 min
Figure 3.1 Metabolite variation in the sponge species Haliclona viscosa and H.
rosea with place of origin. Modified from Köck (2006). [79]
The reason for the differences of secondary metabolites in Haliclona viscosa between
the geographic locations has not been addressed yet, but the different environments
the organisms were sampled in suggest an influence of environmental conditions.
This concept is supported by the observed variation of the metabolites with year. An
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alternative is a misidentification of the Arctic specimen or phenotypic/population
differences between the habitats.
The n-butanol fraction of the crude extract of the Arctic Haliclona viscosa con-
tained a number of 3-alkyl pyridinium- and 3-alkyl tetrahydropyridine alkaloids
(both termed 3-APA)1 that were identified as responsible for the observed bioactivity.
3-APAs are well known from different Haplosclerid sponges and are not confined to
a geographic region. They consist of a pyridinium or tetrahydropyridinium moiety
that is connected, usually in 1- and/or 3-position, to an alkyl chain of variable length.
These compounds are arranged as open, cyclic or polycyclic structures. The open
and cyclic compounds form monomers, dimers, trimers and polymers.
N N N
CH3CH3
n n
12
Figure 3.2 Halitoxin (12, n = 3, 4, 5).
The first 3-alkyl pyridinium- or 3-alkyl tetrahydropyridine alkaloid, halitoxin
(12), a linear polymeric 3-APA with branched alkyl chains, was isolated in 1978
by Schmitz et al. [80] from different Haliclona species that were later reclassified
to the genus Amphimedon. The finding was followed in 1982 by the isolation of
petrosin (13), a bis-quinolizidine alkaloid, from the sponge Petrosia (=Neopetrosia)
seriata [81] and the related xestospongins A-D in 1984. [82] The first member of the
structurally rather complex manzamines, manzamine A (14) from Haliclona sp., was
elucidated in 1986 [83] while at the same time the sarains 1-3 (15-17) were identified
in Reniera (= Haliclona) [78] sarai. All of the above mentioned compounds are
cytotoxic and ichtyotoxic and stimulated an enforced search for similar compounds,
represented today by the large number of more or less complex structures identified
from five different sponge orders2 from around the world. However, the largest
1 According to IUPAC nomenclature, the tetrahydropyridine nomenclature is different from the
pyridinium nomenclature leaving the tetrahydropyridine alkaloids isolated from Haliclona to
be 1,5-alkyl substituted. Although false, the 3-alkyl tetrahydropyridine concept is maintained
throughout this thesis for agreement with previously published tetrahydropyridine and 3-alkyl
pyridinium compounds.
2 Order Haplosclerida (compounds reported from six families: Chalinidae, Petrosiidae, Niphatidae,
Callyspongiidae, Halichondriidae and Phloeodictyidae), Astrophorida (Stelletta maxima),
Lithistida (Theonella swinhoei), Dictyoceratida (Ircinia sp.) and Poecilosclerida (Echinochalina
sp.).
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number of 3-APAs is reported from sponges of the order Haplosclerida with the
genera Haliclona, Amphimedon and Xestospongia being most often studied and thus
revealing most of the compounds. Most of the 3-APAs display at least moderate
biological activity of various kinds.
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Figure 3.3 Petrosin (13), Manzamine A (14) and Sarain 1 (15).
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In Haliclona, six linear 3-alkyl pyridinium compounds have been isolated so far.
Viscosaline C (18)3 was isolated from the Arctic sponge Haliclona viscosa and
combines two 1,3-linked alkyl pyridines with the amino acid β-alanine. [74] Another
two viscosalines, B and E4, from the same sponge, are described in the dissertation
thesis of Christoph Timm, prepared in the research group of M. Köck. [84] Viscosalines
B and E possess alkyl chains of unequal length and therefore exist in two isomeric
constitutions each, B1 (19), B2 (20), E1 (21) and E2 (22), with the β-alanine moiety
connected to either the longer or the shorter chain (Figure 3.4). The sixth linear
compound is a poly 3-alkyl pyridinium salt (23, Poly-APS), a polymer of variable
size, isolated from a Mediterranean Haliclona sarai [85] and, very recently, also from
Haliclona sp. from the Pacific coast of Guatemala. [86]
N
N
H2
O
O
N
m
n
18-22
N
n
23
Figure 3.4 Viscosaline C (18, m = n = 9), B1 (19, m = 9, n = 8), B2 (20, m = 8,
n = 9), E1 (21, m = 10, n = 9), E2 (22, m = 9, n = 10) and Poly-APS (23, n = 29,
99).
All other 3-APAs isolated from Haliclona are cyclic or polycyclic compounds. Of
the cyclic monomers, only one true 3-APA, haliclocyclin F (24)5 has been isolated,
again from the Arctic sponge Haliclona viscosa. [87] Another monomeric compound,
haliclocyclin F1 (25) with a C14 alkyl chain that carries a double bond, was identified
but could not be isolated. [84] Besides this, a 1,3-alkyl trihydropyrimidine monomer
3 Published as "viscosaline" (18), termed "C" later [84] for the similarity in chain lengths with
cyclostellettamine C (33) and the identification of additional viscosalines with different alkyl
chain lengths.
4 Viscosalines B and E were present in crude extract fractions formerly termed X2 and X4,
respectively.
5 Published without a name as a "monomeric, cyclic 3-APA" that contains a C14 alkyl chain;
however, naming is necessary due to the identification of additional monomeric 3-APAs in the
crude extract of Haliclona viscosa (see Section 3.3.1).
23
3 Haliclona viscosa
with a branched alkyl chain, haliclorensin B (26), was isolated from a Madagascan
Haliclona tulearensis together with a number of azecane derivatives. [88–90]
N
4
24
N
N
26
Figure 3.5 The monomeric 3-APAs haliclocyclin F
(24) isolated from Haliclona viscosa and haliclorensin
B (26) from H. tulearensis.
The cyclic dimers can be arranged by their degree of unsaturation. The halicla-
mines form the simplest, i.e. least unsaturated structures, with two tetrahydropy-
ridines connected in 1- and 3-position by two alkyl chains of variable length. To
date, six naturally occurring haliclamines are known; haliclamines C-F (27-30),
isolated from the Arctic Haliclona viscosa, contain saturated alkyl chains [91,92] while
haliclamines A (31) and B (32), isolated from Haliclona sp. from Hiburi-jima,
Japan, contain mono- and/or bis-unsaturated alkene chains. [93] Four additional
haliclamines with double bonds in the alkyl chains are mentioned in the disserta-
tion thesis of C. Timm [84] but not further elucidated. They are haliclamine/C20/1,
haliclamine/C21/1, haliclamine/C22/1 and haliclamine/C22/2 where nomenclature fol-
lows the concept "<compound name>/<total length of the alkyl chains>/<number
of double bonds>". [84]
N
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Figure 3.6 Haliclamines C-F (27: m = 2, n = 4, 28:
m = 3, n = 4, 29: m = 2, n = 3, 30: m = 4, n = 4)
and haliclamines A (31, m = 2, n = 5, ∆9,9′) and B
(32, m = 2, n = 5, ∆9,9′,14′).
Cyclostellettamines are structurally similar to the haliclamines but possess pyri-
dinium moieties instead of the tetrahydropyridines in haliclamines. Cyclostellett-
amine C (33) with saturated alkyl chains was identified in the Arctic H. viscosa [84]
and several additional cyclostellettamines were isolated from other, non-Haliclona
sponges. Cyclostellettamine-like compounds with monounsaturated alkyl chains are
represented by cyclohaliclonamine A (34, n = 1) which was isolated from Haliclona
sp. from Bise Island, Japan, [94] an unnamed cyclostellettamine derivative isolated
from Haliclona sp. from the Pacific coast of Guatemala (39) [86] and njaoaminium
A-C (40-42) which stem from a Reniera (=Haliclona) sp. from Tanzania. [95]
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Figure 3.7 Cyclostellettamine C (33), cyclohaliclonamines A-E (34-38, n = 1− 5)
and a cyclostellettamine derivative from Guatemala (39).
While the chains in cyclostellettamine C (33) contain 13 methylene groups, the
compound 39 reported from Guatemala contains 11 methylene/methyne groups
and cyclohaliclonamine A (34) and njaoaminium A-C (40-42) possess chains of ten
methylene/methyne groups. Additionally, njaoaminium B (41) and C (42) contain
methyl side chains in the interconnecting alkyl chains and cyclohaliclonamine A (34)
and njaoaminium A (40) differ in the position of the double bond.
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Figure 3.8 Njaoaminium A-C (40-42).
Cyclic trimers are represented by viscosamine C (43)6 that contains three saturated
alkyl chains of 13 methylene groups each and was isolated from H. viscosa from the
Arctic, [96] as well as a viscosamine that contains saturated alkyl chain with a total
of 38 methylene groups. [84] Two derivatives with monounsaturated alkyl chains are
represented by the unnamed compound 44 from Haliclona sp. from the Pacific coast
of Guatemala [86] and cyclohaliclonamine B (35, n = 2) from Haliclona sp. from
Bise Island, Japan. [94] The two derivatives differ in the position of the double bond.
All four compounds are different in the length of the alkyl chain; viscosamine C
(43) contains the longest chains of 13 methylene groups while compound 44 and
cyclohaliclonamine B (35) possess chains of 11 and 10 methylene/methyne groups,
6 Originally published as "viscosamine", but termed viscosamine C (43) for the presence of
additional viscosamines in the crude extract of H. viscosa.
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respectively. The yet unidentified viscosamine from the Arctic H. viscosa contains
alkyl chains of unequal length, probably 12/13/13.
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Figure 3.9 Viscosamine C (43)
and a derivative from Guatemala
(44).
In addition to the cyclic dimeric cyclohaliclonamine A (34) and the trimeric
cyclohaliclonamine B (35), three more members of the cyclohaliclonamines are
reported, cyclohaliclonamines C-E (36-38, n = 3 − 5). They form tetrameric,
pentameric and hexameric macrocycles that are unprecedented among the 3-APAs
in Haliclona. [94] All of them possess alkyl chains of 10 methylene/methyne groups
and a double bond in the last but third bond of the alkyl chain.
Halicyclamine A (45), [97] haliclonacyclamines A-D (46-49) [98,99] and 22-hydroxy-
haliclonacyclamine B (50) [100] are tetracyclic 3-APAs that are related to the ha-
liclamines. They can be seen as haliclamines in which the double bond of one
tetrahydropyridine is used to connect the two azacycles. The haliclonacyclamines
A-D (46-49) and 22-hydroxyhaliclonacyclamine B (50), in contrast to halicyclamine
A (45), lack the double bond in the second tetrahydropyridine, resulting in two
interconnected piperidine moieties. All haliclonacyclamines possess one C10 and one
C12 alkyl chain but differ in the number and position of double bonds in these chains.
Halicyclamine A (45) and 22-hydroxyhaliclonacyclamine B (50) were isolated from
Haliclona sp. from Biak and Flores Island, Indonesia, while haliclonacyclamines
A-D (46-49) were isolated from Haliclona sp. from Heron Island, Australia.
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Figure 3.10 Halicyclamine A (45), haliclonacyclamines A-D (46-49) and 22-
hydroxyhaliclonacyclamine B (50).
Similar to halicyclamine A (45) and the haliclonacyclamines A-D (46-49) are
the sarains-1 to -3 (15-17) and isosarain-1 (51) isolated from Haliclona sarai from
the Bay of Naples, Italy. Sarains-1 to -3 (15 - 17) and isosarain-1 (51) consist of a
quinolizidine moiety connected to a tetrahydropyridine moiety. The tetrahydropyri-
dine is connected in 1- and 3-position to two alkyl chains that are, in turn, connected
to the quinolizidine in meta-position to the nitrogen. They differ in the length of
one of the alkyl chains and the number and position of the double bond therein.
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Figure 3.11 Sarains 1-3 (15-17) and isosarain-1 (51). The position of the double
bond in the alkyl chain of sarain-3 (17) is not determined.
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Figure 3.12 Isosarain-1 (51)).
Haliclonin A (52) constitutes the next step in complexity of the 3-APA compounds
present in Haliclona. It was recently isolated from a Haliclona sp. from Jeju Island,
Korea [101] and provides a novel skeletal class with two condensed rings.
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Figure 3.13 Haliclonin A (52)
and Sarain-A (53).
An even more complex condensed ring system is represented by sarain A (53).
It is characterized by a central tetracyclic cage in the middle of two cyclic alkyl
chains. [102] Two structurally similar sarains, sarain B and C, were isolated from the
same sponge, Haliclona sarai, with sarain B containing "[. . .] an additional carbon
atom and double bond" in the alkyl chain between N1’ and C3 while sarain C "[. . .]
is the superior homolog of Sarain B". [102]
The most complex 3-APAs isolated from Haliclona sponges are the manzamines.
They are β-carboline alkaloids with intricate nitrogen-containing polycyclic systems.
The complexity of the compounds and their biological activity fired the search for new
examples of the manzamine family resulting today in a large number of manzamines
published from different Haplosclerid sponges. Yet only four, manzamines A-C (14,
54, 55) and Y (56), [83,103,104] are reported from Haliclona sp. They are, as most
manzamine alkaloids (Table A.5), isolated from sponges collected in the Okinawa
prefecture, Japan. The joint occurrence of manzamines in different sponge genera
led to the assumption that commensal bacteria instead of the host sponge produce
these types of secondary metabolites, [104] but this hypothesis was not assessed yet.
28
3.1 Known 3-APAs isolated from Haliclona sp.
N
N
N N
H
OH
H
H
14
HN
N
N N
H
O
H H
54
N N
H
N
55
N
N
N N
H
OH
H
OH
56
Figure 3.14 Manzamines A (14), B (54), C (55), and Y (56).
Looking at the distribution of 3-APAs in a global context, sponges from the
Western Pacific yielded the largest number of 3-APAs and the highest structural
diversity (Table 3.1 and A.5, Figure A.1). However, it must be noted that the type
of structure published and the area of origin are influenced by the scope, interest and
methods of the individual researcher operating in a defined geographic area. The
high number of compounds reported from the Western Pacific is therefore reflected
in the "trends in geographic distribution of collection sources" for all marine natural
products published. [42]
With the 3-APAs in Haliclona, there seems to be a trend for shorter alkyl chains
with increased water temperature. Similarly, the structural complexity seems to
increase with increasing water temperature. In addition, it must be noted that
the cyclic dimeric 3-alkyl tetrahydropyridines are represented by the rather large
number of haliclamines while cyclostellettamine C (33) is the only cyclic dimeric
3-alkyl pyridinium compound found in H. viscosa to-date.
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Table 3.1 3-Alkyl pyridinium and 3-alkyl tetrahydropyridine alkaloids reported
from sponges of the genus Haliclona, sorted by geographic region (Is. = Island, w/
DB = with double bonds).
Nra Geographic Areab Compound Sponge
1 SJM, Kongsfjord Viscosaline C (18) [74] H. viscosa
Viscosaline B1/2 (19, 20), E1/2 (21, 22) [84] H. viscosa
Haliclocyclin F, F1 (24, 25) [84,87] H. viscosa
Haliclamine C-F (27-30) [91,92] H. viscosa
Haliclamine/C20/1, Haliclamine/C21/1 [84] H. viscosa
Haliclamine/C22/1, Haliclamine/C22/2 [84] H. viscosa
Cyclostellettamine C (33) [84] H. viscosa
Viscosamine C (43) [96] H. viscosa
Viscosamine/C38/0 [84] H. viscosa
2 SVN, North. Adriatic Poly-APS (23) [85] H. sarai
3 ITA, Bay of Naples Sarain-1 (15), -2 (16), -3 (17) [105] H. sarai
Isosarain-1 (51) [102,106] H. sarai
Sarain-A (53), -B, -C [107] H. sarai
4 JPN, Hiburi-jima Haliclamines A (31), B (32) [93] Haliclona sp.
JPN, Bise Is. Cyclohaliclonamine A-E (34-38) [94] Haliclona sp.
5 KOR, Jeju Is. Haliclonin A (52) [101] Haliclona sp.
6 JPN, Manzamo Is. Manzamine A (14) [83] Haliclona sp.
Manzamine B (54), C (55) [103] Haliclona sp.
JPN, Iriomote Is. Manzamine A-C (14, 54, 55), Y (56) [104] Haliclona sp.
7 IDN, Biak Halicyclamine A (45) [97] Haliclona sp.
8 IDN, Flores Is. 22-Hydroxyhaliclonacyclamine B (50) [100] Haliclona sp.
9 AUS, Heron Is. Haliclonacyclamine A (46), B (47) [98] Haliclona sp.
Haliclonacyclamine A-D (46-49) [99] Haliclona sp.
10 GTM, Pacific coast Cyclostellettamines w/ DB (39) [86] Haliclona sp.
Viscosamine w/ DB (44) [86] Haliclona sp.
Poly-APS (23) [86] Haliclona sp.
11 TZA, Pemba Is. Njaoaminium A-C (40-42) [95] Reniera sp.
12 MDG, Salary Bay Haliclorensin B (26) [90] H. tulearensis
a Numbers refer to geographic regions as denoted in Figure A.1.
b Country codes: AUS = Australia, GTM = Guatemala, IDN = Indonesia, ITA = Italy,
KOR = Korea, MDG = Madagaskar, SVN = Slovenia, SJM = Svalbard & Jan Mayen,
TZA = Tanzania.
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This observation is interesting with regard to the bioactivity of the compounds.
In the original bioactivity screening of sessile or slow moving Arctic invertebrates,
the n-butanol fraction of the Arctic Haliclona viscosa crude extract showed feeding
deterrence [72,108] and antimicrobial activity [73,74]
The 3-alkyl pyridinium and 3-alkyl tetrahydropyridine alkaloids present in the
n-butanol fraction are responsible for the bioactivity and in the course of that study,
several of the metabolites were isolated or synthesized and tested as pure compounds.
The isolated viscosaline C (18) was identified as the compound that deterred feeding
in Anonyx nugax and Asterias rubens while the 3-alkyl tetrahydropyridine alkaloids
haliclamines C (27) and D (28) were not feeding deterrent. [73] Viscosaline C (18)
inhibited the growth of four out of five bacterial strains isolated from the sponge’s
habitat and haliclamines C (27) and D (28) inhibited two of the five bacterial
strains. [73]
The compounds were also tested for growth inhibition in different gram-positive
(gram+) and gram-negative (gram–) bacteria, yeasts and fungi as well as for cytotoxi-
city on mouse fibroblasts L929. [84,87] To test the influence of alkyl chain length, size of
the macrocycle and number of charges on the bioactivity, synthetic compounds were
included that were not identified in natural crude extracts. While most compounds
were not active against the yeasts and fungi, all compounds with alkyl chain lengths
longer than eight methylene groups inhibited gram+ and gram– bacteria and were
cytotoxic against mouse fibroblasts. [84]
A review about the known 3-alkyl pyridinium and 3-alkyl piperidine alkaloids states
that 3-APA monomers, dimers and trimers possess greater antimicrobial activity,
while higher polymers show more pronounced cytolytic, cytotoxic and antifouling
activities, but not as an absolute rule. [109] This is confirmed by Timm, [87,110] where
antimicrobial activity of cyclic compounds decreased with increasing oligomerization
and/or total number of charges. Cyclic monomeric 3-APAs showed the highest
activity. Compounds with equal size of the macrocycle but higher number of charges
(pyridinium moieties) showed decreased antimicrobial activity. The relationship
between cytotoxicity and antimicrobial activity was negatively correlated; i.e. the
most cytotoxic compound viscosamine C (43) showed the least antimicrobial activity
while the highest antimicrobially active compound, the synthetic cyclic monomer
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haliclocyclin C (57, C13 alkyl chain), was least cytotoxic. This is in accordance
with the findings of Anan et al. (1996) of the macrocyclic monomeric 3-APA with
a C13 alkyl chain (see Section 3.3) being less cytotoxic than cyclostellettamine C
(33). [111] Linear 3-APAs with fully saturated alkyl chains or terminal methylene
groups showed no antimicrobial and low cytotoxic activity but addition of a terminal
amino or hydroxyl group resulted in significantly heightened activity. [87]
In addition, the alkyl chain length influenced the cytotoxicity and antimicrobial
activity; longer chains resulted in increased activity. [110] On the other hand, 3-alkyl
tetrahydropyridines proved to be less active than 3-alkyl pyridinium compounds of
equal chain length. [84,87]
The bioactivity of 3-APAs with unsaturated chains was not tested in this series
since natural or synthetic haliclamines and cyclostellettamines with unsaturated
alkyl chains were not at hand. However, 3-APAs with unsaturated alkyl chains
like the cyclohaliclonamines A-E (34-38) [94], njaoaminium A (40) [95] and the cyclo-
stellettamine (39) and viscosamine (44) from Guatemala [86] as well as haliclamines
A (31) and B (32) [93] were tested for cytotoxicity on different cell lines by the
respective authors.
Although the results cannot be directly compared for the use of different cell
types as basis for the cytotoxicity assays, the 3-alkyl pyridinium alkaloids with
unsaturated alkyl chains show low general cytotoxicity on the tested cell lines
whereas the haliclamines A (31) and B (32) are significantly toxic against mouse
fibroplasts. The cyclostellettamine and viscosamine isolated from a Haliclona sp.
from Guatemala showed IC50 values of >20 µg ml−1 against murine macrophage
J774.A1 [86] while Haliclamine A and B were significantly cytotoxic against L1210
cells (1.5 and 0.9 µg ml−1) and P388 mouse leukemia cells (0.75 and 0.39 µg ml−1,
respectively). [93]
This seems to reverse the finding of haliclamines with saturated alkyl chains being
less cytotoxic than cyclostellettamines; the addition of double bonds seems to increase
their cytotoxic potential more than double bonds in cyclostellettamines. Haliclamine
B (32) with one mono- and one bisunsaturated alkyl chain was significantly more
cytotoxic than haliclamine A (31) with two mono-unsaturated alkyl chains. [93]
The mode of action for cytotoxic, antimicrobial, enzyme inhibitory and receptor
modulating activity in 3-APAs has not been studied, yet. [109] An exception is the
cause for the cytolytic activity which has been addressed for halitoxin (12) and
Poly-APS (23). Due to their positively charged pyridinium ring and the aliphatic
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moieties which are reminiscent of the "polar head" and "nonpolar tails" of detergents,
Poly-APS (23) produces discrete membrane lesions with an average diameter of
5.8 nm which results in moderate haemolytic activity. [112] By assuming a similar
mode of action in halitoxin (12) and taking into account the increase in activity with
increasing molecular weight, this explains the strong haemolytic activity, lethality
to mice, [80,113] irreversible membrane potential depolarization and action potential
inhibition of halitoxin (12). [109] However, cytolysis has not yet been reported for
linear monomers and cyclic compounds and it is uncertain whether these compounds
have not been tested or were tested and did not possess e.g. haemolytic activity.
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3.3 New secondary metabolites in Haliclona viscosa
Sample volumes in the Spitsbergen sponge samples are limited by the small size of
the individuals, their slow growth rate and the attention to sustainable sampling
in the fragile Arctic ecosystem. Small sample volumes hinder the isolation of
compounds in the quantities required for structure elucidation by nuclear magnetic
resonance (NMR). Thus only the major secondary metabolites in Haliclona viscosa
were isolated and identified by the combination of high resolution mass spectrometry
(HRMS) and NMR. Two previous dissertation theses prepared by Christian Volk [114]
and Christoph Timm [84] in the Köck working group concentrated on the isolation
and structure elucidation of secondary metabolites from Haliclona viscosa.
To date, five different structural classes are known among the 3-APAs contained
in the Arctic Haliclona viscosa; 3-alkyl pyridinium alkaloids are represented by the
linear, open viscosalines, macrocyclic monomeric haliclocyclins, the macrocyclic
dimeric cyclostellettamine C (33) and macrocyclic trimeric viscosamines; the cyclic
dimeric haliclamines are the only representatives of 3-alkyl tetrahydropyridines
(Section 3.1). The difference among the members of each structural class is only in
the length of the alkyl chain and the number of double bonds therein.
Haliclamine C (27) and D (28) constitute the major components in the crude
extracts of all H. viscosa samples obtained so far, with exception of the year 2001, and
were first identified by C. Volk. [91] Other compounds isolated by him are viscosaline
C (18), [74] cyclostellettamine C (33) and viscosamine C (43). [96]
Several additional compounds were identified in the thesis of C. Timm. Since the
quantity of these compounds was too low to allow their isolation, C. Timm relied
on synthetic preparation of the proposed structures and compared their chemical
properties (retention times, masses, UV data) to those of the natural products in
the crude extract. In this manner, he isolated the monomeric, cyclic haliclocyclin
F (24) [87] and found haliclocyclin F1 (25), two new viscosalines, B and E, one
haliclamine, haliclamine/C23/0 with saturated alkyl chains, four haliclamines with
unsaturated alkyl chains, haliclamine/C20/1, haliclamine/C21/1, haliclamine/C22/1
and haliclamine/C22/2 [84] as well as one viscosamine with a total of 38 methylene
groups (Table 3.2). [84]
The present thesis uses a chromatographic method that achieves better separation
of compound peaks in high performance liquid chromatography (HPLC) compared
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Table 3.2 3-APAs in Haliclona viscosa published prior to the presented thesis. The
compounds are sorted according to their affiliation with structural class.
linear/cyclic Pyr/THPa oligomer compound name alkyl chains DB
linear Pyr dimer viscosaline B1 (19) 12/13 0
viscosaline B2 (20) 13/12 0
viscosaline C (18) 13/13 0
viscosaline E1 (21) 13/14 0
viscosaline E2 (22) 14/13 0
cyclic Pyr monomer haliclocyclin F (24) 14 0
haliclocyclin F1 (25) 14 1
cyclic Pyr dimer cyclostellettamine C (33) 13/13 0
cyclic Pyr trimer viscosamine B (80) 12/13/13 0
viscosamine C (43) 13/13/13 0
cyclic THP dimer haliclamine C (27) 9/11 0
haliclamine D (28) 10/11 0
a Pyr = pyridinium, THP = tetrahydropyridine, DB = double bonds, 12/13 = number of
methylene groups in each of the two alkyl chains.
to previous analyses (no raw data available, for comparison see dissertation thesis
of C. Timm [84]). Improved compound peak resolution consequently leads to better
differentiation and higher detailedness of compound-specific mass spectra in HRMS
thus facilitating the structure elucidation of compounds. Despite the improved
chromatographic separation, the large number of similar 3-APAs in the crude extract
of H. viscosa hinders the complete baseline-separation of chromatographic peaks;
several of the 3-APAs still co-elute or overlap. While compounds of the same
compound class but with different chain lengths can be separated well (Figure
3.17), compounds associated with different compound classes may elute in one
chromatogram peak. Although this results in superimposed mass spectra, compounds
of different compound classes can confidently be recognized by their exact mass,
characteristic molecular ions and fragmentation pattern, even inside the same mass
spectrum.
This is exemplified in the identification of haliclocyclin C (57, Section 3.3.1) which
has a singly charged molecular ion [M]+ ofm/z = 260. This compound was previously
included in a fraction that contained cyclostellettamine C (33), haliclocyclin F1
(25) and a new viscosamine 12/13/13 (fraction X7 in the dissertation thesis of C.
Timm [84]) as the major metabolites. Since cyclostellettamine C (33) shows a doubly
charged molecular ion [M]2+ of m/z = 260, the ions of the two compounds were
superimposed and were thus not differentiated. However, both compounds are clearly
separated in the LC analysis used for the presented thesis and thus distinguishable
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in the MS spectrum. As before in the thesis of C. Timm however, the quantity and
purity of the analytes achieved by preparative chromatography prevents informative
results by NMR experiments.
Alkyl CH : 1.00-1.402
8.49
8.10
8.97 9.09
4.59
1.80-2.00
2.70-2.90
N
N +
+
m
n
12 11 10 9 8 7 6 5 4 3 2 1 ppm13
Figure 3.15 1H-NMR spectrum of a crude extract fraction (1.5mg) obtained from
the sponge Pachychalina sp. in DMSO-d6. Alkyl chain methyl groups are marked
in blue and aromatic hydrogen are marked in purple. Modified from Grube et al.
(2005). [115]
In addition, the repetitive 3-alkyl pyridinium or tetrahydropyridine motif in 3-
APAs causes NMR spectra to show only one structural unit of the molecule and the
large number of similar methylene units results in a strong overlap of the aliphatic
protons. NMR spectra are thus not ideally suited to distinguish large numbers of
structurally very similar 3-APAs. An example for this constitutes a crude extract
fraction (1.5mg) obtained from the Brazilian sponge Pachychalina sp. The fraction
contains eleven different cyclostellettamines (A-F and G, H, I, K and L) as well as
ingenamide G, [116] but the NMR spectrum of the complete fraction only indicates
the presence of one cyclostellettamine substructure (Figure 3.15). While it is possible
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to determine from NMR spectra, whether the compounds present contain pyridine
or tetrahydropyridine moieties, the number of different compounds and their chain
lengths cannot be deduced.
In these cases it is advantageous to use liquid chromatography – mass spectrometry
(LCMS) and liquid chromatography – tandem mass spectrometry (LCMS/MS)
methods to identify the natural compounds, e.g. directly in the crude extract. In
the 1.5mg crude extract fraction of Pachychalina sp. mentioned above, Oliveira et
al. [116] succeeded in identifying twelve compounds by applying LCMS methods. Thus,
liquid chromatography mass spectrometry constitutes the basic method for obtaining
information about the chain length, number of double bonds, and connectivity of
the substructures in 3-APAs, especially where only small amounts of sample are
available.
However, for mass spectrometry to be a useful tool in identifying different 3-APA
compound classes and the constitution of their members, detailed knowledge about
the compound class specific ion- and MS-fragmentation pattern is essential. This is
especially true where all structure assignments of new 3-APAs in H. viscosa base on
high resolution mass spectra and fragmentation of the full scan spectrum. A large
part of the presented thesis therefore concentrates on the fragmentation of different
3-APAs.
The MS fragmentation of 3-alkyl pyridinium alkaloids is different from the fragmen-
tation of 3-alkyl tetrahydropyridine alkaloids. Fragmentation of 3-alkyl pyridinium
alkaloids like the cyclostellettamines is described by Grube et al. [117] The MS frag-
mentation of 3-alkyl tetrahydropyridines, haliclamines, is described in detail in
manuscript 1 (page 183).
N
5
N
4
Haliclamine E
(29)
N
6
N
6
Haliclamine F
(30)
Figure 3.16 New haliclamines with saturated alkyl chains published as part of the
presented thesis.
For the presented thesis, four new haliclamines with saturated chains are identified
in the crude extract of Haliclona viscosa by HPLC-HRMS experiments. Two of
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Figure 3.17 Secondary metabolites in Haliclona viscosa. Blue – newly identified as
part of the presented thesis. Black – previously known compounds [84] whose structure
was refined. Compounds are included in two exemplary crude extract base peak
chromatograms (m/z = 50 − 1000 ) from the years 2000 and 2001. Several new
compounds coelute with the published compounds given in black numbers.
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them, haliclamines E (29) and F (30), are published in cooperation with C. Timm
(see publication 1 on page 161). Another two, haliclamines J (61) and K (62),7 are
included in manuscript draft form but the final confirmation by synthetic products
is still missing (see manuscript 2 on page 223). In addition to the first report of
the cyclic monomer haliclocyclin C (57) from a natural source, two additional new
haliclamines J (61), and K (62) with saturated alkyl chains, two new haliclamines
with unsaturated chains, one viscosaline and three additional viscosamines are
identified in the crude extract of Haliclona viscosa while at the same time knowledge
about the structures of previously identified haliclamines with unsaturated alkyl
chains and viscosalines is expanded. To differentiate between new and known
compounds, new compounds are marked by an asterisk in the compound description
in Section 3.3.1-3.3.6.
As mentioned before, the structure elucidation or refinement of new or known
compounds builds almost exclusively on mass spectrometric experiments but it uses
a different method or instrument parameters than previous analyses. This leads to
slightly different mass spectra in both viscosalines and viscosamines and is therefore
discussed again using previously reported compounds as an example to allow direct
comparison.
3.3.1 Monomeric 3-alkyl pyridinium alkaloids
The cyclic monomeric 3-APAs haliclocyclins F (24) and F1 (25), were first reported
from the Arctic sponge Haliclona viscosa in the dissertation thesis of C. Timm.
Haliclocyclin F (24, Figure 3.18) was published in 2008 and represented a novel
structural class among the naturally occurring 3-APAs. [87] The haliclocyclins are
the only compounds known to-date in the crude extract of the sponge that are
characterized solely by a singly charged molecular ion. Owing to their single nitrogen,
no multiply charged ions or fragments are expected, nor observed (Figure 3.18).
The second cyclic monomer, haliclocyclin F1 (25), is unpublished yet and since
no spectrometric data are given in Timm’s thesis, the results obtained from this
compound are presented here (Figure 3.19). It elutes at a retention time of 17.8min,
7 Haliclamines G (12/12), H (13/13) and I (11/14) are synthetic haliclamines that are not yet
reported from nature. [92]
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peak m/z mol. form. ∆m
C [M]+ 274.2523 C19H32N 9.6 ppm
C: compound mass
150 200 250 300 350 400 450 m z/
274.2523 [M]+
Figure 3.18 Structural formula, compound mass and high resolution mass spectrum
for the peak at 20.5min, identified as haliclocyclin F (24).
close to a third cyclic monomer, haliclocyclin C (57) and a viscosaline (see Section
3.3.5).
The mass of the singly charged molecular ion [M]+ is m/z = 272.2370 which yields
a molecular formula of C19H30N. The mass is two mass units lower than compound
24 and suggests that a monomeric cyclic 3-APA with an alkyl chain of 14 methylene
units contains a double bond in the chain.
The position of the double bond inside the alkyl chain cannot be determined purely
by HRMS analysis of crude extracts. Mass spectrometric analysis of double bonds in
alkyl chains is difficult by H-shifts that happen prior to the cleavage and hamper an
exact localization. [118] A solution to this problem may be the immobilization of the
double bond by e.g. oxidative addition of dimethyl disulphide [119] or ethanethiol [120]
to transform the double bond to its 1,2-bis-thiomethyl or -thioethyl derivative,
respectively. Induced by charge localization at either sulphur atom, the molecular
ions of dimethyl disulphide and ethanethiol are susceptible to α-cleavage at the
former double bond position. This results in sulphonium ions that should be readily
identified in the mass spectrum. [118] For 3-APAs this method would have to be
tested for its suitability since also the double bonds inside the pyridine (Pyr) or
tetrahydropyridine (THP) moiety might be oxidized. Determination of the position of
40
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Figure 3.19 Structural formula, compound mass and high resolution mass spectrum
of the peak at 17.8min, identified as haliclocyclin F1 (25). The exact position of the
double bond is not determined, yet.
the double bond in haliclocyclin F1 (25) as well as its chromatographic confirmation
by comparison with the synthetic analogue is in progress.
In the known 3-APAs with unsaturated alkyl chains, a single/the first double bond
is separated by one or two methylene groups from the 3-position of the Pyr/THP
moiety or by two to five methylene groups from the nitrogen in 1-position. Multiple
double bonds usually occur in conjugation.
Haliclocyclin C (57)*8
At almost the same retention time as haliclocyclin F1 elutes a third cyclic monomer,
compound (57), that is previously unreported from natural sources. It is identified
by a diagnostic singly charged molecular ion [M]+ at m/z = 260.2368 while no
doubly or triply charged molecular ions are present. The molecular ion assigns the
formula C18H30N. The mass corresponds to the doubly charged molecular ion of
cyclostellettamine C (33) but for its charge. The molecular formula is consistent
with a pyridine moiety connected to an alkyl chain of 13 methylene groups. To
8 * New compounds or previously known compounds whose structure could be refined are marked
with an asterisk.
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C [M]+ 260.2368 C18H30N 1.9 ppm
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Figure 3.20 Structural formula, compound mass and high resolution mass spectrum
for the peak at 17.8min, identified as haliclocyclin C (57).
satisfy the molecular formula, the pyridine can be attached to an open alkyl chain
that carries a terminal methylene group or a double bond inside the chain. The other
option is that the alkyl chain is attached, possibly in 1- and 3-position (to follow
the example of the other 3-APAs in H. viscosa), to the pyridine thereby forming a
macrocycle as is known from haliclocyclin F (24).
The macrocycle 57 was synthesized in 1996 by Anan and coworkers [111] for the
structural comparison between 57 and the then newly synthesized cyclostellettamine
C (33) as well as for comparison of the bioactivity between the two compounds.
In addition, the macrocyclic monomer 57 was synthesized by Timm [87] to examine
the effect of the chain length on the bioactivity of 3-alkyl pyridinium alkaloids.
Therefore, it is available for a comparison of retention times between the compound
in the crude extract of H. viscosa and the pure, synthetic compound.
The synthetic monomer, haliclocyclin C (57), elutes at the same retention time
as the natural compound 57 in the crude extract. The HPLC-HRMS analysis of the
synthetic compound 57 yields the mass m/z = 260.2360 [M]+ which corresponds to
the molecular formula C18H30N with a mass accuracy of 4.9 ppm. The chromato-
graphic analysis of a mixture of the crude extract and the synthetic haliclocyclin
C (57) results in increased intensity of the compound peak in the crude extract
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Figure 3.21 Overlay of the HPLC-
HRMS base peak chromatogram of the
crude extract of a Haliclona viscosa sample
from 2000 (black), the synthetic Haliclocy-
clin C (57, blue), and a mixture of both
(dotted line). Due to the use of different
chromatographic methods, the retention
times deviate from the original analysis.
6 8 10 12 14 16 18 min
57
(Figure 3.21). Thus, it can be concluded that the natural compound 57 very likely
has the same structure as the synthetic haliclocyclin C (57, see manuscript on page
217). This is the first report of the macrocyclic monomer 57 from natural sources.
3.3.2 Haliclamines with saturated alkyl chains
Haliclamines and cyclostellettamines with saturated alkyl chains can be recognized
in HRMS by their fragments that constitute the mass equivalent of a THP or Pyr
moiety connected to one alkyl chain (see Grube et al. [117] and manuscript 1 on
page 183). Consequently, two fragments are expected in compounds with chains
of different length. In non-fragmentation mode, the fragments are usually of low
intensity but nevertheless clearly present.
N
NH2
N
H2N
8
12
12
58
N
NH2
N
N
H
8
10
12
HN NH2
59
N
NH2
N8
8
12
N
NH212
60
Figure 3.22 Pachychalines A-C (58-60).
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When relying almost exclusively on mass spectrometric results, considerations
regarding the connectivity of the alkyl chains in 3-APAs should be performed. Most
3-APAs published to-date are head-to-tail linked pyridinium or tetrahydropyridine
compounds; however, there are also examples for head-to-head and tail-to-tail linked
naturally occuring pyridinium alkaloids. The pachychalines A-C (58-60) isolated
from Pachychalina sp. from the Caribbean are linear 3-(aminoalkyl) pyridinium
salts with head-to-tail, head-to-head and tail-to-tail linked pyridinium moieties. [121]
The molecular mass of head-to-tail linked 3-APAs is not distinguishable from
head-to-head or tail-to-tail linked structures. However, if the fragmentation in
head-to-head and tail-to-tail linked compounds bases on the same mechanisms
as observed in head-to-tail linked pyridinium and tetrahydropyridine compounds,
the three can be distinguished by their fragments. The fragmentation of 3-alkyl
pyridinium compounds in in-sourcecollision induced dissociation (CID) experiments
builds on three different fragmentation reactions; Hofmann fragmentation, onium
reaction and McLafferty rearrangement. 3-Alkyl tetrahydropyridine fragmentation
is dominated by the retro-Diels-Alder reaction (Figure 3.23).
In the 3-alkylpyridinium compounds, all three fragmentation reactions lead to
fragments of the same mass and thus cannot be distinguished in MS experiments. In
the case of the cyclostellettamines, the major fragments comprise the mass equivalent
of a pyridine moiety connected to either alkyl chain. This first fragmentation step
may then be followed by cleavage of the alkyl chain, but the highest intensity
fragments constitute pyridine moieties with "intact" alkyl chains (Figure 3.23). [117]
N N
n
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N
n
N
n-1
H
N
n
Hofmann Onium McLafferty
N NH
n
m
HN
m
retro-Diels-Alder
Figure 3.23 Proposed main fragments of head-to-tail linked cyclostellettamines
(fragment masses for n = 4: m/z = 204, n = 5: m/z = 218, n = 6: m/z = 232, n = 7:
m/z = 246, n = 8: m/z = 260) and haliclamines (all cyclostellettamine fragment
masses by m/z = 4 higher).
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Similar fragmentation mechanisms in tail-to-tail linked 3-alkyl pyridinium alkaloids
would lead to a fragment that consists of two pyridine moieties interconnected in
3-position by an alkyl chain. Timm synthesized a head-to-tail and a tail-to-tail linked
viscosaline, subjected it to fragmentation experiments and confirmed that head-to-
tail linked viscosalines were distinguishable from tail-to-tail linked viscosalines by
their mass (Figure 3.24, for viscosaline fragmentation see Section 3.3.5). [84] While the
head-to-tail linked viscosaline C (18) showed a Pyr + alkyl chain type fragment at
m/z = 260, fragmentation of the tail-to-tail linked viscosaline resulted in a fragment
of m/z = 339, corresponding to two pyridine moieties connected by an alkyl chain,
as well as the aminoalkyl fragment m/z = 198.
Fragmentation of cyclostellettamine C (33) which has the same chain lengths as
viscosaline C (18) is expected to result in the same fragment m/z = 339. In contrast
to the tail-to-tail linked viscosaline however, tail-to-tail linked cyclostellettamines
would not show the aminoalkyl fragment that, in viscosaline C (18), derives from
cleavage of the amino-acid carrying alkyl chain (Figure 3.25). In macrocyclic dimers,
tail-to-tail linked compounds are the equal of head-to-head linked compounds.
Differences may be seen in linear or trimeric and polymeric cyclic pyridinium
alkaloids but the fragmentation of these compounds has not been examined, yet.
Tetrahydropyridines can probably be distinguished in the same way. The tetrahy-
dropyridine fragmentation results in methylene-iminium ions (manuscript 1, page
183). In the case of tail-to-tail linked tetrahydropyridines, this fragmentation mech-
N N
H
N
9
COOH
NH
N9
+
m/z = 608
9
m/z = 339
NH39
m/z = 198
Figure 3.24 Fragmentation of tail-to-tail linked viscosaline C (18). Modified from
Timm. [84]
N
N
m
n
NH
N
n
Figure 3.25 Proposed fragmentation for tail-to-tail linked cyclostellettamines. Frag-
ment masses for n = 4: m/z = 283, n = 5: m/z = 297, n = 6: m/z = 311, n = 7:
m/z = 325, n = 8: m/z = 339.
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anism most likely results in fragments that contain two nitrogen atoms and are
thus discernible from their head-to-tail linked analogs by exact mass (Figure 3.26).
However, this proposed fragmentation needs to be experimentally confirmed.
Since the njaoaminiums B (41) and C (42) represent examples of 3-APAs with
branched alkyl chains, [95] also the possibility of methyl (and other homologously)
branched alkyl chains should be considered in this context. The molecular mass of
compounds with branched Cn alkyl chains does not differ from those with straight
Cn+1 alkyl chains. However, the fragmentation pattern is different by favoured
cleavage in proximity to the branch which allows the determination of the position
of e.g. methyl branches by mass spectrometric methods. In contrast to double
bonds, the position of methyl branches is stable inside an alkyl chain. Direct
σ-cleavage leads to a relative (though not diagnostic) increase in intensity of the
charge-retaining fragment mass peak while α-cleavage leads to loss of CnH2n and
CnH2n+1 fragments. [122]
None of the proposed fragments for tail-to-tail linked pyridinium or tetrahydropy-
ridine alkaloids are observed in the compound peaks resulting from LC-MS analysis
of the crude extract, nor is chain branching specific fragmentation observed in the
compounds. Therefore, the identification of new compounds bases on the known
structure of 3-APAs in Haliclona viscosa, i.e. head-to-tail linked compounds with
unbranched alkyl chains.
N
NH
m
n
N
HN
m
Figure 3.26 Proposed fragmentation for cyclic dimeric tail-to-tail linked haliclami-
nes. Fragment masses for m = 4: m/z = 183, m = 5: m/z = 197, m = 6: m/z = 211,
m = 7: m/z = 225, m = 8: m/z = 239.
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Haliclamine J (61)* — haliclamine 10/10 (0/0)
N
5
N
5
61
peak m/z mol. form. ∆m
C [M+H]+ 443.4370 C30H56N2 2.3 ppm
C [M+2H]2+ 222.2225 C30H57N2 3.7 ppm
F1/2 [M+H]+ 222.2225 C15H28N 3.7 ppm
F3 [M+H]+ 400.3949 C28H50N 2.7 ppm
F4 [M+H]+ 414.4104 C29H52N 2.4 ppm
C: compound masses, F: fragment masses
200 250 300 350 400 450 m z/
C [M+2H]2+
222.2225
C [M+H]+
443.4370
10.4%
31.1%
43
100%
Figure 3.27 Structural formula, compound and fragment masses and high resolution
mass spectrum for the peak at 13.8-14.0min, identified as haliclamine J (61). F1/2
= THP + alkyl chain type fragments, F3 and F4 = fragments derived from loss of
N -methylene methanamine and methanimine, respectively.
Compound 61 at a retention time of 13.8-14.0min shows a singly charged pseudo-
molecular ion [M+H]+ at m/z = 443.4370 and a doubly charged pseudomolecular
ion [M+2H]2+ at m/z = 222.2225 corresponding to the molecular formula C30H55N2
[M]. The same molecular formula and similar masses are assigned to haliclamine C
(27), but 27 elutes at a retention time of 14.0-14.2min. Haliclamine C (27) contains
two alkyl chains of 9 and 11 methylene groups, respectively. The high resolution
mass spectrum of haliclamine C (27) shows mass peaks of two fragments F1 at
m/z = 208.2090 and F2 at m/z = 236.2331 which represent the mass equivalent of a
THP moiety connected to either alkyl chain. In the mass spectrum of compound 61
the fragments superimpose with the doubly charged pseudomolecular ion peak which
suggests the alkyl chains to be of equal length of 10 methylene groups. This is sup-
ported by the observed relative isotope peak intensity (PI, given in % relative to the
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monoisotopic peak) of the doubly charged pseudomolecular ion which deviates from
the calculated PI as well as the observed isotope pattern (see inlay in Figure 3.27).
While the calculated isotope PI is 100 : 33.3 : 5.5, the observed PI is 100 : 31.1 : 10.4.
The increase in intensity of the X+2 isotope peak of the doubly charged ion is caused
by an underlying X+1 isotope peak of the singly charged fragment F1/2. The X+2
isotope peak of F1/2 consequently lies at m/z = 224.2244. Both results suggest that
compound 61 should be a haliclamine 10/10 with saturated alkyl chains (0/0).
Apart from the main fragments that constitute the mass equivalent of a THP moi-
ety connected to either alkyl chain, the mass spectrum shows incipient fragmentation
that is discussed in manuscript 1 (page 183). The fragment F3 that derives from
loss of N -methylene methanamine (∆m/z = 43) is present at m/z = 400.3949 while
the fragment F4 that emerges from loss of methanimine (∆m/z = 29) is present at
very low intensity at m/z = 414.4104.
Haliclamine K (62)* — haliclamine 10/12 (0/0)
Compound 62 elutes at 17.0-17.3min and shows a singly charged pseudomolecular
ion [M+H]+ atm/z = 471.4699 and a doubly charged pseudomolecular ion [M+2H]2+
at m/z = 236.2385. This corresponds to a molecular formula of C32H60N2 [M], the
same as has been established for haliclamine F (30) which elutes at a retention time of
16.8-17.0min. With the alkyl chains of haliclamine F (30) being of equal length of 11
methylene groups the fragments that represent the THP moiety connected to an alkyl
chain concur with the doubly charged pseudomolecular ion. In the mass spectrum
of compound 62 however, two fragment peaks are visible at m/z = 222.2218 and
m/z = 250.2538. They correspond to fragments that carry alkyl chains of 10 and 12
methylene groups, respectively.
The fragment masses that correspond to the loss of N -methylene methanamine
(F3) and methanimine (F4) are visible at m/z = 428.4253 and m/z = 442.4423,
respectively. Both new haliclamines with saturated alkyl chains must be confirmed
by further chromatographic, MS and NMR experiments (manuscript draft on page
223).
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N
7
N
5
62
peak m/z mol. form. ∆m
C [M+H]+ 471.4699 C32H61N2 5.5 ppm
C [M+2H]2+ 236.2385 C32H62N2 5.2 ppm
F1 [M+H]+ 222.2218 C15H28N 0.7 ppm
F2 [M+H]+ 250.2538 C17H32N 3.5 ppm
F3 [M+H]+ 428.4253 C30H54N 0.5 ppm
F4 [M+H]+ 442.4423 C31H56N 3.6 ppm
C: compound masses, F: fragment masses
200 250 300 350 400 450 m z/
C [M+H]+
471.4699
C [M+2H]2+
236.2385
F [M+H]1
+
222.2218
F [M+H]2
+
250.2538
43
Figure 3.28 Structural formula, compound and fragment masses and high resolution
mass spectrum for the peak at 17.0-17.3min, identified as haliclamine K (62). F1/2
= THP + alkyl chain type fragments, F3 and F4 = fragments derived from loss of
N -methylene methanamine and methanimine, respectively.
3.3.3 Haliclamines with monounsaturated alkyl chains
Similar to haliclamines with saturated alkyl chains, double bonds may be assigned
to either THP + alkyl chain type fragment by the mass of the double bond carrying
fragment being two mass units lower than the corresponding fragment with saturated
chains.
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Dehydro-Haliclamine C (63)* — haliclamine 9/11 (0/1)
N
N
4
6
63
peak m/z mol. form. ∆m
C [M+H]+ 441.4214 C30H53N2 2.5 ppm
C [M+2H]2+ 221.2146 C30H54N2 3.6 ppm
F1 [M+H]+ 208.2090 C14H26N 4.5 ppm
F2 [M+H]+ 234.2228 C16H28N 5.0 ppm
F3 [M+H]+ 398.3794 C28H48N 3.2 ppm
F4 [M+H]+ 412.3938 C29H50N 3.7 ppm
C: compound masses, F: fragment masses
200 250 300 350 400 450 m z/
C [M+H]+
441.4214
43
C [M+2H]2+
221.2146
F1 [M+H]
208.2090
+ F2 [M+H]
234.2228
+
Figure 3.29 Structural formula, compound and fragment masses and high resolution
mass spectrum for the peak at 12.7-12.8min, identified as dehydro-haliclamine C (63).
F1/2 = THP + alkyl chain type fragments, F3 and F4 = fragments derived from loss
of N -methylene methanamine and methanimine, respectively. The exact position of
the double bond is not determined, yet.
Compound 63 elutes at a retention time of 12.7-12.8min. Its molecular mass is by two
mass units lower than the mass of haliclamine C (27) and J (61) and suggests that
the compound contains an additional double bond. With an additional double bond,
either chain fragment can be by two mass units lower than those of haliclamine C (27)
and J (61), resulting in possible fragment peaks at m/z = 208 & 234 for haliclamine
9/11 (0/1), m/z = 206 & 236 for haliclamine 9/11 (1/0) and m/z = 220 & 222
for haliclamine 10/10 (1/0). In the mass spectrum of compound 63, two distinct
fragment peaks are visible atm/z = 208.2090 andm/z = 234.2228. This corresponds
to alkyl chains of 9 and 11 methylene units with a double bond in the (CH2)11 alkyl
chain.
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Dehydro-Haliclamine D (64)* — haliclamine 10/11 (0/1)
N
N
5
6
64
peak m/z mol. form. ∆m
C [M+H]+ 455.4384 C31H55N2 5.2 ppm
C [M+2H]2+ 228.2229 C31H56N2 5.5 ppm
F1 [M+H]+ 222.2224 C15H28N 3.6 ppm
F2 [M+H]+ 232.2221 C16H28N 1.9 ppm
F3 [M+H]+ 412.3938 C29H50N 5.1 ppm
F4 [M+H]+ 426.4089 C30H52N 1.2 ppm
C: compound masses, F: fragment masses
C [M+H]+
455.4384
43
C [M+2H]2+
228.2229
F [M+H]
222.2224
1
+ F2 [M+H]
232.2221
+
200 250 300 350 400 450 m z/
Figure 3.30 Structural formula, compound and fragment masses and high resolution
mass spectrum for the peak at 14.3-14.5min, identified as dehydro-haliclamine D (64).
F1/2 = THP + alkyl chain type fragments, F3 and F4 = fragments derived from loss
of N -methylene methanamine and methanimine, respectively. The exact position of
the double bond is not determined, yet.
Compound 64 elutes at a retention time of 14.3-14.5min and shows a molecular
mass that is two mass units lower than that of haliclamine D (28) or of a potential
haliclamine 9/12. The mass suggests a double bond in one of the chains. This
would result in fragment peaks at m/z = 222 & 234 for haliclamine 10/11 (0/1),
m/z = 220 & 236 for haliclamine 10/11 (1/0), m/z = 208 & 244 for haliclamine 9/12
(0/1) or m/z = 206 & 248 for haliclamine 9/12 (1/0). The fragments observed in
the mass spectrum of compound 64 are m/z = 222.2224 and m/z = 234.2221 and
therefore correspond to a haliclamine with alkyl chains of 9 and 11 methylene groups
of which the (CH2)11 alkyl chain contains a double bond.
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Dehydro-Haliclamine F (65)* — haliclamine 11/11 (1/0)
N
N
6
6
65
peak m/z mol. form. ∆m
C [M+H]+ 469.4537 C32H57N2 4.5 ppm
C [M+2H]2+ 235.2310 C32H58N2 6.4 ppm
F1 [M+H]+ 234.2222 C16H28N 2.6 ppm
F2 [M+H]+ 236.2331 C16H30N 9.7 ppm
F3 [M+H]+ 426.4094 C30H52N 4.7 ppm
F4 [M+H]+ 440.4200 C31H54N 11.6 ppm
C: compound masses, F: fragment masses
C [M+H]+
469.4537
43
C [M+2H]2+
235.2310
F1 [M+H]
234.2222
+
F2 [M+H]
236.2331
+
200 250 300 350 400 450 m z/
100%
35.2%
9.6%
Figure 3.31 Structural formula, compound and fragment masses and high resolution
mass spectrum for the peak at 15.8min, identified as dehydro-haliclamine F (65).
F1/2 = THP + alkyl chain type fragments, F3 and F4 = fragments derived from loss
of N -methylene methanamine and methanimine, respectively. The exact position of
the double bond is not determined, yet.
Compound 65 elutes at a retention time of 15.8min and has a molecular mass that
is two mass units lower than that of haliclamine F (30) and K (62). Compound 65
shows fragment peaks at m/z = 234.2222 and m/z = 236.2331, with the latter being
overlaid by the doubly charged pseudomolecular ion but clearly identified by the
peak pattern (figure 3.31) and the elevated X+2 isotope peak of the doubly charged
pseudomolecular ion (PI calcd. 100 : 35.6 : 6.4; found 100 : 35.2 : 9.6). Fragment peaks
that correspond to haliclamine 10/12 (1/0, m/z = 220 & 250) or haliclamine 10/12
(0/1, m/z = 222 & 248) are missing.
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Dehydro-Haliclamine J (66)* — haliclamine 10/10 (1/0)
N
N
5
5
66
peak m/z mol. form. ∆m
C [M+H]+ 441.4216 C30H53N2 2.9 ppm
C [M+2H]2+ 221.2155 C30H54N2 7.6 ppm
F1 [M+H]+ 220.2076 C15H26N 7.4 ppm
F2 [M+H]+ 222.2203 C15H28N 5.9 ppm
F3 [M+H]+ 398.3796 C28H48N 3.6 ppm
F4 [M+H]+ 412.3898 C29H50N 9.7 ppm
C: compound masses, F: fragment masses
C [M+H]+
441.4216
43
C [M+2H]2+
221.2155
200 250 300 350 400 450 m z/
F
220.2076
1 [M+H]
+
32.9%
11.5%
100%
F
222.2203
2 [M+H]
+
Figure 3.32 Structural formula, compound and fragment masses and high resolution
mass spectrum for the peak at 13.0min, identified as dehydro-haliclamine J (66). F1/2
= THP + alkyl chain type fragments, F3 and F4 = fragments derived from loss of
N -methylene methanamine and methanimine, respectively. The exact position of the
double bond is not determined, yet.
Compound 66 elutes at a retention time of 13.0min and shows very similar molecular
masses as dehydro-haliclamine C (63) which results in the same molecular formula of
C30H52N2 [M] as for dehydro-haliclamine C (63). Since dehydro-haliclamine C (63)
is assigned to the peak at 12.7-12.8min, this new compound 66 is likely to represent
haliclamine 9/11 (1/0) or haliclamine 10/10 (1/0). Haliclamine 9/11 (1/0) requires
fragment peaks of m/z = 206 & 234 and while m/z = 236.2234 can be found, the
m/z = 206 peak is missing. Haliclamine 10/10 (1/0) requires fragment peaks of
m/z = 220 & 222. Both can be found in the compound spectrum; m/z = 220.2076
and m/z = 222.2203. However, the m/z = 222 peak is overlaid by the doubly
charged pseudomolecular ion. A comparison of the peak intensities between the
calculated and the effective doubly charged pseudomolecular ion yields a significantly
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enlarged X+2 doubly charged pseudomolecular ion isotope peak; instead of an
isotope PI ratio of 100 : 33.8 : 5.5, the doubly charged pseudomolecular ion shows an
isotope ratio of 100 : 32.9 : 11.5. Thus compound 66 is assigned as the haliclamine
10/10 (1/0) isomer.
Ambidehydro-Haliclamine F (67)* — haliclamine 11/11 (1/1)
N
4
4
N
67
peak m/z mol. form. ∆m
C [M+H]+ 467.4376 C32H55N2 3.5 ppm
C [M+2H]2+ 234.2222 C32H56N2 2.3 ppm
F1/2 [M+H]+ 234.2222 C16H28N 2.3 ppm
F3 [M+H]+ 424.3960 C30H50N 5.3 ppm
F4 [M+H]+ 438.4087 C31H52N 1.8 ppm
C: compound masses, F: fragment masses
C [M+H]+
467.4376
43
C [M+2H]2+
234.2222
200 250 300 350 400 450 m z/
F
234.2222
1/2 [M+H]
+
100%
34.4%
12.9%
Figure 3.33 Structural formula, compound and fragment masses and high resolution
mass spectrum for the peak at 14.7-14.8min, identified as ambidehydro-haliclamine F
(67). F1/2 = THP + alkyl chain type fragments, F3 and F4 = fragments derived from
loss of N -methylene methanamine and methanimine, respectively. The exact position
of the double bonds is not determined, yet.
Compound 67 elutes at a retention time of 14.7-14.8min. The molecular mass of
the compound mass lies four mass units below the mass of haliclamine F (30) and K
(62) and suggests two double bonds. They may be located one in each alkyl chain
or both in either alkyl chain, leaving a number of possibilities for fragment masses;
m/z = 236 & 232 for haliclamine 11/11 (0/2), m/z = 234 & 234 for haliclamine 11/11
(1/1), m/z = 218 & 250 for haliclamine 10/12 (2/0), m/z = 222 & 246 for haliclamine
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10/12 (0/2), and 220 & 248 for haliclamine 10/12 (1/1). None of these masses can
be found in the compound spectrum with the exception of m/z = 234.2222 which
constitutes the doubly charged pseudomolecular ion. However, the peak pattern and
the peak integrals confirm that a singly charged peak representing the molecular
formula C16H28N underlies the pseudomolecular ion (PI calcd. 100 : 35.9 : 6.3, found
100 : 34.4 : 12.9, X+2 isotope peak at m/z = 236.2234). Compound 67 can therefore
be assigned as haliclamine 11/11 with a double bond in each alkyl chain.
3.3.4 Haliclamines with bisunsaturated alkyl chains
Didehydro-Haliclamine D (68)* — haliclamine 10/11 (0/2)
N
N
3
4
68
peak m/z mol. form. ∆m
C [M+H]+ 453.4164 C31H53N2 8.7 ppm
C [M+2H]2+ 227.2095 C31H54N2 13.7 ppm
F1 [M+H]+ 222.2187 C15H28N 13.1 ppm
F2 [M+H]+ 232.2048 C16H26N 19.4 ppm
F3 [M+H]+ 410.3738 C29H48N 10.6 ppm
F4 [M+H]+ 424.3901 C30H50N 8.6 ppm
C: compound masses, F: fragment masses
C [M+H]+
453.4164
43
C [M+2H]2+
227.2095
F [M+H]
222.2187
1
+ F2 [M+H]
232.2048
+
200 250 300 350 400 450 m z/
Figure 3.34 Structural formula, compound and fragment masses and high resolution
mass spectrum for the peak at 13.8min, identified as didehydro-haliclamine F (68).
F1/2 = THP + alkyl chain type fragments, F3 and F4 = fragments derived from loss
of N -methylene methanamine and methanimine, respectively. The exact position of
the double bonds is not determined, yet.
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Compound 68 that is present at low abundance in Haliclona viscosa sampled in 1999
and in the 2009 cave sample elutes at a retention time of 13.8min. The molecular
masses correspond to the molecular formula C31H52N2 [M] and lie four mass units
lower than the molecular mass of haliclamine D (28). Four mass units difference
suggest the presence of two additional double bonds which, as before, may be located
together in either alkyl chain or one in each chain. This leaves the fragment masses
m/z = 220 & 234 for haliclamine 10/11 (1/1), m/z = 218 & 236 for haliclamine
10/11 (2/0), and m/z = 222 & 232 for haliclamine 10/11 (0/2) as possibilities for
compound 68. While neither m/z = 220 nor m/z = 234, m/z = 218 and m/z = 236
can be observed in the compound mass spectrum, the masses m/z = 222.2187 and
m/z = 232.2048 are present. They represent a saturated alkyl chain of 10 methylene
units and a bisunsaturated alkyl chain of 11 carbons. This defines the compound as
haliclamine 10/11 (0/2).
3.3.5 Viscosalines
In addition to viscosaline C (18) which was originally reported by Volk under
the name "viscosaline" but later termed "C" for its corresponding chain lengths to
cyclostellettamine C (33), Timm [84] suggests two additional viscosalines, viscosaline
B and E which each occur in two isomeric constitutions, B1 (19), B2 (20), E1 (21)
and E2 (22). [123]
Timm does not succeed in differentiating the constitutional isomers in HPLC-
HRMS experiments since the chromatographic separation is not successful. Also
the mass spectrometric analysis of synthetically prepared isomers does not give
unambiguous results in the context of assigning the position of the alkyl chains.
His final discrimination of the four viscosalines builds on a derivatization approach;
he derivatizes the synthetically prepared isomers prior to MS measurement which
allows him to determine isomer-specific fragments. Derivatization of the viscosaline
B- and E-containing fractions of the H. viscosa crude extract and subsequent HPLC-
HRMS measurement yields baseline separated compound peaks which each show
isomer-specific fragments. From this he draws the conclusion that both isomers of
viscosaline B and E are present in the crude extract. Achim Grube, a former PhD
student in the Köck research group, later succeeds in separating and differentiating
the underivatized, synthetic isomers by HPLC. [123]
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Figure 3.35 Proposed fragmentation of viscosaline E1 (21) under CID-MS condi-
tions in an ion trap mass spectrometer. [123]
Grube also investigates the fragmentation pattern of the synthetic viscosalines
under CID-MSn conditions in an ion trap mass spectrometer. He states that
fragmentation of the singly charged molecular ion results in an initial loss ofm/z = 72
which he attributes to a simultaneous loss of CO2 and ethene. Subsequently, a
fragmentation into the Pyr + alkyl chain type fragments also observed during
fragmentation of the cyclostellettamines (Figure 3.35) occurs for which a neutral
loss of NH3 (m/z = 17) has to proceed. [117] However, with both Pyr + alkyl chain
type fragments of viscosalines with dissimilar chain lengths co-existing in the same
mass spectrum it is not possible to assign the position of the two alkyl chains.
In a different approach he uses a reduced trap drive level (analogous to in-source-
CID, see Section 3.3.2 and manuscript 1 on page 183) which results in increased
fragmentation prior to the entrance of the ions into the ion trap. Thus, a number of
fragments become visible in the full scan spectrum apart from the Pyr + alkyl chain
type fragments that aid in structure assignment. In viscosaline E1 (21), a doubly
charged m/z = 281.8 derives from the singly charged precursor m/z = 622.5 by an
α-cleavage inside the amino acid moiety. This unusual event of a doubly charged
progeny emerging from a singly charged precursor is explained by the nature of the
precursor; it persists as a zwitterion and carries an additional charged pyridinium
nitrogen; cleavage of the negatively charged part of the zwitterion results in the
double positively charged ion m/z = 281.8 (Figure 3.36). Accordingly, the fragment
m/z = 281.8 may occur in two different forms in which the charges are located at
different nitrogen atoms .
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Figure 3.36 Proposed fragmentation of viscosaline E1 (21) under in-source-CID +
MSn conditions in an ion trap mass spectrometer. Modified from Timm et al. [123]
Trapping and fragmentation of the doubly charged m/z = 281.8 of viscosaline
E1 (21) results in the singly charged fragments m/z = 260.3, m/z = 303.3 and
m/z = 519.5. Of these fragments, only m/z = 303.3 is a characteristic fragment by
which the constitution of the viscosalines can be assigned. This fragment represents
a pyridine moiety connected in position 3 to an imine-carrying C14 alkyl chain;
the imine derives from α cleavage inside the amino acid residue. This fragment
is characteristic for viscosaline E1 (21) where the amino acid connecting alkyl
chain carries 14 methylene groups (Figure 3.36). The corresponding singly charged
imine fragments for C13 and C12 alkyl chains are m/z = 289.2, m/z = 275.3,
respectively. [123]
It should be noted, however, that this fragmentation (as well as any other fragmen-
tation method used to differentiate the viscosaline isomers), still requires a preceding
separation of the isomers.
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N
N
H2
N
O
O
11
11
18
peak m/z mol. form. ∆m
C [M]+ 608.5172 C39H67N3O2 3.7 ppm
C [M+H]2+ 304.7621 C39H68N3O2 3.2 ppm
C [M+2H]3+ 203.5130 C39H69N3O2 15.6 ppm
F1 [M+H]2+ 260.2376 C36H60N2 1.3 ppm
F2 [M+H]2+ 274.7509 C37H63N3 22.3 ppm
F2 [M+2H]3+ 183.5018 C37H64N3 1.3 ppm
C: compound masses, F: fragment masses
200 250 300 350 400 450 500 550 600 m z/
C [M]+ 608.5172
C [M+H]
304.7621
2+
C [M+2H]
203.5130
3+
F
260.2376
1
2+
F
183.5018
2
3+
F
274.7509
2
2+
7.008
7.007
7.008
7.008
7.0077.009
7.004
7.0097.006
7.009
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7.007
F2
3+ C3+ F1
2+
150
Figure 3.37 Structural formula, compound and fragment masses and high resolution
mass spectrum for viscosaline C (18). The region important to determine the alkyl
chain cleavage is expanded. F1 = fragment mass derived from β-alanine loss, F2
= fragment masses derived from acetate loss. The decreasing mass accuracy with
decreasing m/z is due to instrument and method settings.
By improvement of the chromatographic separation within the presented thesis
it is possible to discriminate the constitutional isomers viscosaline B1 (19) and B2
(20) as well as E1 (21) and E2 (22) already in the crude extract, without prior
derivatization, and without tandem mass spectrometry experiments. By the use
of a "softer" fragmentation method than in the original publication of viscosaline
C (18) and Timm’s thesis, the compounds show a slightly different fragmentation
pattern which is helpful in discriminating the isomers. The most apparent difference
to the published mass spectrum is an observable alkyl chain cleavage in the chain
that carries the amino acid residue. This cleavage is important when determining
the length of the alkyl chain that carries the amino acid. It is especially helpful
in viscosalines with dissimilar chain lengths or when determining the alkyl chain
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affiliation of a possible double bond. This new fragmentation pathway is discussed
again in the following for viscosaline C (18).
Viscosaline C (18) elutes at a retention time of 16.4-16.8min. It is one of the
major compounds in H. viscosa samples. The HRMS (ESI+) spectrum of viscosaline
C (18) shows a number of characteristic peaks. On one hand, the singly, doubly
and triply charged molecular ions assign the molecular formula C39H66N3O2 ([M],
Figure 3.37).
In addition, the spectrum shows a doubly charged fragment F1 at m/z = 260.2376,
and a corresponding singly charged ion at m/z = 519.4665 present at very low
intensity. The fragment m/z = 260 could be mistaken for an overlaid cyclostellett-
amine C (33) peak. Since cyclostellettamine C (33) elutes at a different retention
time, the fragment peak can be assigned to viscosaline C (18) that has lost the
β-alanine unit; this is achieved by an α-cleavage inside the amino acid to split
off acetate, followed by an onium reaction to yield fragment 69 (Figure 3.39).
Starting at the doubly charged fragment F1, the fragments of a successive loss of
14 mass units (typical for alkyl chain cleavage) are clearly visible as the doubly
charged m/z = 253.2304, m/z = 246.2237, m/z = 239.2148, etc. This alkyl chain
cleavage can be followed, though at lower intensity than the molecular and main
fragment masses, to the doubly charged m/z = 176.1472 which corresponds to
3-methyl-1-(13-(pyridinium-1-yl)tridecyl)pyridinium (70).
Another characteristic fragment, F2, constitutes the triply chargedm/z = 183.5018
(71). This fragment represents viscosaline C (18) in which acetate is lost from the
β-alanine carrying alkyl chain by an α-cleavage. The corresponding doubly charged
fragment is visible at m/z = 274.7509 (Figure 3.37). A cleavage of the second alkyl
chain is not observed; splitting off the pyridinium moiety, probably by an α-cleavage,
N
NH7
7
69, F1
m/z = 260.2376
N
NH7
70, m/z = 176.1472
N
NH7
N
H7
71, F2
m/z = 183.5018
Figure 3.38 Structure of fragments in the MS-spectrum of viscosaline C (18).
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m/z = 608.5 [M]+
m/z = 304.8 [M+H]2+
m/z = 203.5 [M+2H]3+
N
N
H
N
10
9
m/z = 274.8 [M+H]2+
m/z = 183.5 [M+2H]3+
N
N
10
9
m/z = 519.5 [M]+
m/z = 260.2 [M+H]2+
N
NH9
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m/z = 176.1 [M+H]2+
O
O
6971
alkyl chain
cleavage
N
H
10
NH9
m/z = 274.2 [M+H]+
m/z = 260.3 [M+H]+
Figure 3.39 Proposed fragmentation pathway of viscosaline C (18) under in-source-
CID conditions.
would result in a loss of m/z = 92 leading to the fragments m/z = 530 [M]+ and
m/z = 265 [M+H]2+. These fragments are not present in the spectrum.
Cleavage of one 3-alkyl pyridine moiety results in a singly charged fragment 72 at
m/z = 349 which is present as m/z = 349.2833 (C21H37N2O2, ∆m = 4.8 ppm) in
the spectrum at very low intensity. Thus it can be concluded that the cleavage of
the amino acid carrying alkyl chain is the predominant fragmentation process under
the applied instrument settings.
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N
H
N
H2
O
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7
72, m/z = 349.2833
Figure 3.40 Proposed fragment that derives from
loss of a 3-alkyl pyridine moiety.
Viscosaline B1 (19) — viscosaline 12/13 (0/0)
N
N
N
H2
O
O
6
7
19
peak m/z mol. form. ∆m
C [M]+ 594.4949 C38H64N3O2 7.4 ppm
C [M+H]2+ 297.7529 C38H65N3O2 1.5 ppm
C [M+2H]3+ 198.8413 C38H66N3O2 16.7 ppm
F1 [M+H]2+ 253.2294 C35H58N2 0.3 ppm
F2 [M+H]2+ 267.7386 C36H61N3 15.3 ppm
F2 [M+2H]3+ 178.8354 C36H62N3 22.3 ppm
C: compound masses, F: fragment masses
150 200 250 300 350 400 450 500 550 m z/
Haliclamine D ( )28
Haliclamine D ( )28
C [M+2H]
198.8408
3+
C [M+H]
297.7537
2+
C [M] 594.5010+
F2
3+
F1
2+
F2
2+
7.008
7.008
7.008
7.007
7.009
7.007
7.009
7.008
7.0077.006
7.008
7.007
28
F2
3+
C3+
F2
2+
F1
2+
Figure 3.41 Structural formula, compound and fragment masses and high resolution
mass spectrum for viscosaline B1 (19). The region important for determining the
alkyl chain cleavage is expanded. F1 = fragment mass derived from β-alanine loss, F2
= fragment masses derived from acetate loss.
Compound 19 elutes at a retention time of 15.2min and is overlaid by haliclamine
D (28). The molecular masses (see Figure 3.41) yield a molecular formula of
C38H63N3O2 which is by CH2 lower than viscosaline C (18). This suggests a
viscosaline with one chain shortened by one methylene group as compared to
viscosaline C (18).
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Two constitutional isomers are supposable in this case; one is a viscosaline 12/13
(19, viscosaline B1), where the chain that connects the two pyridinium moieties
contains 12 methylene groups while the alkyl chain that carries the β-alanine moiety
is 13 methylene groups long; the other is a viscosaline 13/12 (20, viscosaline B2)
where the pyridinium moiety connecting chain carries 13 methylene units and the
β-alanine carrying chain comprises 12 methylene groups. Both isomers are difficult
to distinguish in mass spectra since the fragments that result from loss of an acetate-
or the cleavage of the β-alanine moiety lead to fragments of equal mass in both
isomers. The only mass by which the isomers can be distinguished is the fragment
73 which should be a doubly charged m/z = 169.1 (n = 6) in viscosaline B1 and a
doubly charged m/z = 176.1 (n = 7) in viscosaline B2.
N
N
N
H2
O
O
6
7
19
N
NHn
73
Figure 3.42 Viscosaline B1 (19) and the doubly charged fragment 73 that derives
from alkyl chain cleavage of the F1 fragment.
The doubly charged fragment that emerges from the loss of a β-alanine unit by α
cleavage and onium reaction is present at m/z = 253.2294. From there, the alkyl
chain fragmentation can be followed to a doubly charged m/z = 169.1 which assigns
viscosaline 12/13 (0/0). This does not rule out the possibility of a viscosaline 13/12
(0/0) being contained in the same spectrum, since its fragments would superimpose
with those of compound 19, but it can be stated that viscosaline 12/13 (0/0) is
present in the chromatogram peak.
The fragments that results from the loss of an acetate moiety, m/z = 267.7386
[M+H]2+ and m/z = 178.8354 [M+2H]3+ are also clearly visible in the spectrum.
Viscosaline B2 (20) — viscosaline 13/12 (0/0)
The extracted ion chromatogram (EIC) for m/z = 594.5 (Figure 3.44) returns a
second compound in close proximity to compound 19 at a retention time of 15.3min.
Compound 20 is also overlaid by haliclamine D (28). The molecular masses (see
Figure 3.43) yield a molecular formula of C38H63N3O2 which is the same as compound
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19. From the retention time and the similarity in molecular masses (see Figure 3.41)
it is reasonable to expect that this is the isomer to 19, viscosaline 13/12 (0/0).
The doubly charged onium fragment lies at m/z = 253.2321. From there, the alkyl
chain cleavage can be followed to m/z = 176.1466 [M+H]2+ but not to m/z = 169.1
[M+H]2+. This rules out a viscosaline 12/13 and, as expected, assigns viscosaline
13/12 (20).
N
N
N
H2
O
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7
6
20
peak m/z mol. form. ∆m
C [M]+ 594.5010 C38H64N3O2 2.8 ppm
C [M+H]2+ 297.7537 C38H65N3O2 1.5 ppm
C [M+2H]3+ 198.8408 C38H66N3O2 14.2 ppm
F1 [M+H]2+ 253.2321 C35H58N2 1.7 ppm
F2 [M+H]2+ 267.7429 C36H61N3 0.5 ppm
F2 [M+2H]3+ 178.8348 C36H62N3 21.7 ppm
C: compound masses, F: fragment masses
150 200 250 300 350 400 450 500 550 m z/
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Figure 3.43 Structural formula, compound and fragment masses and high resolution
mass spectrum for viscosaline B2 (20). The region important for determining the
alkyl chain cleavage is expanded. F1 = fragment mass derived from β-alanine loss, F2
= fragment masses derived from acetate loss.
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Figure 3.44 Extracted ion chro-
matogram of m/z = 594.5 (blue) for
viscosalines B1 (19) and B2 (20) superim-
posed by the crude extract chromatogram
of the 2001 sample of Haliclona viscosa
(black). Both chromatograms are scaled to
100% intensity of the highest peak and do
not reflect true compound intensities.
14 16 18 20 min22
19
20
Viscosaline E1 (21) — viscosaline 13/14 (0/0)
N
N
N
H2
O
O
7
8
21
peak m/z mol. form. ∆m
C [M]+ 622.5315 C40H68N3O2 2.2 ppm
C [M+H]2+ 311.7703 C40H69N3O2 4.5 ppm
C [M+2H]3+ 208.1847 C40H70N3O2 14.4 ppm
F1 [M+H]2+ 267.2457 C37H62N2 2.1 ppm
F2 [M+H]2+ 281.7587 C38H65N3 1.2 ppm
F2 [M+2H]3+ 188.1789 C38H66N3 22.4 ppm
C: compound masses, F: fragment masses
C [M+2H]
208.1847
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Figure 3.45 Structural formula, compound and fragment masses and high resolution
mass spectrum for viscosaline E1 (21). The region important for determining the
alkyl chain cleavage is expanded. F1 = fragment mass derived from β-alanine loss, F2
= fragment masses derived from acetate loss.
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Compound 21 elutes at a retention time of 18.0min and coelutes with haliclocyclin
F1 (25). 21 is by one methylene group larger than viscosaline C (18).
Two constitutional isomers can be proposed for this compound; viscosaline 13/14
(0/0) and viscosaline 14/13 (0/0). The constitutional isomers can be distinguished
by their 73-type fragment which should have a mass of m/z = 176.1 [M+H]2+ for
viscosaline E1 or m/z = 183.1 [M+H]2+ for viscosaline E2.
In the mass spectrum of compound 21 the alkyl chain cleavage can be followed
to a doubly charged m/z = 176.1472, as before in viscosaline C (18). This does
not eliminate the alternative of viscosaline E2 (22) being contained in the same
compound peak since a fragment at m/z = 183 [M+H]2+ is part of the alkyl chain
cleavage of viscosaline E1 (21) but it can be concluded that the peak contains
viscosaline E1.
The fragments that results from the loss of an acetate moiety, m/z = 281.7587
[M+H]2+ and m/z = 188.1789 [M+2H]3+ are also clearly visible in the spectrum.
The peak that emerges from the loss of a β-alanine unit by α-cleavage and onium
reaction is present at m/z = 267.2457 [M+H]2+.
14 16 18 20 min22
21
22
Figure 3.46 Extracted ion chro-
matogram of m/z = 622.53 (blue) for
viscosalines E1 (21) and E2 (22) superim-
posed by the crude extract chromatogram
of the 2001 sample of Haliclona viscosa
(black). Both chromatograms are scaled to
100% intensity of the highest peak and do
not reflect true compound intensities. The
structure of the compounds at 17.6min
and 20.3min could not be determined, yet.
Viscosaline E2 (22) — viscosaline 14/13 (0/0)
The EIC of m/z = 622.53 (Figure 3.46) yields a second compound in close proximity
to the peak of compound 21 at a retention time of 18.1min. Apart from the singly
charged molecular ion, also the doubly and triply charged molecular ions as well
as the fragment ions have a similar mass as those observed in 21. From the close
retention time to the viscosaline 14/13 (0/0, 21) and the similarity in masses it
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peak m/z mol. form. ∆m
C [M+H]+ 622.5234 C40H68N3O2 11.6 ppm
C [M+2H]2+ 311.7653 C40H69N3O2 11.8 ppm
C [M+3H]3+ 208.1805 C40H70N3O2 5.7 ppm
F1 [M+2H]2+ 267.2458 C37H62N2 2.7 ppm
F2 [M+2H]2+ 281.7547 C38H65N3 12.9 ppm
F2 [M+3H]3+ 188.1709 C38H66N3 2.3 ppm
C: compound masses, F: fragment masses
Figure 3.47 Structural formula, compound and fragment masses and high resolution
mass spectrum for viscosaline E2 (22). The region important for determining the
alkyl chain cleavage is expanded. F1 = fragment mass derived from β-alanine loss, F2
= fragment masses derived from acetate loss.
is reasonable to expect that compound 22 is the constitutional isomer to 21. It
can be distinguished by the fragment 73 that derives from alkyl chain cleavage.
The doubly charged fragment F1 that arises from α-cleavage and subsequent onium
reaction of the β-alanine unit is found at m/z = 267.2458. The alkyl chain cleavage
emanating from this fragment can be followed to m/z = 183.1512 [M+H]2+ but
not to m/z = 176.1 [M+H]2+. This rules out a viscosaline E1 (21) and assigns
viscosaline E2 (22).
Dehydro-Viscosaline E1 (74)* — viscosaline 13/14 (0/1)
Compound 74 elutes at a retention time of 17.7 min where it coelutes with haliclamine
F (30). The characteristic molecular ion pattern and the m/z = 7 fragmentation
indicates that the compound is a viscosaline. The molecular mass is two mass units
lower than compound 21 and 22 which suggests a double bond in one of the alkyl
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chains. The alkyl chain fragmentation can be followed from the doubly charged
m/z = 266.2367 to a doubly charged ion at m/z = 176.1482 which assigns the
viscosaline as a viscosaline 13/14 (0/1). Viscosaline 13/14 (1/0) would be given by
a doubly charged fragment m/z = 175.6, viscosaline 14/13 (0/1) by m/z = 183.2
and viscosaline 14/13 (1/0) by m/z = 182.7. 74 constitutes a previously unreported
compound.
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peak m/z mol. form. ∆m
C [M]+ 620.5130 C40H66N3O2 3.1 ppm
C [M+H]2+ 310.7608 C40H67N3O2 0.9 ppm
C [M+2H]3+ 207.5116 C40H68N3O2 8.3 ppm
F1 [M+H]2+ 266.5116 C37H60N2 2.0 ppm
F2 [M+H]2+ 280.7502 C38H63N3 8.3 ppm
F2 [M+2H]3+ 187.5057 C38H64N3 4.0 ppm
C: compound masses, F: fragment masses
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Figure 3.48 Structural formula, compound and fragment masses and high resolution
mass spectrum for dehydro-viscosaline E1 (74). The region important for determining
the alkyl chain cleavage is expanded. F1 = fragment mass derived from β-alanine loss,
F2 = fragment masses derived from acetate loss. Dashed bonds indicate the range for
the likely position of the double bond.
By following the fragmentation steps of the alkyl chain which is represented by
∆m/z = 7.007 (calcd.) steps for methylene groups in doubly charged compounds,
the double bond can be identified by the ∆m/z = 5.999 (calcd.) mass difference.
While the H-shift mentioned above hinders the exact localization, it is possible to
assign the range in which the doubly bond is likely to occur. The spectrum of
compound 74 (Figure 3.48) displays four groups of doubly charged peaks that have a
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distance of both m/z = 7 and m/z = 6 to their preceding or following alkyl cleavage
peak group. Each group shows two doubly charged peaks that are 2 mass units
(or m/z = 1) apart. The first group lies at m/z = 260.2372 and m/z = 259.2287,
the second at m/z = 253.2231 and m/z = 252.2217, the third at m/z = 246.2150
and m/z = 245.2077 and the fourth at m/z = 239.2068 and m/z = 238.2041. The
first pure ∆m/z = 7 cleavage peak lies at m/z = 232.2052. This locates the double
bond between position 34 and 39 (Figure 3.48). However, a significant shift in the
intensity of the fragments occurs between m/z = 259.2287 and m/z = 252.22174.
This suggests that the favoured fragmentation, which is probably promoted by the
double bond, produces the fragment m/z = 259. This fragment corresponds an
alkyl chain length of 13 methylene units and tentatively assigns the double bond to
position 38− 39, i.e. in conjugation to the amide nitrogen. However, further mass
spectrometric analysis and possibly derivatization of the double bond is necessary
to give a clear picture, since also viscosalines with saturated alkyl chains show this
shift in intensity of the fragments.
3.3.6 Viscosamines
Viscosamine C (43), termed "C" for its chain lengths that correspond to cyclostellett-
amine C (33), elutes at a retention time of 19.8min. It is the most abundant of the
viscosamines and was reported before. [96]
The most pronounced mass peak in the spectrum of viscosamine C (43) is the triply
charged molecular ion [M]3+ at m/z = 260.2382. In addition, the compound shows
a number of characteristic fragment (F) and adduct/salt (A) peaks. Two doubly
charged ions of almost equal intensity lie at m/z = 390.2350 and m/z = 412.8512.
The sum formula assigned to the fragment ion F1 at m/z = 390 holds one hydrogen
more and one charge less than that of the molecular ion (Figure 3.49). This is
reminiscent of the cyclostellettamine fragmentation under in-source-CID conditions,
where one fragment contained one charge less than the precursor ion and one
hydrogen more. In cyclostellettamines, this fragment appears only in orthogonal
time of flight (oTOF) mass spectrometry measurements under concomitance of
formic acid and is assigned as a reduced form of a Hofmann fragment (Figure
3.50). [117] Since the HPLC-HRMS measurements of Haliclona viscosa crude extracts
use similar MS conditions, the same mechanism can be proposed for viscosamine
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peak m/z mol. form. ∆m
C [M]3+ 260.2382 C54H90N3 3.4 ppm
F1 [M+H]2+ 390.8637 C54H91N3 6.5 ppm
F2 [M+H]2+ 389.8637 C54H89N3 5.5 ppm
A1 [M+H]2+ 412.8512 C55H91N3O2 4.9 ppm
A2 [M+H]2+ 446.8519 C56H90N3F3O2 7.1 ppm
C: compound masses, F: fragment, A: adduct/salt
C: 260.2382 [M]3+ F [M+H]1
2+:
390.8637
A :1 [M+H]
412.8512
2+
200 250 300 350 400 450 m z/
21.9943
F2: [M+H]
389.8637
2+
Dehydro-Viscosamine
D ( )83
56.9975
A :2 [M+H]
446.8519
2+
Figure 3.49 Structural formula, compound masses and high resolution mass spec-
trum for viscosamine C (43). The compound coelutes with dehydro-viscosamine D
(83). The peak area of fragments and adducts/salts is expanded.
C (43) to explain the fragment at m/z = 390. It results in an opening of the
macrocycle and the loss of one charge (75).
The mass difference between the doubly charged F1 fragment ion m/z = 390
and the second doubly charged ion of similar intensity, A1 at m/z = 412, is
m/z = 21.9943. This correlates very well to CO2 (calcd. m/z = 21.9944, ∆m =
3.0 ppm). Carbon dioxide may be derived from reaction with the formic acid that
is simultaneously involved in reduction of the Hofmann fragment to form 75. [117]
Formation of adduct ions is favoured in ESI-MS as compared to EI-MS due to the
lower energy used for ionisation that increases the lifetime of the collision complex.
While CO2 adducts are not typical during LC-MS experiments and not stable in
nature, Villiers et al. [124] have very recently isolated a CO2 adduct of a nitrogen base
for the first time. Similar to the structure described by Villiers et al., the pyridine
nitrogen in 75 may be involved in binding CO2, which would result in an adduct 76.
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Figure 3.50 Viscosamine C fragment 75 derived from reduction of the Hofmann
fragment 77 and possible CO2 adduct (76).
The doubly charged ion at m/z = 412 also shows a mass difference of m/z =
23.0029 to a third characteristic doubly charged ion F2 at m/z = 389.8451. The F2
ion is two mass units lower than the F1 ion and constitutes the Hofmann fragment
77 that is also observed in the related cyclostellettamines. [117,125] The mass difference
of m/z = 23 can be attributed to formic acid (calcd. m/z = 23.0022) with a mass
deviation of 30.8 ppm. Therefore it remains unresolved whether m/z = 412 is the
CO2 adduct of 75 or the formic acid salt of 77, or both.
The formic acid salt 78 is supported by the presence of a fourth characteristic
doubly charged ion A2 at m/z = 446.8519 which is only present at very small
intensity. A2 shows a mass difference of m/z = 56.9975 to the F2 ion which
tentatively assigns a trifluoroacetic acid (TFA) salt (79, calcd. m/z = 56.9959) with
an accuracy of 28.4 ppm.
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Figure 3.51 Hofmann fragment (77) of viscosamine C and possible formic acid (78)
and trifluoroacetic acid salt (79).
While formic acid is introduced into the sample during chromatographic separation,
the presence of TFA is unresolved, yet. The crude extract had not been in contact
71
3 Haliclona viscosa
with TFA. Other ions that could be present in the instrument e.g. sodium formate
clusters from calibration, do not satisfy the observed mass difference. If the observed
ion is a TFA salt, it must be concluded that TFA is present as residual impurities in
glassware or the instrument and thus contaminates the sample. However, that raises
the question why TFA salts are not observed in the mass spectra of other 3-APAs
identified in the same crude extract of Haliclona viscosa. Since TFA is unlikely to be
the natural counterion of 3-APAs in the sponge, it is therefore reasonable to assume
that the mass difference of m/z = 56.9959 derives from a different, yet unidentified
counterion. For example, fumaric acid (M=116) which is a natural biosynthesis
byproduct, is close in mass to the molecular mass of TFA. MALDI-MS is a method
that requires little sample preparation and is therefore closer to showing the natural
state of the molecule than other, laboratory-intensive sample processing methods.
Thus, MALDI-MS could be a useful tool to elucidate the structure of the natural
counterion. Until further results are available, the ion observed in the spectrum of
the viscosamine C (43) must be regarded as the TFA salt.
The masses given in the original publication of viscosamine C (43) in part differ
from the masses observed during LC-MS analysis of the H. viscosa crude extract. [96]
These differences are due to different mass spectrometers used for the analysis and
the workflow of isolating the compound. The original publication of viscosamine C
(43) agrees in the triply charged molecular ion [M]3+ at m/z = 260, the Hofmann
fragment at m/z = 389 [M+H]2+ and the TFA salt at m/z = 446 [M+H]2+.9 Instead
of the formic acid salt it shows an acetic acid salt at m/z = 419 [M+H]2+. The
reduced Hofmann fragment at m/z = 390 [M+H]2+ is not observed in the original
publication.
9 It should be noted that in this case, TFA was introduced during chromatographic purification
of the isolated compound.
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Viscosamine B (80) — viscosamine 12/13/13 (0/0/0))
N
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peak m/z mol. form. ∆m
C [M]3+ 255.5668 C53H88N3 5.4 ppm
F1 [M+H]2+ 383.8550 C53H89N3 7.1 ppm
F2 [M+H]2+ 382.8463 C53H87N3 4.7 ppm
A1 [M+H]2+ 405.8508 C54H89N3O2 8.8 ppm
A2 [M+H]2+ 439.8459 C55H88N3F3O2 11.4 ppm
C: compound masses, F: fragment, A: adduct/salt
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Cyclostellettamine C ( )33
Figure 3.52 Structural formula, compound masses and high resolution mass spec-
trum of the peak at 18.9min, identified as viscosamine B (80). The compound coelutes
with cyclostellettamine C (33). The peak area of the fragments and adducts/salts is
expanded.
The mass pattern of viscosamine C (43) can be found in a chromatogram peak that
coelutes with cyclostellettamine C (33) at 18.9min. The molecular mass is 14 mass
units less than viscosamine C (43). This suggests that one alkyl chain is shortened
by a methylene group. Also in this compound, the proposed carbon dioxide adduct
is clearly visible at a distance of m/z = 21.9958 to the doubly charged molecular
ion peak.
A compound of this mass was reported before by C. Timm as a viscosamine
that contains 38 methylene groups in the alkyl chain. [84] Due to the absence of a
fragmentation that can assign the alkyl chain length, the compound may be assigned
as viscosamine 12/13/13 (0/0/0) but other alkyl chain lengths, e.g. 11/12/14, cannot
be ruled out. To induce a fragmentation, the crude extract should be submitted
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to higher fragmentation energies in the hope of producing Pyr + alkyl chain type
fragments as are known from the cyclostellettamines. This work is in progress.
Viscosamine D (81)* — viscosamine 13/13/14 (0/0/0)
N
N
N
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9
9
81
peak m/z mol. form. ∆m
C [M]3+ 264.9063 C55H92N3 10.9 ppm
F1 [M+H]2+ 397.8661 C55H93N3 4.5 ppm
F2 [M+H]2+ 396.8560 C55H91N3 5.5 ppm
A1 [M+H]2+ 412.8512 C56H93N3O2 5.8 ppm
A2 [M+H]2+ 453.8543 C57H92N3F3O2 5.0 ppm
C: compound masses, F: fragment, A: adduct/salt
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Figure 3.53 Structural formula, compound masses and high resolution mass spec-
trum of the peak at 19.8min, identified as viscosamine D (81). The compound
coelutes with viscosamine C (43). The peak area of the fragments and adducts/salts
is expanded.
A new viscosamine can be discerned in a peak at 20.5min. It is 14 mass units
larger than viscosamine C (43) which indicates an additional methylene group in
one of the alkyl chains (Figure 3.53). The proposed carbon dioxide adduct is visible
at a distance of ∆m/z = 21.9943 to the doubly charged molecular ion peak while
the TFA salt is present at ∆m/z = 56.9975 to the Hofmann fragment. As before,
different chain lengths, e.g. 12/13/15, cannot be ruled out.
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Dehydro-Viscosamine C (82)* — viscosamine 13/13/13 (0/0/1)
N
N
N
9
9
9
82
peak m/z mol. form. ∆m
C [M]3+ 259.5665 C54H88N3 4.2 ppm
F1 [M+H]2+ 389.8539 C54H89N3 4.2 ppm
F2 [M+H]2+ 388.8451 C54H87N3 1.7 ppm
A1 [M+H]2+ 411.8492 C55H89N3O2 4.9 ppm
A2 [M+H]2+ 445.8492 C56H88N3F3O2 6.9 ppm
C: compound masses, F: fragment, A: adduct/salt
200 250 300 350 400 450 m z/
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Figure 3.54 Structural formula, compound masses and high resolution mass spec-
trum of the peak at 18.9min, identified as dehydro-viscosamine C (82). The compound
coelutes with cyclostellettamine C (33) and viscosamine B (80). The peak area of
the fragments and adducts/salts is expanded. The position of the double bond is not
determined, yet.
With the knowledge about the mass- and fragment pattern of viscosamine C (43), a
second new viscosamine can be identified in the mass spectrum of viscosamine B
(80), but at much lower intensity (Figure 3.54).
Also this compound coelutes with cyclostellettamine C (33) at 18.9min. The
molecular mass is 2 mass units lower than viscosamine C (43). This suggests that
one alkyl chain carries a double bond. The proposed carbon dioxide adduct is clearly
visible at a distance of m/z = 21.9953 to the doubly charged molecular ion. With
the compound being cyclo-symmetrical but for the double bond, it can be assigned
as viscosamine 13/13/13 (0/0/1).
Double bonds in viscosamines were reported earlier; a Haliclona sp. from the
Pacific coast of Guatemala yielded an unnamed viscosamine 44 with C11 alkyl chains
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that contained three double bonds, one in each alkyl chain and assigned to the same
position in each chain. [86]
Dehydro-Viscosamine D (83)* — viscosamine 13/13/14 (0/0/1)
A third new viscosamine (82) is visible in the mass spectrum of viscosamine C (43)
at low intensity (Figure 3.55). Compound 83 shows a mass that is by 12 mass units
larger than viscosamine C (43). This corresponds to the extension of one of the
alkyl chains by a methylene group and the occurence of a double bond (Figure 3.55).
N
N
N
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9
9
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peak m/z mol. form. ∆m
C [M]3+ 264.2377 C55H90N3 1.6 ppm
F1 [M+H]2+ 396.8622 C55H91N3 5.3 ppm
F2 [M+H]2+ 395.8605 C55H89N3 20.8 ppm
A1 [M+H]2+ 418.8587 C56H91N3O2 5.8 ppm
A2 [M+H]2+ 452.8416 C57H90N3F3O2 3.2 ppm
C: compound masses, F: fragment, A: adduct/salt
Viscosamine C ( )43
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Figure 3.55 Structural formula, compound masses and high resolution mass spec-
trum of the peak at 19.8min, identified as dehydro-viscosamine D (83). The compound
coelutes with viscosamine C (43). The peak area of the fragments and adducts/salts
is expanded. The position of the double bond is not determined, yet.
Also in this compound, the proposed carbon dioxide adduct A1 is clearly visible
at a distance of m/z = 21.9952 to the doubly charged molecular ion peak. The
Hofmann fragment F2 and the proposed TFA salt A2 are discernible as well. With
this information the compound can be assigned as viscosamine 13/13/14 (0/0/1).
In the present compound 83 and with the methods at hand, it is not possible to
distinguish which chain carries the double bond. This leaves three possibilities for
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the compound’s constitution; viscosamine 13/13/14 (0/0/1), viscosamine 13/13/14
(0/1/0) and viscosamine (13/13/14 (1/0/0). In the haliclamines and viscosalines
with dissimilar chain lengths that are proposed in this thesis, a double bond is
always part of the longer alkyl chain. Until further experiments are performed it
can be assumed that compound 83 constitutes a viscosamine 13/13/14 (0/0/1).
It must also be mentioned that due to the absence of fragments that constitute
the mass equivalent of a pyridinium connected to an alkyl chain that were observed
for cyclostellettamines the possibility persists that the compound is a viscosamine
12/13/15 (0/0/1). However, the observation of a co-elution pattern (see below,
Section 3.3.7) assigns the compound as a viscosamine 13/13/14 (0/0/1).
3.3.7 Other observations
Several other observations result from the performed compound screening. The struc-
tures of all compounds that elute at retention times before 12min and after 23min
are unidentified, yet, and under examination. The mass spectra of these compounds
do not conform to the typical mass spectra of known of 3-alkyl tetrahydropyridines
or pyridinium alkaloids although the masses detected in these compound peaks are
similar to haliclamine masses. In haliclamines that possess unequal chain lengths,
double bonds are found in the longer alkyl chain.
In addition, a clustering pattern is visible in the chromatogram analysis; by the
current evaluation method, compounds with one methylene group difference in the
alkyl chain elute with approximately 1min difference in retention time. At the same
time, compounds with saturated alkyl chains often coelute with compounds that
possess one methylene group less in one of the chains but one double bond more.
However, 3-alkyl tetrahydropyridines are well separated from 3-alkyl pyridinium
alkaloids in the chromatogram with a change from tetrahydropyride to pyridinium
happening at approximately 16min retention time, correspondent to a solvent
composition of 40% acetonitrile and 60% water. An exception from this are the
viscosalines which coelute with the haliclamines (THP) but possess Pyr moieties.
The reason for this is the amino acid which increases the polarity of the compounds.
In the absence of a mass spectrometric method, the observed clustering could be
useful to predict the likely structure of the eluting compounds purely by chromato-
graphic methods.
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3.4 Sampling areas and Haliclona samples
During the sampling seasons of 2007-2009, two geographically distant sites were
visited for sponge sampling: the Arctic Kongsfjord in the Spitsbergen archipelago
and the temperate Orkneys, Great Britain. Both areas had been visited for sponge
sampling between 1999 and 2003 by our working group. The most significant
difference between the two sampling areas is in water temperature and the light
regime. Both sites comprise similar fauna, with variation in the abundance and
composition of species. The sessile fauna consists mainly of sea anemones, sea
squirts, barnacles, bryozoans, molluscs, tube worms and sponges. The mobile fauna
comprises snails, a large variety of crustaceans, brittle stars, sea stars and sea urchins,
annelid worms and fishes. [126] In addition, the hard bottom is populated by a variety
of brown and red macroalgae and their co-occurring fauna. Since sponges are filter
feeders, also the planktonic organisms that fall prey to sponges should be mentioned;
they comprise various microalgae, juvenile metazoans like copepod nauplii, bivalve
veliger, Protozoa like ciliates, foraminifera and rotifers, (dino)flagellates, bacteria
and viruses. [127,128]
3.4.1 Kongsfjord, Spitsbergen
Spitsbergen is the largest island of the Svalbard archipelago, located between 74-
81°N and 010-035°E. Due to its northerly location, Spitsbergen is an Arctic island
but it is characterized by comparably mild winters considering other territories at
this latitude. The ocean around the island is dominated by two main water masses:
relatively warm Atlantic Water (AW) and cold Arctic Water (ArW). Atlantic Water
is contained in the West Spitsbergen Current (WSC), the northernmost branch of
the warm North Atlantic Current (NAC, "Gulf Stream"). The WSC flows northward
along the western continental slope of Spitsbergen (Figure 3.56). It carries heat
and very saline water into high latitudes and occupies the upper ca. 600m in the
eastern Fram Strait. After circulating the Arctic basins as well as thorough mixing
and cooling, the AW water emerges as ArW from the Arctic basins southward
and flows along the east coasts of both Greenland (East Greenland Current, EGC)
and Spitsbergen (East Spitsbergen Current, ESC). A small portion of the East
Spitsbergen Current (ESC) turns north at the southern tip of Spitsbergen and
follows the coast line northward. Since this part of the ESC flows on the shelf, it
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Figure 3.56 Map of
Svalbard and the cur-
rent system in the north-
ern Atlantic. The green
circle indicates the geo-
graphic location of the
Kongsfjord. EGC East
Greenland Current, ESC
East Spitsbergen Cur-
rent, WSC West Spits-
bergen Current, RAC Re-
turn Atlantic Current,
JMC Jan Mayen Current,
NwAC Norwegian At-
lantic Current. Changed
from www.awi.de.
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separates the WSC from direct contact with coastal Spitsbergen, which entails that
the fjords on the western coast of Spitsbergen usually contain cool ArW.
The Kongsfjord is located on the north-western coast of Spitsbergen at about
79°N and 011°W. The fjord opens in north-westerly direction, stretches inland for
about 20 km and is approximately 10 km wide at the mouth. It is separated into two
main areas by the island Blomstrandhalvøya; the south-eastern, shallow (50-200m)
and rather protected part and the north-western, deeper (200-400m) and more
exposed part (Figure 3.57). [129]
The wind system, the general shape of the fjord and other physical parameters of
the area like fresh water input and light regime determine the circulation pattern,
salinity, temperature, sea ice expansion, water transparency etc. Tides have an
amplitude of only about 1m, therefore almost no tidal currents occur in the inner,
and weak currents in the mouth part of the fjord. However, with winds blowing
from the West or katabatic winds from the glaciers some areas can be exposed to
heavy wave action.
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Figure 3.57 Kongsfjord bathymetric map. The sampling areas Kongsfjordneset,
Hansneset Cave, Hansneset Step are marked with the numbers 7, 9, and 10, respectively.
Source: Norsk Polarinstitutt.
The inner part of the fjord is surrounded by five glaciers that contribute a
considerable amount of fresh water to the fjord by calving events or ablation. Other
sources of fresh water are melting snow and sea ice as well as summer rainfalls. The
fresh water input creates a very stable stratification in spring and summer with
a brackish water layer of only a few meters thickness that has a salinity of about
30-33 psu and even below 28 psu close to river mouths and glaciers in the inner
part of the fjord. This brackish layer is separated by a strong halocline from the
underlying salty water masses and their circulation and shows an own circulation that
is influenced by wind forcing. The autumn cooling destabilizes the stratification. [129]
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The fresh water that results from melting snow and calving glaciers also carries
large amounts of suspended matter and therefore undergoes fast heating from solar
radiation (from the winter low of ca. –1.8°C to the summer high of 4-6°C). In the
subjacent water masses, temperatures can be as high as 4°C in summer but show
large interannual fluctuation. The reason for this is the oscillation of the WSC that
especially influences the deeper water masses. [130] Usually, the water that enters the
Kongsfjord is Transformed Atlantic Water (TAW) that differs significantly from the
water in the core of the WSC (temperature (T) > 3°C, salinity (S) > 34.9 psu). The
TAW is a result of mixing of AW with shelf water (ArW) which produces water
of decreased temperature and salinity (T > 1°C, S > 34.7 psu). In winter 2006, a
strong and long-lasting northerly wind in combination with the Ekman drift resulted
in an upwelling of warm and very saline AW from the WSC core that intruded
almost the complete Kongsfjord and led to anomalous high temperatures of about
8°C in the fjord in winter. [131] This winter time warming also had a large impact
on the ice cover, causing the thinnest and least ice in the fjord observed during the
preceding decade. [132] The warming also had an impact on the winter zooplankton
community in the fjord by advection of species that are usually only found in warmer
waters. [133] Since such winter time warming phenomena happen periodically in the
Kongsfjord, the fjord is considered a sub-Arctic fjord in constrast to other fjords at
the same latitude. [127]
The seasonal light regime in the Kongsfjord area is significantly different from the
temperate Orkneys. The period of polar night ranges from October 28 to February
14 and the midnight sun shines from April 21 to August 21. During the period
of midnight sun, the irradiance from the sun at nighttime is only slightly smaller
than during daytime. This results in considerable photostress for all shallow water
organisms. In contrast, the period of polar night does not allow any photosynthetic
processes and phytoplankton as a food resource may be depleted in this period.
Suspended matter introduced by melt water influences both the irradiance of UV
and visible light penetrating the water column and may attenuate the photostress
imposed during summer. The clearest waters and consequently the deepest euphotic
zones are found in early spring at the mouth of the fjord, furthest away from the
main freshwater sources. While the euphotic zone reaches down to approximately
33m in the outer parts of the fjord it may be less than 1m close to a glacier front. [129]
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In the Kongsfjord, three places with hard bottom substrate are known to host
a rich hard bottom fauna and are regularly visited by divers for sponge sampling:
Hansneset Step, Hansneset Cave and Kongsfjordneset.
Hansneset Step
Hansneset Step (N 78° 59.147’, E 011° 57.715’) lies on the foot of a number of sizeable
semi-submerged rocks that are located about 100 m from the western coast of the
island Blomstrandhalvøya. From a level area at about 6m depth (high tide) directly
below the rocks stretches a wall down to approximately 12m. There it levels into
a first step that is horizontally tilted in south-westerly direction. From this step a
less angular slope stretches to 18m to a second step. Sponge sampling in the 2008
and 2009 sampling season was exclusively performed between the 6m platform and
the 18m step. In spring and summer, the steps are overgrown by a large variety
of marine macroalgae. Sponges can be found between these macroalgae as well as
on the walls. On the steep walls, sponges seem to be more abundant10 and are
more easily accessed than on flat areas. Two types of Haliclona sponges co-occur
in Hansneset Step: the purple, elastic form (Figure 3.58, approximately three-four
individuals per square meter) and, to a much lesser extent, the white, soft form (no
picture from Hansneset step available, 0.1 individuals per square meter). The purple
form may grow in large cushions with many chimneys and cover considerable parts
of the wall while the white-fragile form usually consists of not more than one or two
chimneys.
Figure 3.58 The substrate in Hansneset
Step is interspersed with small holes and
ridges that give the place a reef-like struc-
ture. Macroalgae are dominant. Sponges
grow in small patches between the algae
and are often covered by sediment or algae
exudates. Photo: M. Schwanitz.
10 Abundance values are estimated. As flat areas are strongly overgrown by macroalgae, the
sponge population on the flat parts is not easily visible and may thus be underestimated.
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Hansneset Cave
Hansneset Cave is a semi-submerged cave at the western coast of Blomstrandhalvøya.
It is located approximately 100m from Hansneset Step, i.e. within vision range. The
cave is approximately 8m wide and 9m high at the mouth, of which 6m lie below
the water line (high tide). It reaches approximately 15m into the rock. The floor is
even, but slightly ascending towards the inner part, and covered with boulders which
show sign of being moved regularly (by waves, ice bergs, etc.) since little overgrowth
can be seen on them. The walls on both sides are concave and well overgrown. At
the inner end of the northern wall lies a niche in about 1-2m depth. The rear wall
is vertical, in places overhanging and tapers to a niche in the south-eastern corner.
A B
Figure 3.59 (A) Hansneset Cave above the water. (B) Typical underwater fauna
in the cave. Photos: M. Schwanitz.
The entrance part of the cave is covered with algae but with decreasing light
intensity the algae density diminishes rapidly towards the inner part. A distinct
zonation can be observed with leaved algae growth reaching about half way into the
cave. Their lower boundary limit has been determined as lying at the 0.7% irradiance
line (visible spectrum) as compared to the surface irradiance. [134,135] Further back,
only encrusting red algae can be found. However, they are strongly overgrown by
bryozoans, actinia, ascidians and sponges. Sponge density is highest in the rear
part and the niches, i.e. the darkest parts of the cave. They grow from about
1m water depth (ice scouring line) down to about 1m above the floor (boulder
scouring line) and cover large parts of the wall. The sponge fauna in the cave at
Hansneset was thorougly examined by M. Assmann; the predominant sponge species
83
3 Haliclona viscosa
is Halichondria panicea, and, according to his observations, only Haliclona excelsa
as a representative of the genus Haliclona is found in the cave. [136]
Kongsfjordneset
On Kongsfjordneset (N 78° 58.635’, E 011° 29.454’, waypoint 8411), a steep wall is
located about 500m from the coast and runs for several hundred meters parallel to
the coast line in a north-westerly direction. Between the shore and the wall exists
a gradual slope of bare rock that is in some places covered with dense stands of
macroalgae. This slope turns into a steep wall in about 10m depth and forms a
step in about 30m depth. It continues to larger depths beyond that. In the upper
part of the wall, patches of brown algae overhang the rock face and cover the sessile
macrofauna of mainly actinians and ascidians (Figure 3.60). Sponges grow in small
patches of two-three chimneys with a density of about one-three individuals per
square meter. Larger sponge patches are rare and increasingly found in greater
depths. Four different sponge groups can be found on this spot: the purple, elastic
group, the white soft group, the brown stiff group, and the white, elastic group.
Sponge cushions with more than three chimneys have only been observed of the
purple, elastic and the white, elastic group.
Figure 3.60 Underwater scenery at
Kongsfjordneset. Actinians and ascidians
are abundant at this site. Photo: M.
Schwanitz.
3.4.2 Great Britain, Orkneys
The Orkney Islands are an archipelago of approximately 100 islands that lie north of
Great Britain, separated from the Scottish mainland by the 10-13 km wide Pentland
11 Waypoint determined by the AWI polar diving operation supervisor, Max Schwanitz.
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003°W
59°N
Saviskaill Head
Red Nev
Orkneys
Shetlands
Mainland
Scotland
Tuquoy Bay
Saviskaill Bay
Figure 3.61 Map of the Orkney Islands, Great Britain. Colored lines indicate the
bathymetry. The section shows mainland Scotland and the Orkney- and Shetland
Islands for orientation. Green circles mark the sponge sampling areas. Changed from
http://www.fettes.com/orkney/bathymetry.htm.
Firth. They are situated on the European continental shelf at approximately 59°N
and 003°W. The ocean around the archipelago is influenced by the Atlantic Water
(AW) of the North Atlantic Current (NAC, "Gulf Stream") that after crossing the
Atlantic in easterly direction is deflected to the North by the continental slope and
the Ireland-Britain island barrier. Water depths between the islands rarely exceed
30m but quickly drop to larger depths along the west coasts. Off the east coast
they reach the average depth of 70m of the continental shelf further away from the
islands (Figure 3.61). The amplitude of the tide is approximately 3-4m which results
in very strong tidal currents between the islands (~2m s−1). The west coast of the
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archipelago is dominated by clear Atlantic waters and strong waves that build up
by wind forcing over the Atlantic. The east coast, in contrast, is influenced by the
more turbid waters of the North Sea. Also the coastal constitution differs between
the East and the West; the western coast consists mainly of steep cliffs, sometimes
of several hundred meters height while the eastern coast is characterized by shallow
shores. Under water, the bottom west of the islands is characterized by coarse sand
and gravel while the East is dominated by sands and mud. [137] Therefore, the west
coast offers better possibilities to sample hard bottom fauna than the east coast.
Water temperatures range between 7 and 15°C owing to the influence of the
Atlantic Water. In contrast to the Arctic Kongsfjord, they rarely fall below 7°C
even during winter time cooling. In winter, the water masses are well mixed, but a
thermocline establishes in late spring. Its strength is dependent on the heat input
and the turbulence generated by tides and the wind. On the other hand, the salinity
does not show strong fluctuations and ranges between 34.5 and 35.3 psu. [137] This
is due to the lack of major tributaries that empty close to the archipelago and the
area being solely influenced by waters of marine origin.
The steep cliffs of the western coasts were picked for fauna examinations during
the 2007-2009 "R/V Heincke" expeditions. Among them, two locations stood out as
suitable sites for sponge sampling: Red Nev (Westray) and Saviskaill Head (Rousay).
They are sites where tidal current speeds are very high, hence they yield a rich hard
bottom fauna that is typical for temperate areas (e.g. Naylor (2005)). [138] Red Ned
was previously visited for sponge sampling during a scientific cruise in 2001 and
2003. At that time, also two other places, Saviskaill Bay and Tuqouy Bay, were
visited for sponge sampling. [139] These two sites, which lie to the East and across
Westray Firth relative to Saviskaill Head, respectively (Figure 3.61), were shortly
visited for sponge sampling between 2007 and 2009 but yielded, probably due to
their more sheltered location and in part sandy bottom, significantly less sponges
than e.g. Saviskaill Head.
Red Nev
Red Nev (N59° 18’, W003° 01’) represents a number of semi-submerged caves on
the island of Westray. The caves are extremely exposed to waves and diving is only
possible after several days of calm weather. The water depth inside the caves is
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approximately 8 m.12 Due to the wave action, the fauna layer inside the caves is at
maximum 1.5 cm thick and consists mainly of ascidians, brittle stars, crustaceans
and sponges but compared to Saviskaill Head rather few cnidarians (S. Fuhrmann,
pers. commun.). Being set back into the cliff front and reaching rather deep, the
caves are poorly illuminated and the flora is constricted to encrusting red algae
while the macroalgae are confined to the cave entrance.
Saviskaill Head
Saviskaill Head (N 59° 12’, W003° 03’) is an exposed cape on the northern coast of
Rousay, overlooking Westray Firth. The cape is exposed to strong tidal currents
that allow diving only during turning tides and in calm weather. The steep, in parts
overhanging cliff falls to a 10m wide step in 30m depth from where it continues to
50m depth and beyond. The upper meters are densely covered by a macroalgae
forest (Figure 3.62A). Below, a large variety of hard bottom fauna is found, with
different Anthozoa species (e.g Alcyonium digitatum and Actinia equina) being
the most abundant larger animals. Sponges are also rather abundant on this cliff
(Figure 3.62B). The macroalgae stalks are often covered by Halichondria panicea
A B
Figure 3.62 Underwater scenery at Saviskaill Head. A: Algae forest with dense
epibiont growth; 11m depth. B: Fauna on the vertical wall; the soft coral Alcyonium
digitatum is abundant at the site; 14m depth; Photo: G. Schmidt (A) and M.
Wehkamp (B).
12 More detailed information about the caves is not available since sampling occasions are extremely
rare and are solely used for sampling, not mapping.
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and Esperiopsis fucorum (Figure 3.62A) while other sponges like Pachymatisma
johnstoni, Cliona celata, Myxilla incrustans, and Haliclona sp. occur deeper, where
the algae cover is not as dense or lacking completely.
Haliclona sponges sampled at these two locations do not differ considerably in
their morphology. The organisms sampled in Red Nev are generally thinner cushions
and greyish in color, but their microstructure does not deviate significantly from
sponges collected in Saviskaill Head. In general, they resemble the purple type
observed in the Kongsfjord but grow in significantly larger cushions.
3.4.3 Haliclona samples
Sponges were collected in three subsequent years between 2007 and 2009. In 2007,
sponges were only collected from around the Orkneys while both the Orkneys and
Spitsbergen were visited for sponge sampling in 2008 and 2009. Due to bad weather
conditions during the expeditions to the Orkneys in 2007 and 2008, the divers could
not access Red Nev hence the majority of Haliclona sponges from the Orkneys in
these two years originated from Saviskaill Head. A total of 11 Haliclona individuals
were sampled around the Orkneys and 56 partial organisms from the Kongsfjord,
Spitsbergen. For sustainability reasons, only a small piece of each Spitsbergen
individual was sampled to determine the presence of 3-APAs, prior to the collection
of a larger subsample from 3-APA containing individuals.
Two morphologically different groups of sponges that belong to the genus Haliclona
were found at the two Orkney sampling sites and four different groups were found
in the Kongsfjord. The group in this context refers to color and haptics of the
sponge, but one has to be aware that sponge color is not a confident identification
feature as it may be highly variable. The haptics on the other hand is a character
determined by the way the spicules are arranged and is considered more confident
than color. The growth form, i.e. whether the sponge grows branches, erect chimneys
or forms rather flat cushions, is also highly variable and strongly dependent on the
habitat, exposure to currents etc. Since the individuals inside a group showed strong
variation in growth form (e.g. Figure 3.63), the growth form was not considered
when assigning groups.
The sponges could not be identified to the species level purely by classical taxo-
nomical methods. Therefore, it remains uncertain whether the groups belong into
one species or are indeed different species. All sponges were examined by light mi-
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croscopy, identified as belonging to the genus Haliclona, and then grouped according
to their microscopic characteristics. These groups corresponded to their most obvious
characteristics, color and haptics. To give a more accurate picture about the phylo-
genetic relationship of the groups, they are currently under genetical investigation by
external researchers. Justification for grouping the individuals notwithstanding the
uncertainty of characters like color and haptics in Haliclona is given by the correlative
appearance of these characters with microscopic characteristics and chemical profiles.
In her dissertation thesis, Heike Lippert states that only two Haliclona species, H.
viscosa and H. rosea, occur in the Kongsfjord, [108] while Michael Assmann reports a
third species, H. excelsa, from the cave at Hansneset. [136] Since the presented thesis
finds four groups, species names are assigned only tentatively to these groups.
The purple, elastic Haliclona
The purple Haliclona has a soft, elastic texture. The sponge is found from approxi-
mately 6-24m depth where it grows in cushions of 8-20 chimneys. The cushions are
usually 2-3 cm thick with elevated oscula. In few cases at protected sites the oscula
sit on pronounced chimneys which can reach 6 or more centimeters in height. Oscula
have a diameter of 0.5-1 cm. A thin membrane perforated by a hole much smaller
than the osculum stretches over the osculum opening after the sponge is preserved
in alcohol, but is not observed in living organisms. The surface of the sponge is
visibly perforated by ostia and has a smooth feel. The sponge is found primarily in
Hansneset but also in Kongsfjordneset (Spitsbergen) where the organisms reach sizes
of 2-3 chimneys. Similar organisms are present in Saviskaill Head (Orkneys) where
large individuals reach cushions sizes of 20-30 chimneys. Since the purple form from
the Orkneys and the purple form from Spitsbergen show no visible difference, the
representatives of both areas are combined into one group (Figure 3.63).
The skeleton contains no ectosome and consists of paucispicular13 primary tracts
connected by irregularly scattered, unispicular secondary tracts (Figure 3.64).
Spicules are slender, pointed oxea, 140-170 µm × 4-7 µm. Spongin is scarce and, if
present, found at the nodes of the spicule net.
The sponge is mainly found on vertical walls, but also among macroalgae fastholds
and can be covered by sediment. When removed from the water and squeezed, the
13 Paucispicular in this context is defined as bundles of 2-4 spicules beside each other.
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A B C
Figure 3.63 The purple, elastic Haliclona. (A) Reference picture of the GS 07/21 individual from
Saviskaill Head (Orkneys) in the lab prior to conservation. (B) Reference picture of the GS 09/05
individual from Hansneset (Spitsbergen) in the lab prior to conservation; square length = 0.5 cm. (C)
A purple Haliclona sponge in its habitat at Hansneset. Pictures by G. Schmidt (A) C. Cychon (B)
and M. Schwanitz (C).
Figure 3.64 Microscopic image of the spicule
arrangement in a purple Haliclona showing the
surface and sub-surface area of a longitudinal
section at 10× magnification, size reference is
given in the upper left corner.
sponge gives away purple-stained, cell-containing water and an acrid smell, but does
not excrete slime. The purple pigmentation reaches well into the sponge interior
and fades to a brown coloring towards the base of the sponge. The organism loses
all color in alcohol. The description of this sponge and its abundance fits well to the
species Haliclona rosea.
In few cases in Spitsbergen specimen parts of the sponge tissue were observed to
have lost all color resulting in translucent areas in the organism. These parts were
more fragile than the surrounding tissue and no pigments or other structures were
observed inside the cells in these areas. This phenomenon is evocative of bleaching
in Haliclona sp. and other sponges in Australian waters [140] and the Caribbean. [141]
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The white, elastic Haliclona
Two different groups of white Haliclona sponges grow in the Kongsfjord. One of
them has an elastic consistency and retains its form well when taken out of the water.
The sponge’s surface appears coarse, an effect which is probably due to the ostia
being rather large and clearly visible. Only one individual was found of this group
but it was incomparably larger (Figure 3.65A) than any other Haliclona sponge
observed in the sampled area. The sponge is slightly slimy and exerts an acrid smell
when manipulated; it is extremely slimy when extracted by chemical methods. As
in the purple, elastic Haliclona, a thin membrane stretches over the osculum as soon
as the sponge is taken out of the water (Figure 3.65B). The sponge also carried a
large number of eggs at the time of sampling that were not present in any other
sponge in the area. It was found on a vertical wall in a ditch facing the main current
direction, situated at ca. 16 m depth (high tide) at Kongsfjordneset and covered an
area of about half a square meter. Despite its robust white outer color the tissue is
increasingly brownish towards the base of the sponge. It turns completely white in
alcohol.
The skeleton is arranged in paucispicular primary and unispicular secondary tracts
which get increasingly disorderly towards the base of the sponge. It contains no
A B C
Figure 3.65 The white, elastic Haliclona. (A) The organism at its habitat at Kongsfjordneset
(Spitsbergen), reference number GS 09/23; the yellow marker cable tie in the lower right corner of the
picture, attached to an orange flag, has a width of ca. 0.5 cm. (B) The same organism in the lab prior
to conservation; length of a square’s edge = 0.5 cm. (C) Microscopic image of the spicule arrangement
showing the surface and sub-surface area of a longitudinal section at 10× magnification, size reference
is given in the upper left corner. Pictures by M. Schwanitz (A), C. Cychon (B) and G. Schmidt (C).
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ectosome, mega- or microscleres. Spicules are oxea or slightly spatulate flanged,
nearly tornote, with a size of 150-180 µm × 6-9 µm. Spongin belts the nodes of the
spicule net but is scarce elsewhere. Except for its color, slime excretion and egg
masses the sponge strongly resembles the purple Haliclona. However, it forms a
separate group because of the difference in chemical profile. Sponges with a similar
chemical profile were previously named Haliclona viscosa. The spicule arrangement
of H. viscosa type species examined at the Zoölogisch Museum in Amsterdam,
Netherlands, shows strong resemblance to the spicule arrangement of the white,
elastic sponge sampled in the Kogsfjord.
The white, soft Haliclona
The other white Haliclona is extremely soft, and offers almost no resistance when
squeezed. Under water it easily regains its form after being squeezed whereas it
subsides easily if handled above the water. It grows in pads of 3-4 but rarely more
chimneys erect on vertical walls, usually in small ditches that offer protection from
currents (Figure 3.66A). The sponge was observed from about 10 to 24m depth
in Kongsfjordneset and, less abundantly, at Hansneset Step. The sponge can be
covered with considerable amounts of sediment, especially at Hansneset Step.
The oscula usually sit on chimneys which may reach heights of 4-6 cm and are, if
well developed, about 1 cm in diameter. The oscula have diameters of 0.5-0.8 cm. No
contraction is observed, and the oscula are not covered by membranes as described
for the purple and the other white Haliclona. Under water, the ostia are not as
easily visible as in the preceding two sponges.
The surface of the sponge has a velvety feel. The tissue is stringy when torn apart
and excretes no slime. A thin layer of white-pigmented cells is visible directly under
the surface and gives the exterior a white flocculent look (Figure 3.66B). This white
layer washes out when the sponge is manipulated. The sponge tissue away from the
extremities is increasingly brownish in color but turns white in alcohol.
The sponge has no ectosome. Unispicular primary tracts are crossed by irregular,
unispicular secondary tracts. They are arranged orderly towards the surface and
increasingly irregular towards the base (Figure 3.66C). Spicules are thick oxea,
130-170 µm × 9-11 µm, no megascleres or microscleres are present. Spicules are
bonded by small amounts of spongin at the nodes of the spicule net.
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A B C
Figure 3.66 The white, soft Haliclona. (A) The organism in its habitat at Kongsfjordneset
(Spitsbergen); the height of the largest chimney is approximately 4 cm. (B) A different organism of
the same group in the lab prior to conservation; length of a square’s edge = 0.5 cm. (C) Microscopic
image of the spicule arrangement showing the surface and sub-surface area of a longitudinal section at
10× magnification, size reference in the upper left corner. Pictures by M. Schwanitz (A), C. Cychon
(B) and G. Schmidt (C).
Figure 3.67 A white, soft Haliclona from the Kongs-
fjord with a "sick" area; GS 09/04.
Only two Haliclona species with unispicular primary tracts, H. cinerea (Grant
1826) [142] and Reniera (=Haliclona) rufescens (Lambe 1892), [143] were reported to-
date from North Atlantic waters. Haliclona cinerea is described as one of the softest
Haliclona species, which fits well to the description of the white, soft Haliclona, but
it does not, as reported from H. cinerea, show slime strands when pulled apart. In
addition, the spicules of the sampled sponges are too thick and the color does not fit
well to be assigned to H. cinerea. The Haliclona rufescens type was unfortunately
examined as a dried sponge, therefore no assertion can be made for its softness.
Though reported from the Pacific, the type was collected from cold water Kamtchatka
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(60° 30’ N) [143] and the spicule size fits well to the white, soft Haliclona collected in
the Kongsfjord.
Similar to the purple, elastic Haliclona, several members of the white, soft Haliclona
were found in the Kongsfjord that seemed to have lost all color (Figure 3.67) resulting
in sickly-looking, slightly translucent and very fragile areas within the organism.
The brown, stiff Haliclona
This form is found exclusively in Hansneset cave (Spitsbergen) where it grows in
small patches of 2-5 oscula. The sponge is confined to the back wall of the cave
and the niches where least light is present (Figure 3.68A). This habitat represents
the most densely overgrown habitat in terms of sponge density and competition for
space can be assumed to be high (Page 83).
The sponge has a rather brittle feel which is intensified when the sponge is
preserved in alcohol, and shows oscula on low-mounded elevations. It excretes no
slime. The sponge is of a same brown color throughout in contrast to the other
sponge groups that have different outer and inner colors (Figure 3.68B), but as the
other sponges it turns white in alcohol.
A B C
Figure 3.68 The brown, stiff Haliclona. (A) The organism in its habitat at Hansneset cave
(Spitsbergen); white arrows indicate the Haliclona among a neighboring sponge, possibly Halichondria
genitrix; the arrow length represents 7 cm in the field. (B) A brown Haliclona in the lab prior to
conservation (reference GS 09/27); length of a square’s edge = 0.5 cm. (C) Microscopic image of
the spicule arrangement showing the surface and sub-surface area of a longitudinal section at 10×
magnification, size reference in the upper left corner. Pictures by M. Schwanitz (A), C. Cychon (B)
and G. Schmidt (C).
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Spicules are slender oxea, 150-170 µm × 4-7 µm. They are arranged in pauci- or
polyspicular14 primary tracts interconnected by unispicular secondary tracts (Figure
3.68C). In general, the skeleton seems much more compact and dense which is the
probable cause for the sponge’s stiffness. The sponge contains no ectosome, mega-
or microscleres. Spongin is routinely present at the nodes of the spicule net but
scarcely elsewhere.
The only Haliclona species reported from the Hansneset cave is H. excelsa. [136]
Haliclona excelsa was recently reclassified to Isodictya palmata. However, I. palmata
shows a significantly different growth form than the sponges sampled in the cave,
none of which grew antler-shaped branches. While, I. palmata grows in boreal and
sub-Arctic North Atlantic, has a yellow-brown color and a firm consistency, all of
which fits to the description of the brown, stiff Haliclona, I. palmata is reported to
contain palmate isochelae which were not observed in the brown, stiff Haliclona.
14 Polyspicular tracts in this context contain 4-8 spicules in parallel.
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3.5 Annual variation in Haliclona viscosa
3.5.1 Interannual variation 1999-2009
The white, elastic sponge Haliclona viscosa shows variation in its metabolites
between different years. The variation can be divided into two components; (a)
presence/absence of specific compound classes and (b) presence/absence of single
compounds inside a compound class.
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24
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3. Kongsfjordneset
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GS 09/23
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B
Figure 3.69 Base peak chromatograms (m/z = 50 − 1000 ) of Haliclona viscosa
crude extracts. A: Interannual metabolite variation in H. viscosa between 1999 and
2003. B: Metabolite variation in H. viscosa in 2009; (1) crude extract of the GS 09/23
individual sampled in June and (2) in July; (3) crude extract chromatogram of GS
09/23-associated bacteria; (4) crude extract chromatogram of a brown, stiff individual
from Hansneset Cave. Numbers denote previously published secondary metabolites.
Dotted lines are inserted for orientation.
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Presence/absence of compound classes is most conspicious between the years 2001
and 2003. This is most obvious with 3-alkyl tetrahydropyridines. Haliclamines C
(27) and D (28) are the major metabolites in most years but they are almost absent
in 2001 (Figure 3.69A). The same is true for other haliclamines which show very low
abundance in normal years but even less in 2001. Instead, the 3-alkyl pyridinium
alkaloids are more prevalent in 2001, with viscosaline C (18) and viscosamine C
(43) being the major metabolites. Consequently, viscosamine C (43) and viscosaline
C (18) were isolated from the 2001 extract and published in 2003 [96] and 2004, [74]
respectively. In contrast, the haliclamines prevail in the 2003 and 2009 extracts and
almost no 3-alkyl pyridinium alkaloids are present in these two years.
Variation inside a compound class is exemplified by Haliclamine K (62) which is
present in the 2003 and 2009 samples (see manuscript on page 223) but not present
in 2001 and only present in very small quantities in 1999 and 2000. In 2001, all
haliclamines with double bonds are absent.
An interesting observation is that most compound classes, haliclocyclins, halicla-
mines, viscosalines and viscosamines, consist of several members with varying alkyl
chain lengths. An exception from this is cyclostellettamine C (33). It is present
in all samples obtained before 2003 but does not have any analogues with shorter
or longer chains in the crude extract of H. viscosa although the co-occurrence of
different cyclostellettamines is known from other Haplosclerid sponges. [116]
The change in the metabolite composition between 2001 and 2003 suggests a
change in environmental factors since the competitive habitat of neighboring sessile
organisms is not subject to rapid changes. However, few environmental monitoring
programs exist to-date in the Kongsfjord area. They record oceanographic data like
salinity, temperature and currents along the main axis of the fjord but not close
to the sampling sites and with too low resolution in the sponge sampling depth.
Other environmental factors like the water transparency, nutrient availability and
plankton composition are not recorded on a regular basis. Without these data, the
correlation of secondary metabolite changes with environmental parameters is highly
speculative. However, the speculation is necessary in view of a continued study of
the secondary metabolite variation in the sponge genus Haliclona to determine the
environmental parameters that should be recorded to allow a better picture.
On one hand, the variation in the compound classes produced by the sponge
can be due to the nutrient uptake varying between the years or between seasons in
which the sponge is sampled. The C:N:P ratio (Redfield ratio = 106:16:1), i.e. the
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availability of carbon, nitrogen and phosporus, strongly influences the appearance of
e.g. plankton blooms which form in early spring as soon as the water temperature
rises to allow high metabolic rates and stratification of the water column increases.
At that time, nutrient levels in the upper water layer are high from winter time
overturn of the water column. Due to high abundance of organisms that use the
nutrients for growing, the stratified layer soon depletes in N while C is never and P
rarely depleted. Minor blooms also occur in early autumn, i.e. after the first mixing
events (storms) when the water temperature is still high. [144]
Before a phytoplankton bloom, the nutrients are available as dissolved organic or
inorganic matter that can be taken up through cell membranes. During the bloom,
the availability of nutrients for a sponge is given by the planktonic organisms that
the sponge can filtrate from the water. After the bloom however, the water column
might be depleted in both nutrients and food particles possibly resulting in a change
of secondary metabolite biosynthesis. For example, if nitrogen is depleted, fewer
compounds may be synthesized that require the incorporation of many nitrogen
entities. In the case of the 3-APAs this may be indicated by longer alkyl chains or
a shift from trimeric to dimeric compounds. The strong presence of viscosalines
and viscosamines in 2001 may therefore be a sign for high nutrient levels. Since
phytoplankton and zooplankton contain different nutrient ratios, the change may
also be due to a change in food source by advected food species. Therefore, the
sampling season and site may be important for the 3-APA content and composition
in Haliclona viscosa.
Nutrient-dependent secondary metabolite production is known e.g. from plants
(e.g. Bryant et al. 1987) [145] and microorganisms. [146–148] In the marine environment,
few studies exist that test the influence of nutrient enrichment or depletion on the
secondary metabolism of organisms. One example is the soft coral Sarcophytum
ehrenbergi that was shown to lower its stress metabolite (terpene) content with
elevated nutrient levels. However, the response is attributed to decreased interspecific
competitiveness in the nutrient enriched environment, not to the initial nutrient
availability. [149]
On the other hand, variation in secondary metabolites can be due to an adjustment
to the defensive need of the sponges. Since sponges are only observed to be under
spatial competition in Hansneset Cave, and only one individual from Hansneset Cave
in 2009 shows low abundance of 3-APAs, the metabolites are presumably not used
for competitive defense against other sponge species. However, they may be used
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against potentially infectious microorganisms, as is indicated by the antimicrobial
activity of viscosaline C (18) and the haliclamines C (27) and D (28).
Since haliclamines display lower cytotoxicity than cyclostellettamines and vis-
cosamines, [84] a shift of the compound composition towards haliclamines can indicate
a lower need for defense as well as a lower fitness to produce energetically "costly"
secondary metabolites. This is observed in the samples collected in 2003 and 2009
which contain almost exclusively haliclamines, few viscosalines at low concentration,
no cyclostellettamine C (33) and no viscosamines (Figure 3.69). However, haliclami-
nes with double bonds probably balance the decrease in biological activity between
3-alkyl pyridinium and 3-alkyl tetrahydropyridine compounds.
Haliclamines with double bonds were more diverse and abundant in 2003 and 2009
than e.g. in the crude extract from a 2001 individual. The sponge sampled in 2009
carried large numbers of eggs at the time of sampling. This may be an indication
that the sponge produces more haliclamines to protect the eggs from predation, or
the eggs themselves are chemically defended. The compounds may also serve as a
cue to signal larvae release. Two studies addressed the chemical defense of marine
invertebrate larvae and concluded that the larvae must be chemically defended since
they are unpalatable to fish but do not contain physical defense mechanisms. [69,70]
A possible chemical defense of sponge larvae may also be the reason why no
3-APAs were found in the other sponge groups present in the Kongsfjord. The
individuals in these groups were generally much smaller than the Haliclona viscosa
found at Kongsfjordneset and did not contain eggs. Whether this is a seasonal or a
maturity phenomenon cannot be resolved at this time.
The compound class variation may also be due to sponge individuality. From
each of the sampling years, only one sample of Haliclona viscosa exists. Today it
is not possible to ascertain, whether different organisms were pooled to form one
sample or whether each sample consists of a single individual. In 2009, only one
large individual was found at Kongsfjordneset that was readily identified by its
3-APA content by thin layer chromatography (Section 3.7.1). The organism was
large enough to have lived at the site for several years and might have been the
source for previous samples, e.g. the 2003 sample. The crude extract of the latter
shows strong similarity to the extract of the 2009 sample, but it remains speculation
whether these results are due to the samples having the same origin. The hypothesis
of individual variation is supported by a second individual (GS 09/27) with lower
3-APA content that was identified by HPLC methods later (Figure 3.69B4).
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3.5.2 Seasonal variation 2009
In 2009, a thin layer chromatography method was used to screen for 3-APA containing
individuals. For this purpose, small pieces of sponges were sampled under water and
the remaining organisms were marked with cable ties (Figure 3.65A). The identified
individual was sampled again and the crude extracts of both sampling periods were
compared.
The Haliclona viscosa individual sampled from Kongsfjordneset in 2009 shows
a shift in its metabolite composition between the first and the second sampling.
Compounds that elute before 12min are absent in the second sampling (Figure
3.69B). Whether this change is due to a seasonal change, i.e. production of 3-APA
biosynthetic precursors earlier in the season and accumulation of the educts later,
or due to the damage inflicted by the sampling process and the animal’s response
to it cannot be determined. The observed shift poses the question, whether the
3-alkyl pyridinium alkaloids present only in the years 1999-2001 are due to a seasonal
change and whether a later sampling of the 2009 individual would also yield 3-alkyl
pyridinium compounds. Further sampling later in the year as well as the elucidation
of the compounds that elute before 12min is required to answer the question, but a
review of the sampling times of the other H. viscosa sponges between 1999 and 2001
suggests that season does not play an important role. All sponges were sampled in
approximately the same season, in late spring and summer (Table A.1).
In 2009, bacteria were isolated from the sponge and extracted. The resulting
crude extract shows the same 3-APAs as are present in the extract obtained from
the whole sponge. Although the possibility remains that a carryover of secondary
metabolites was obtained during the extraction procedure, this result indicates that
bacteria may be involved in the production of the secondary metabolites of Haliclona
viscosa.
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3.6 Secondary metabolite variation in different Haliclonas
The motivation for the presented study is the spatial and temporal variation of
secondary metabolites observed in Haliclona viscosa from two different geographical
locations, the Orkneys and Spitsbergen. These observations founded on approved
Haliclona viscosa samples from both locations. During research for the presented
thesis, the sampled Haliclona sponges could not be identified to the species level for
lack of an experienced Haliclona taxonomist. Therefore, a combination of molecular
genetics and different chemical methods tries to supplement taxonomic identification
characteristics.
3.6.1 Intraspecific variation in Haliclona
The secondary metabolites found in a given Haliclona group at a given site do not
show significant variation both in diversity and abundance (not shown). Of the
four Haliclona groups obtained during the sampling seasons 2007-2009, the purple,
elastic group is the only one that occurs in Spitsbergen and the Orkneys. It shows
significant deviations of secondary metabolites between the different sampling sites.
5 10 15 20 25 30 min
Hansneset Step
Kongsfjordneset
Saviskaill Head
purple, elastic
purple, elastic
purple, elastic
Figure 3.70 Comparison of base peak
chromatograms (m/z = 50 − 1000 ) ob-
tained from crude extracts of purple, elas-
tic Haliclona specimens collected at differ-
ent sites in the Kongsfjord, Spitsbergen
(Hansneset Step and Kongsfjordneset) and
the Orkney Islands (Saviskaill Head). Due
to low concentration of the metabolites,
column specific peaks are visible (shaded
area) although the analysis uses the same
chromatographic gradient as for H. vis-
cosa samples (Figure 3.17 and 3.69). Chro-
matograms are scaled to 100 % intensity
of the highest peak.
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None of the sampled purple, elastic Haliclonas produces 3-alkyl pyridinium alkaloids.
The compound peaks observed in Figure 3.70 invariably elute in high (>60%)
acetonitrile (ACN) concentration or pure ACN (30-35 min) and therefore probably
constitute primary metabolites like sterols, fatty acids and glycerolipids. The
composition of these strongly nonpolar compounds in the purple, elastic Haliclona is
significantly different between the two sampling sites Hansneset and Kongsfjordneset
in Spitsbergen, and both are different from the sampling site in the Orkneys.
The lipid composition can give valuable information about the food source of an
organism. While the lipids produced naturally in a given sponge species are assumed
to be constant for all individuals of the species, different food sources or commensal
organisms may influence the total lipid composition of an individual. For example,
zooplankton has a different lipid composition than phytoplankton or bacteria. The
coastal Kongsfjordneset is influenced by oceanic waters while Hansneset is located
in the inner part of the fjord and is influenced by fresh water and sediment runoff
from glaciers and rivers. The food sources may therefore be different between the
two sites, with cold- and freshwater adapted food species in Hansneset whereas the
food species in Kongsfjordneset may be advected by the currents passing off the
western coast.
Since the structure of the highly nonpolar compounds in Haliclona was not
examined during the study, no further assertion can be made towards the nature of
the compounds. However, a closer examination in the future might yield valuable
results in the chemotaxonomic identification since a similar approach has been
assessed with sterols in other marine sponges. [150]
Sterols are used in all eukaryotic organisms as membrane constituents that mod-
ulate the passive movement of solutes across the membrane bilayer. Eukaryotic
organisms that are not able to synthesize their own sterols require an exogenous
source of the molecules. The greatest diversity of sterols is encountered among the
most simply constructed eukaryotic organisms and sponges yield the most diverse
array of sterols found in all marine invertebrate phyla. As physiological complexity
increases from invertebrate to vertebrate, a progressive reduction in the number of
sterols is found, along with an increasing occurrence of cholesterol. This has been re-
lated to the importance of cholesterol in the development of an increasingly complex
nervous system. [53] Therefore it is not surprising to find a large diversity of sterols in
a single sponge species and specific sterols may be used as chemotaxonomic marker
compounds. On the other hand, if the composition of the nonpolar compounds
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in the Haliclonas is assumed to be species or phenotype specific, all three purple,
elastic Haliclonas should be different species or different phenotypes of the same
species, respectively.
3.6.2 Interspecific variation in Haliclona
A comparison of interspecific metabolite variation of all Haliclonas sampled in the
Kongsfjord yields very different results for the different Haliclona groups. Only the
white, elastic sponge sampled at Kongsfjordneset and a brown, stiff Haliclona sampled
in the cave at Hansneset contain 3-alkyl pyridinium- or 3-alkyl tetrahydropyridine
alkaloids (3-APAs). These metabolites are discussed in detail in Section 3.3 and 3.5.
Haliclona samples obtained in the Kongsfjord
While the nonpolar compounds in the purple, elastic Haliclona vary between sites,
the secondary metabolites between two Haliclona groups – the brown, stiff Haliclona
sampled in 2008 in the cave at Hansneset and the white, soft Haliclona from
Kongsfjordneset – are not markedly different. Taking into account the site difference
described above for the purple, elastic Haliclonas, a difference would be expected
for the white, soft and the brown, stiff sponge sampled at Kongsfjordneset and
Hansneset, respectively. This contradicts the conclusion about the food source being
responsible for the nonpolar metabolite composition given above for the purple,
elastic Haliclona.
Since the white, soft and the brown, stiff Haliclona are morphologically very
distant, there must be a different reason for the concurrence. Similar chemical
defense mechanisms are unlikely since the brown, stiff Haliclona grows in a habitat
with much higher sponge density than the white, soft Haliclona and would therefore
be expected to produce different or more metabolites. One environmental factor that
unites the two groups is light intensity. For the white, soft Haliclona light intensity
is limited due to water depth while the cave overhang limits the light for the brown,
stiff Haliclona. This would require commensal photosynthetic organisms that are
involved in the metabolite production. The purple, elastic Haliclona sampled at
Kongsfjordneset is subject to the same light limitation as the white, soft Haliclona
and shows a similar metabolite composition although present in different relative
compound intensities (Figure 3.71).
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Figure 3.71 Comparison of base peak chromatograms (m/z = 50− 1000 ) obtained
from crude extracts of different Haliclona specimens collected in the Kongsfjord,
Spitsbergen. The shaded areas mark column-specific peaks. The analysis uses the
same chromatographic gradient as for H. viscosa samples (Figure 3.17 and 3.69).
Chromatograms are scaled to 100 % intensity of the highest peak each, observable by
varying intensity of the column-specific peaks.
A striking difference is observed between the two brown, stiff Haliclonas sampled
in the cave at Hansneset in subsequent years. The individual sampled in 2009
shows 3-APAs at low intensity in addition to other metabolites also present in other
Haliclona groups. The major compounds of the 3-APAs are haliclamine D (28) and
dehydro-haliclamine F (65). The other 3-APAs in that sponge are unidentified, yet.
The difference between the two brown, stiff Haliclonas indicates that the 2009
individual may have been misclassified. A different possibility is that the production
of the 3-APAs in that sponge has recently started suggesting that the appearance of
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3-APAs is linked to the life stage of a sponge. This possibility is supported by the
low intensity and diversity of 3-APAs in the individual.
Haliclona samples obtained from the Orkneys
Compound variation for the Orkney Haliclona groups is similar to the variation
observed in the Spitsbergen "dark-dwelling" groups. The Haliclona from Saviskaill
Head shows a similar compound composition as the Haliclona from Red Nev, but
the compound intensity is significantly different. While the purple, elastic Haliclona
was sampled from several meters depth, the grey, stiff Haliclona was sampled from
the cave in Red Nev. The observed difference in metabolite intensity may thus be
due to similar processes as in Spitsbergen, i.e. production of the metabolites by
commensal photosynthetic organisms.
5 10 15 20 25 30 min
Saviskaill Head
Red Nev Caves
Figure 3.72 Comparison of base peak
chromatograms (m/z = 50 − 1000 ) ob-
tained from crude extracts of different
Haliclona specimens collected around the
Orkney Islands. The shaded area marks
column-specific peaks. The analysis uses
the same chromatographic gradient as for
H. viscosa samples (Figure 3.17 and 3.69).
Chromatograms are scaled to 100 % inten-
sity of the highest peak each, observable
by varying intensity of the column-specific
peaks.
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3.7 Alternative taxonomy
Several questions emerge from the results of the HPLC-HRMS screening:
1. Does a given sponge species always produce the same chemical compounds
which can be used as a characteristic?
2. Are the compounds produced by the sponge itself or by associated bacteria?
3. If they are produced by associated bacteria, and if the bacteria are advected
by the water currents drawn through the sponge body, would these compounds
be found in other sponge species in the same habitat?
4. Does a given sponge species always contains the same bacteria composition
which therefore can be used as an additional characteristic, or are bacteria
ingested with food particles and thus strongly variable between different
habitats?
5. Are there bacteria strains that are resident/invariable in a Haliclona species?
6. If bacteria are ingested would a similar bacteria composition be found in
various Haliclona species that occupy the same habitat?
These questions cannot successfully be answered without trusted species identifi-
cation. The few characteristics available for a taxonomic identification of Haliclona
viscosa call for alternative methods to identify this sponge. For this purpose, several
molecular biology and chemical taxonomy methods are available. Molecular biology
offers the possibility to study the composition of associated bacteria or the sponge
genome directly. Chemical taxonomy examines the compound composition produced
by the sponge and/or the associated bacteria.
One of the most challenging tasks, before any further studies can be accomplished,
is the sampling of the desired sponge. If the sponge is hard to identify by classical
taxonomic methods, but possible to identify by its chemical fingerprint, there is
large potential for a chemical "rapid test" that answers whether the desired sponge
is found or not. After one season in Spitsbergen that did not yield any sponges that
contained 3-APAs although they had been reported from the area earlier, a method
was devised that allowed the quick, preliminary identification of 3-APA-containing
individuals.
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3.7.1 Thin layer chromatography
None of the Haliclonas obtained to-date from the Orkneys yielded 3-APAs. The
absence of 3-APAs in Orkney samples, a result that transpired from examination
of the sponges after return to the laboratory in Bremerhaven, was therefore not
surprising. A preliminary study of each sponge’s 3-APA content was deemed
impossible during vessel-based expeditions since this requires the return to the
sampling spot after a possible confirmation as well as the luck of finding the
individual. Both requirements are not easily met considering the ships schedule and
the dependence upon the weather and tides.
In contrast, the hard-substrate locations in the Kongsfjord are well known to the
divers, less exposed to weather and tides, easily accessible and clearly arranged.
Another advantage is the presence of a chemical lab at the research site in Ny-
Ålesund. Reversed-phase thin layer chromatography (RP-TLC) was chosen for its
speed, low requirements in chemical and technical equipment and low sponge crude
extract consumption. On the RP-TLC plate, crude extracts were compared to
a standard mixture of several synthetic cyclostellettamines and haliclamines (see
Section 5).
By this method, one individual (identifier GS 09/23, Figure 3.73 no. 23) was
identified in the 2009 samples that very likely contained 3-APAs as well as a number
of unknown alkaloids. However, a second individual that was later shown to contain
3-APAs by HPLC experiments (identifier GS 09/27, Figure 3.73 no. 27) was not
recognized. The reason for this may be a too-low crude extract application to the
RP-TLC plate or the general low concentration and abundance of 3-APAs in that
sponge.
3.7.2 Matrix assisted laser desorption/ionisation (MALDI)
The exact compound composition of a sponge can be a diagnostic feature in com-
bination with classical taxonomic methods. However, the presence or absence of
specific compounds alone should not decide over a species affiliation as long as
the reason for presence or absence of compounds is not determined. Several chro-
matographic methods can be used to assign the chemical compounds of a sponge
but the evaluation of classical chromatographic methods is rather time consuming.
Next to these methods, a technique would be favorable that combines analytical
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Figure 3.73 RP-TLC plate with crude extracts from
various Haliclona individuals (no. 23-28) applied against
a standard mixture (Ref) of cyclostellettamines and hali-
clamines.
precision and speed with a possibility to evaluate the results by a computerized
algorithm which allows the high sample throughput and evaluation necessary to
make a statement about ecological relevance of the findings. This possibility is given
in a mass spectrometric analysis tool like MALDI mass spectrometry. MALDI-MS
is a powerful method to analyze and characterize macromolecules like proteins [151],
carbohydrates [152], oligonucleotides [153] and synthetic polymers. [154] It is also in-
creasingly used to investigate bacteria with regard to their chemotaxonomy [155]
and secondary metabolism. [156] For technical reasons however, MALDI-MS is not
the method of choice for small molecules although a few reports exist (e.g. Grube
et al. [157] and Cohen & Gusev, 2002 [158]). In spite of that, MALDI-TOF-MS was
applied to a subset of Haliclona crude extracts and yielded interesting results for
the 3-alkyl pyridinium alkaloids.
The MALDI mass spectrum of the Haliclona viscosa sampled in 2003 shows
two areas with numerous compound masses between m/z = 420− 500 and m/z =
640−740 (Figure 3.74). The mass range atm/z = 420−500 correlates to haliclamines
and cyclostellettamines, and a closer look into the mass pattern shows that the
mass peaks are by 2 mass units apart (Figure 3.75). The clusters inside the mass
range m/z = 420 − 500 have a mass difference of m/z = 14. This agrees with
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Figure 3.74 Typical MALDI-TOF-MS spectrum of a Haliclona viscosa specimen.
The spectrum is uncalibrated.
the results obtained from HPLC-HRMS analysis where many compounds differ
by the length of the alkyl chain (m/z = 14) and the number of double bonds
(m/z = 2) but many more compound masses are visible in MALDI-MS than have
been identified (including the identification suggestions in Section 3.3) by standard
LC-MS techniques.
Although the observed masses in MALDI-MS correspond to computed masses of
different cyclostellettamines and dehydro-cyclostellettamines, only cyclostellettamine
C (33) was identified in H. viscosa crude extracts by LC-MS methods. However,
the possibility is given that various cyclostellettamines cannot be identified by
chromatographic methods due to their low concentration in the crude extract. The
possibilities of LC-(ESI)-MS of assigning chain lengths and double bonds as well as
compound abundance are not met by MALDI-MS which suggests that both methods
should be used in parallel.
The masses at m/z = 640− 740 are unexplained yet. A speculation is that they
constitute salts of the haliclamines and cyclostellettamines. The mass difference
between the first and the second mass range of approximately m/z = 222 points to
the second mass range showing double TFA salts (M=114), but a reaction of the
compounds with α-cyano-4-hydroxy cinnamic acid (HCCA, M=189) is also possible
although the mass difference does not fit very well. Both counterions, TFA and
HCCA are introduced into the sample as contents of the MALDI matrix solution.
On the other hand MALDI-MS constitutes an analysis method that mirrors very
closely the natural state of the sample since extensitve sample processing does not
occur. In this manner, the natural counterions of the 3-APAs may be analyzed
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Figure 3.75 Detail of a typical MALDI-TOF-MS spectrum (Figure 3.74) of a
Haliclona viscosa specimen. Known haliclamines and suggested cyclostellettamines
are marked by the appropriate letter of their trivial names. Masses of compounds
proposed in section 3.3 are marked with an asterisk. The spectrum is uncalibrated.
in the MALDI mass spectrum but it is uncertain whether the mass difference of
m/z = 222 reflects a natural counterion or an artefact introduced during sample
preparation.
Compound peaks for the monomeric 3-APAs, viscosalines and viscosamines are
missing in the spectrum. This is due to the variation in compound class already
observed in LC-MS analysis. For the MALDI-MS examination, the 2003 sample
had to be chosen because it required raw material (dried sponge powder) which was
no longer available for the samples of 1999, 2000 and 2001. The 2009 sample has
not been examined, yet, but is expected to show similar results as the 2003 sample
since 3-alkyl pyridinium alkaloids are absent in that sample as well. The usability
of formerly prepared and dried crude extracts will have to be tested in the future.
Another interesting feature is that all compound masses detected in the MALDI-
MS spectrum of H. viscosa are singly charged masses. In HPLC-ESI-MS, the singly
charged molecular ions show very low intensity while doubly and triply charged
masses prevail. This is a direct effect of the different ionization methods used for
the analysis; ESI supports the formation of multiply charged ions, especially during
LC-(ESI)-MS where chromatography provides a constant excess of acid. Although
MALDI also enhances multiple charges, the effect seen here may be due to an early
fragmentation happening in the haliclamines, e.g. due to the laser impact. By this,
a doubly charged haliclamine might lose a charge without change in mass (e.g. by
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a retro-Diels-Alder reaction) and may thus be seen only as a singly charged ion
(Figure 3.76).
The mass peak intensities observed in MALDI-MS cannot be due to relative
compound quantities in the crude extract; according to HPLC-MS analyses which
give a much more accurate picture about relative abundances of different compounds,
haliclamines C (27) and D (28) constitute the major metabolites in the examined H.
viscosa individual (see Figure 3.69A-2003). However, the corresponding masses for
27 and 28, m/z = 443 and m/z = 457, respectively, are not the highest mass peaks.
Instead, the compound masses that, in theory, offer several structural possibilities
(constitutional isomers) have higher mass abundance. For example, m/z = 439 may
be a haliclamine C (27) or J (61) with two double bonds. This leaves five possibilities
for chain length and double bond variation; haliclamine 9/11 (1/1), haliclamine 9/11
(2/0), haliclamine 9/11 (0/2), haliclamine 10/10 (1/1) and haliclamine 10/10 (0/2).
All of them are supposable to occur in H. viscosa, as is suggested by the number of
new structures proposed in part 3.3. The much lower m/z = 441 is occupied only
by haliclamine C (27) and J (61), which supports this hypothesis.
On the other hand, the MALDI spectrum shows the mass equivalent of compounds
that have not yet been identified as natural products from the sponge but are known
as synthetic products. An example of this is cyclostellettamine Q at m/z = 449
that contains a C10 and a C11 alkyl chain. Cyclostellettamine Q is the pyridinium
analogue of haliclamine D (28).
The other Haliclona groups sampled in the Kongsfjord and the Orkneys do not
show a distinctive peak pattern (Figure 3.77). On one hand this is consistent with the
results obtained during LC-MS analyses (Section 3.6), with low general abundance
of secondary metabolites and strong variation in the visible peaks. On the other
hand, the spectra do not show the, although small, similarities observed between the
different Haliclona groups in chromatographic analyses. The peak pattern (Figure
N NH NH NH
m/z = 471m/z = 471
NH NH
undetected MALDI 
intermediate ?
6
6
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6
Figure 3.76 Proposed fragmentation of haliclamine F (30) in MALDI-MS
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Hansneset Step
purple, elastic
200 300 400 500 600 700 800 900 m z/
Kongsfjordneset
purple, elastic
200 300 400 500 600 700 800 900 m z/
Saviskaill Head
purple, elastic
200 300 400 500 600 700 800 900 m z/
Figure 3.77 Comparison of MALDI-TOF-MS spectra obtained from analysis of
the crude extract of purple, elastic Haliclona sponges from different sampling sites.
The area shaded in grey can show unspecific matrix peaks and should be evaluated
cautiously for species specific compounds. Dotted lines are inserted for orientation.
3.77-3.79) varies strongly even within the samples of one group (not shown). The
method is not established enough to allow a clear statement about the visible peaks
being matrix peaks, impurities from sample preparation or true species specific
metabolites that change between organisms due to intra- or interspecific variation.
These results are elusive and not easily compatible with the informative results
obtained for Haliclona viscosa. MALDI-MS poses several challenges for taxonomic
applicability. One is the right choice of matrix as matrix peaks can overlie or congest
with species specific analyte peaks. Another one is the use of laser energy that can
easily lead to compound fragmentation. The distribution of the analytes inside the
sample spot is a third challenge that can give a false picture on the compounds
contained in a sample. Adduct ions of Na+ and K+ frequently occur in MALDI-MS,
possibly enlarge the number of compound peaks and thus hinder the evaluation of
complex compound mixtures. In addition, crude extracts are usually a blend of
various compound classes with a large number of unknown compounds. Methods
used in classical chromatographic analyses like derivatisation of specific compound
classes cannot be used in complex mixtures of unknown compounds as it would
lead to unpredictable products. In addition, the compound concentration is highly
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Figure 3.78 Comparison of MALDI-TOF-MS spectra obtained from analysis of the
crude extract of different Haliclona groups obtained from different sampling sites in
Spitsbergen. The area shaded in grey can show unspecific matrix peaks and should
be evaluated cautiously for species specific compounds. Dotted lines are inserted for
orientation.
inhomogeneous between species or even between individuals of one species. Therefore
it is difficult to judge the amount of crude extract needed for each analysis. A
mechanism similar to the matrix suppression effect (MSE), [159–161] where an excess
of analyte is used to suppress matrix peaks, can be active in samples with one or few
highly concentrated and a number of lower-concentrated metabolites. The so-called
analyte suppression effect (ASE) induces suppression of lower-concentrated analytes.
Since the minor metabolites often decide over a species affiliation, MALDI-MS would
be unserviceable if these difficulties cannot be overcome.
200 300 400 500 600 700 800 900 m z/
200 300 400 500 600 700 800 900 m z/
Saviskaill Head
purple, elastic
Red Nev Caves
grey, stiff
Figure 3.79 Comparison of MALDI-TOF-MS spectra obtained from analysis of the
crude extract of two Haliclona groups from the Orkneys. The area shaded in grey can
show unspecific matrix peaks and should be evaluated cautiously for species specific
compounds. Dotted lines are inserted for orientation.
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To address the uncertainties, a study is in progress that examines the potential
of MALDI-TOF-MS to analyze small compounds directly in the crude extract
of sponges (manuscript in preparation). To achieve this, thirteen species from
eleven genera, all members of the class Demospongiae, are subject to a compound
screening and comparison with standard LC-MS methods. The focus is laid on the
possibilities of identifying known compounds with a single sample processing method
that was uniformly applied to all species without species- or compound-specific
method optimization, a prerequisite for a fast, universal screening and dereplication
procedure. The results of this analysis are still under evaluation and therefore not
described here, but despite contradicting arguments, MALDI seems a promising
technique to achieve a first insight into sponge secondary metabolites. However, in
species that show low general abundance in secondary metabolites like the majority
of Haliclona specimens obtained from Spitsbergen and the Orkneys to-date, chemical
methods have a poor potential in being a useful tool in taxonomy. In such cases,
phylogenetic methods may be more beneficial.
3.7.3 Molecular phylogenetics
Since the genome of a species is also rather variable, conserved genome sequences
must be used. Therefore, the genome of a set of Haliclona sponges sampled in the
Kongsfjord in 2008 and 2009 is currently under investigation by a cooperation with
the Bininda-Emonds working group at the University of Oldenburg. The subject of
the study, as in most projects involved in the so-called "Barcoding Project", is the
CO1 gene15 on the mitochondrial DNA which has a length of 648 base pairs and is
prone to very little variation (approximately 2% in organisms inside a species). This
is due to the mitochondria (and thus mitochondrial DNA) being inherited only from
the mother, while cell nucleus DNA in animals is inherited from both, mother and
father. On the other hand, mitochondrial DNA has a relatively fast mutation rate,
which results in significant variation in its DNA sequences between species (5% total
or 10% of intraspecific variation [162]). This is a relevant criterion for the method
to allow a statement as to whether two organisms should be grouped or belong to
different species. The method can not be used to identify the species directly as
15 Mitochondrial Cytochrome C Oxidase subunit-1 gene.
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too few sponge specific entries exist in the barcoding database. Results from this
investigation are expected soon.
A different molecular biology method uses the 18S ribosomal DNA (rDNA) gene
to compare the relationship status of the sample with other samples deposited in a
database. This study is performed in a collaboration between the Hentschel working
group in Würzburg and the Köck group in Bremerhaven, by the student Laura
Gallego.
The 18S (eukaryotes) or 16S (bacteria) gene is commonly used for the purpose of
species identification and database entries exist for the gene sequences of a large
number of known species. Basis for the study is a set of samples obtained from
the Kongsfjord and from the Orkneys in 2008. In that year, however, no Haliclona
viscosa was sampled in the Kongsfjord which limits the obtained results to the other
three species found in the Kongsfjord.
The DNA in the samples is extracted, amplified, and cloned, then extracted again
and sequenced. The sequences are compared to database entries. The isolation of
DNA from a sponge is unspecific, i.e. all eukaryotic DNA is extracted. Therefore, the
DNA of e.g. associated polychaetes, ingested dinoflagellates and neighboring sponges
is extracted and amplified as well. All clones taken together are thus expected to
reflect the complete organism association inside the sample. This is confirmed by the
DNA database search for the three Haliclona groups in the Kongsfjord that returns
hits of the dinoflagellate Gymnodinium sp. and the ciliates Halteria grandinella
and Metacylis angulata for the Spitsbergen Haliclona species (Table 3.3). These
organisms are probably prey items of the sponges.
When focussing on the clone sequences that contain sponges as hits, the study
returns three possibilities for 18S rDNA clones obtained from the purple, elastic Hali-
clona sampled at Hansneset step (Spitsbergen): Aplysina fistularis (93% similarity),
Mycale fibrexilis (100% similarity) and Haliclona sp. OGL2003 (97% similarity);
the latter returns also for the brown, stiff Haliclona and for the white, soft Haliclona
but with differing similarity values. Aplysina fistularis can be neglected as it is a
Caribbean sponge. Also Mycale fibrexilis can probably be neglected as it is abun-
dant on the East coast of the USA and therefore probably a warm water organism.
However, Mycale sponges are also present in the Kongsfjord area and can have
been sampled as a neighboring organism. For M. fibrexilis, a barcode sequence is
available; therefore, the barcode project at the University of Oldenburg may clarify
these results.
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Table 3.3 Results from 18S rDNA sequencing of Haliclona samples.
Origin Clone Best hit Length Simil. Identity Class
BS/HNC 1 Gymnodinium sp. 7-15 ITS1 clone 7-15 603 bp 87% 484/556 Dinophyceae
2 Gymnodinium sp. 7-15 ITS1 clone 7-15 603 bp 86% 549/634 Dinophyceae
5 Haliclona sp. OGL2003 2624 bp 97% 39/40 Demospongiae
Amphimedon queenslandica 4101 bp 96% 155/161 Demospongiae
8 Halteria grandinella 3621 bp 84% 620/734 Ciliophora
PE/HNS 1 Metacylis angulata clone Meta00-8 486 bp 95% 394/413 Ciliophora
14 Aplysina fistularis 878 bp 93% 832/887 Demospongiae
18 Mycale fibrexilis 2499 bp 100% 159/159 Demospongiae
20 Haliclona sp. OGL2003 2624 bp 97% 39/40 Demospongiae
WS/KFN 1 Haliclona sp. OGL2003 2624 bp 99% 162/163 Demospongiae
Haliclona amphioxa isolate BDA2 2715 bp 96% 162/168 Demospongiae
2 Gymnodinium aureolum strain SWA 16 3423 bp 89% 260/292 Dinophyceae
PE/RN 1 Hymeniacidon heliophila 964 bp 83% 670/800 Demospongiae
Halichondria panicea 1104 bp 98% 360/364 Demospongiae
2 Microciona prolifera 2457 bp 91% 162/189 Demospongiae
PE/SH 1 Microciona prolifera 2457 bp 85% 162/189 Demospongiae
2 Hymeniacidon heliophila 964 bp 83% 670/798 Demospongiae
Halichondria panicea 1104 bp 99% 361/364 Demospongiae
Simil. = Similarity; bp = base pairs. Sponge groups: BS = brown, stiff;, PE = purple, elastic; WS = white,
soft. Origin: HNC = Hansneset Cave; HNS = Hansneset Step; KFN = Kongsfjordneset; RN = Red Nev; SH =
Saviskaill Head.
The Haliclona sp. OGL2003 hit is considered the closest candidate hit since
it returns for all three Spitsbergen Haliclona groups. The original Haliclona sp.
OGL2003 has been sampled on the coast of Massachusetts (USA), [163] i.e. an area
influenced by cold Arctic Water (ArW) transported south by the East Greenland
Current (EGC). However, the hit returning for all three Spitsbergen Haliclona
groups does not necessarily indicate that all three samples are the same as the
Haliclona sp. OGL2003, nor that all three groups belong to one species. Rather, it
indicates that the three groups are closely related to Haliclona sp. OGL2003.
While the purple, elastic and the brown, stiff sponge have the same similarity
values with Haliclona sp. OGL2003 (39/40 base pairs in a 2624 base pair long gene
fragment, i.e. 97% similarity), the white, soft Haliclona has a much better fit of
162/163 base pairs (99% similarity). This suggests that the white, soft Haliclona is
different from the other two and that possibly the other two belong in one group.
Between the Haliclona sponges sampled at two different sites at the Orkneys, the
study returns identical results. Both specimen show similarity with Halichondria
panicea, the bread crumb sponge (98% similarity for the Red Nev sample and 99%
similarity for the Saviskaill Head sample). Both of them also show similarity with
a Microciona prolifera sampled in Massachusetts (91% similarity of the Red Nev
sample and 85% similarity for the Saviskaill Head sponge). Microciona prolifera
(=Clathria prolifera), the red beard sponge, is common in the North-West Atlantic
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but its morphology is so different from the sampled organisms that this hit can be
neglected. However, the suggestion that the sampled sponges should be considered
as a Halichondria panicea cannot be easily neglected. Halichondria panicea is a
very variable sponge both in morphology and color, but it possesses an ectosome
which was not found in the two samples and its spicules are larger than the ones
found in the samples. However, the spicule size in H. panicea is very variable,
between 100 and 480 µm, which would fit into the results obtained for the two
specimens. Therefore, the possibility of the sponges being Halichondria panicea
specimens cannot be completely dismissed, but the result also suggests that both
sponge samples should be grouped.
3.7.4 Associated bacteria
Laura Gallego also studied the question of bacterial community composition in the
Haliclona sponges sampled at different sampling sites and to what extend a grouping
of the individuals following classical taxonomic methods is reasonable (manuscript
in preparation [164]).
Sequence variations between different microbial species’ DNA result in different
fragmentation ("denaturation") properties of DNA molecules. According to the
content and distribution of guanidine and cytosine inside the DNA fragments, the
molecules will form specific bands when separated in an electrostatic field that
is applied to a molecular sieve gel during denaturing gradient gel electrophoresis
(DGGE). The bands can be used to visualize variations in microbial genetic diversity
and provide a rough estimate of the richness and abundance of predominant microbial
community members.
When looking at the DNA banding pattern of the bacterial community in the
Haliclona sponges it is clear that the Spitsbergen sponges have a rather homogeneous
bacterial community while the Orkney sponges conform to a large extend but also
show additional bacteria varieties. A Quality-One (Q-One) analysis of DGGE bands
obtained from amplification and separation of different DNA fragments groups
the purple, elastic (Hansneset step) and the brown, stiff sponge (Hansneset cave)
closely together. This is not surprising as they were sampled from geographically
proximal sites. The similarity in the secondary metabolite composition of the two
sponges is also observed in LC-MS analyses (Figure 3.71). The area is influenced
by the same water mass, therefore advected bacteria are expected to be present
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Figure 3.80 DGGE gel (A) and Q-One Analysis on the distribution of the bacterial
communities (B) present in different Haliclona sponges sampled in Spitsbergen and
the Orkneys. Data shown by courtesy of L. Gallego.
in both sponges. The white, soft Haliclona sampled at Kongsfjordneset16 differs
from the two. Still more distant is the purple, elastic Haliclona sampled in the
Orkneys (Figure 3.80). As the Orkneys in general are influenced by a similar water
mass ("Gulf Stream") but are characterized by strongly diverging environmental
conditions otherwise (especially temperature), the separation of Orkney samples
from Spitsbergen samples fits in the picture.
A comparison between the purple, elastic Haliclona at Hansneset, Kongsfjordneset
and the Orkneys with a white, soft Haliclona from Kongsfjordneset shows that both
the white and the purple sponge at Kongsfjordneset contain a bacteria composition
that is more similar to the Orkneys than to Hansneset (Figure 3.81). The secondary
metabolite similarity between the purple, elastic Haliclona at Kongsfjordneset and
the white, soft Haliclona from the same area is also found in LC-MS experiments
(Figure 3.71). Although the secondary metabolites are different in intensity, the
compound pattern between the two sponges is similar. This acknowledges the
importance of advection processes and uptake by filtration in contrast to resident
and inherited bacteria. The Kongsfjordneset and Orkney environment are similar
in being oceanic environments while the Hansneset area is a coastal environment
influenced by high sediment loads. The Haliclona samples from Red Nev (Orkneys)
16 In 2008, no white, soft sponges were found in Hansneset.
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also group closely together, but away from the oceanic Kongsfjordneset (Spitsbergen)
and Saviskaill Head (Orkneys) as well as the coastal Spitsbergen samples. This
suggests an adaption of the bacterial community to the cave habitat. In general,
the two Red Nev samples show very few bands in the DGGE gel which indicates
little diversity in the bacterial community (Figure 3.81)
Another question addressed by the analysis is whether it is possible to group the
sampled organisms at a given sampling site by morphological characters and color.
The DGGE results show very similar banding patterns for different individuals of
a sponge group sampled at one site and thus supports the approach to group the
individuals (Figure 3.82 and 3.83).
Sequencing of the bacterial DNA yielded that the purple, elastic Haliclona from
the Orkneys contains β- and γ-Proteobacteria and Bacteria while the purple, elastic
Haliclona from Hansneset is similar but does not contain the β-Proteobacteria. In
the Hansneset specimen, four out of ten examined clones identify as Arctic surface
sediment associated clones and one as a surface seawater associated clone. The other
five are uncultured bacteria clones. The association with sediment bacteria fits well
into the general discription of the Hansneset environment which is influenced by
turbid waters that result from river runoff and melting glacial ice.
Five out of ten clones obtained from the Orkney sample associated bacteria
identify as Haliclona simulans associated clones, two are a "marine sponge associated
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Figure 3.81 DGGE gel (A) and Q-One Analysis on the distribution of the bacterial
communities (B) present in different Haliclona sponges sampled in Spitsbergen (HNS
= Hansneset step, KFN = Kongsfjordneset) and the Orkneys (SH/O =Saviskaill Head,
Orkneys). Data shown by courtesy of L. Gallego.
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Figure 3.82 DGGE gel (A) and Q-One Analysis on the distribution of the bacterial
community (B) present in several organisms of the purple, elastic Haliclona sampled
in Spitsbergen or the Orkneys (Saviskaill Head vs. Red Nev). Data shown by courtesy
of L. Gallego.
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Figure 3.83 DGGE gel (A) and Q-One Analysis on distribution of the bacterial
community (B) present in several organisms of the white soft Haliclona sampled
at Kongsfjordneset (KFN) and the brown, stiff Haliclona sampled in the cave at
Hansneset (HNC). The study was performed for the chemical similarity of the two
sponge groups, disregarding the color. Data shown by courtesy of L. Gallego.
Spongibacter nickelotolerans"; another two are an Emiliania huxleyi chloroplast
strain and therefore probably prey-derived and the last two are an Arctic surface
sediment associated clone and an uncultured bacterium.
The association of the purple, elastic Haliclona from the Orkneys with Haliclona
simulans associated clones suggests that the sampled sponge is a H. simulans.
Haliclona simulans does indeed show very variable growth forms and can grow in
thin cushions but is usually an erect growing, branching sponge. A picture in the
Encyclopedia of Marine Life [165] shows a purple cushion-like sponge that looks similar
to the sampled sponges. However, the taxonomic sponge description does not fit,
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especially as the sponge is described as hard and brittle. Thus, the H. simulans
associated clone may not be confined to H. simulans but also be present in other
sponges.
The brown, stiff Haliclona found in Hansneset cave associates with Bacteria and
α- and γ-Proteobacteria. Two out of nine are Arctic surface sediment associated
clones, four are uncultured bacteria, one is an Axinella corrugata associated α-
Proteobacterium, one is a gill symbiont (γ-Proteobacterium) of the vent mussel
Bathymodiolus puteoserpentis that lives around hydrothermal vents in the Atlantic
ocean and one is a Lake Mackenzie (Texas) water associated clone.
The white, soft Haliclona from Kongsfjordneset also associates with the Lake
Mackenzie clone as well as clones found in Arctic, Antarctic and Spitsbergen seawater.
Two are uncultured bacteria and one is a Tethya aurantium associated clone. The
absence of sediment associated clones in this sponge confirms that the habitat is
much more influenced by oceanic water than the coastal site Hansneset Step.
Conclusion
The differences in bacterial communities between purple, elastic Haliclonas sampled
at different sites in the same fjord shows that bacterial communities should carefully
be consulted for taxonomic identification. As in the example of the Haliclona
simulans associated clone, the possibility of the same bacteria being present in
related sponge species should always be considered. Several bacteria species seem
to be ubiquitously present, even if they are mainly found in a specific sample; this
is the case in the gill symbiont of a hydrothermal vent mussel which lives in a
significantly different environment than the sampled sponge; another example is
the Lake Mackenzie (Texas) water clone that usually lives in fresh water in a warm
environment but is found in a marine Arctic sponge. However, the finding of the
bacteria’s DNA inside the sponge does not allow inference about the viability of the
bacterium.
The study of the direct phylogenetic relationships of the sponge samples in the
Kongsfjord and from around the Orkneys suggests that two hitherto separated
groups should be united to form one group; the purple, elastic sponge should be
joined with the brown stiff Haliclona and the Saviskaill Head sample should be
united with the Red Nev cave sample. The latter is also proposed by the results
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of classical taxonomic identification. The identity of the sponges is, however, still
unknown.
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Stylissa caribica
Stylissa caribica. Picture taken
by G. Schmidt
Stylissa caribica is a sponge that belongs to the
order Halichondrida, family Dictyonellidae, and
was first described in 1998. It is the only Stylissa
species known from the Caribbean,1 while an-
other three species, Stylissa massa, S. flabelli-
formis, and S. variabilis, share a habitat in the
Indo-west Pacific region. A fourth species known
as Acanthella or Axinella carteri, also occurs in
the Pacific and was re-classified to the genus
Stylissa. [78] Stylissa caribica is subject to natural
products research since 2001 and proves to be a
rich source of pyrrole-imidazole alkaloids, [167,168]
which are currently the object of a different PhD
thesis. In addition to various pyrrole-imidazole alkaloids, Achim Grube isolated four
compounds from a different compound class during the course of his study of S.
caribica. [168] They are cyclic peptides and were conjointly identified. [169]
Cyclic peptides are reported regularly from different bacteria, funghi, plants and
animals. The most well-known is probably cyclosporine A (84), an undecapeptide
produced by the fungus Trichoderma polysporum.2 In general, cyclic peptides differ
1 S. caribica was claimed to be the same species as Teichaxinella morchella Wiedenmayer, 1977 [166]
which was recently reclassified to Axinella corrugata but confirmation/rejection by taxonomists
is missing. [78]
2 The fungus was reclassified to Tolypocladium inflatum. Later, several other fungi species were
also found to produce cyclosporine A.
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widely in peptide chain length and amino acid composition but common to most
of them is their bioactive potential that would make them an interesting object for
pharmaceutical use.
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Cyclic peptides are characterized by their
exceptional stability compared to linear
peptides of the same sequence and chain
length. They are much more stable towards
heating and extreme pH and without a be-
ginning or an end they are not targeted
by proteolytic enzymes. The ends of linear
peptides are often flexible and ill-defined, in
contrast to their highly structured interior.
This flexibility is bad from an entropic per-
spective when proteins bind to their molec-
ular receptors, leading to reduced binding
affinity and biological activity. [170] The resistance to protease digestion and improved
thermodynamic stability of cyclic peptides can improve the biological activity of a
peptide in vivo. [171] This is exemplified by the loss of hemolytic activity in the linear
analogue of the cyclic peptide kalata B1. [172,173]
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Cyclic peptides are not uncommon in sponges. Table 4.1 represents a selection
of heptapeptides isolated from Halichondrida sponges. From Stylissa caribica, nine
heptapeptides were reported so far, phakellistatin 13 (85), stylisins 1 (86) and 2
(87), [196] and the stylissamides A–F (88–93) [169,197], while there are no reports of
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Table 4.1 Cyclic heptapeptides isolated from different sponges of the order Hap-
losclerida, class Demospongiae.
Compound namea Sequence (cyclo-)b isolated fromc Reference
Axinastatin 1 Pro-Phe-Val-Val-Pro-Val-Asn Axinella sp. [174,175]
Axinastatin 2 Pro-Phe-Val-Leu-Pro-Val-Asn Axinella sp. [176,177]
Axinastatin 3 Pro-Phe-Ile-Leu-Pro-Val-Asn Axinella sp. [176,177]
Axinastatin 4 Pro-Leu-Trp-Val-Pro-Leu-Thr Axinella carteri [177]
Axinellin A Pro-Phe-Thr-Ile-Phe-Pro-Asn Axinella carteri [178]
Euryjanicin A Pro-Ile-Ser-Phe-Val-Pro-Trp Prosuberites laughlini [179]
Euryjanicin B Pro-Phe-Val-Pro-Pro-Ala-Thr Prosuberites laughlini [180]
Euryjanicin C Pro-Ile-Ser-Ile-Pro-Leu-Phe Prosuberites laughlini [180]
Euryjanicin D Pro-Ile-Phe-Ser-Pro-Ile-Phe Prosuberites laughlini [180]
Hymenamide A Pro-Pro-Val-Pro-Phe-Trp-Arg Hymeniacidon sp. [181]
Hymenamide B Pro-Pro-Asn-Phe-Val-Glu-Phe Hymeniacidon sp. [181]
Hymenamide C Pro-Phe-Gly-Pro-Glu-Leu-Trp Axinella carteri [182]
Hymenamide D Pro-Tyr-Asp-Pro-Leu-Ala-Ile Hymeniacidon sp. [183]
Hymenamide E Pro-Thr-Thr-Pro-Tyr-Phe-Phe Hymeniacidon sp. [183]
Hymenamide F Pro-Pro-Ala-Val-Met-Leu-Arg Hymeniacidon sp. [184]
Malaysiatin Pro-Pro-Phe-Val-Val-Val-Asn Pseudoaxinyssa sp. [185]
Phakellistatin 1 cPro-Ile-cPro-Tyr-cPro-Phe-Ile Phakellia costata [186,187]
Stylotella aurantium
Phakellistatin 2 cPro-Tyr-cPro-Phe-cPro-Ile-Ile Phakellia carteri [175,188–190]
Stylotella aurantium
Phakellistatin 4 Pro-Thr-Pro-Phe-Ile-Phe-Ser Phakellia costata [188]
Phakellistatin 5 Pro-Phe-Asn-Ala-Met-Ala-Ile Phakellia costata [191,192]
Phakellistatin 6 Pro-Ile-Pro-Phe-Pro-Trp-Leu Phakellia costata [193]
Phakellistatin 13 (85) Pro-Gly-Phe-Pro-Trp-Leu-Thr Phakellia fusca [194]
Stylissa caribica
Pseudoaxinellin 1 Pro-Val-Asn-Pro-Phe-Val-Val Pseudoaxinella massa [195]
Stylisin 1 (86) Pro-Leu-Pro-Tyr-Pro-Ile-Phe Stylissa caribica [196]
Stylisin 2 (87) Pro-Ile-Pro-Tyr-Pro-Pro-Phe Stylissa caribica [196]
Stylissamide A (88) tPro-Tyr-Lys-tPro-cPro-Val-Tyr Stylissa caribica [169]
Stylissamide B (89) cPro-Phe-cPro-tPro-cPro-Ile-Tyr Stylissa caribica [169]
Stylissamide C (90) cPro-Tyr-cPro-Phe-cPro-Phe-Ile Stylissa caribica [169]
Stylissamide D (91) cPro-Tyr-cPro-Leu-cPro-Phe-Ile Stylissa caribica [169]
Stylissamide E (92) cPro-Tyr-tPro-Ala-Ile-Gln-Ile Stylissa caribica [197]
Stylissamide F (93) tPro-cPro-Phe-Asp-tPro-Arg-Phe Stylissa caribica [197]
Stylostatin 1 Pro-Phe-Asn-Ser-Leu-Ala-Ile Stylotella aurantium [198]
Stylopeptide 1 Pro-Ile-Pro-Leu-Ile-Phe-Ser Stylotella aurantium [199]
Wainunuamide tPro-His-tPro-cPro-Gly-Leu-Phe Stylotella aurantium [200]
a Only heptapeptides are mentioned that contain proteinogenic amino acids.
b cPro = cis-proline, tPro = trans-proline, Pro = proline with undetermined configuration.
c Species names are given as mentioned in the original publication and may have change since.
cyclic peptides from other Stylissa species. However, if the taxonomic reclassification
of Axinella carteri to the genus Stylissa proves to be valid, then three (possibly
six) heptapeptides must be considered present in Stylissa from the Pacific ocean:
axinastatin 4, axinellin A and hymenamide C (as well as axinastatins 1-3 if Axinella
sp. was also a Stylissa sp.).
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The most intriguing feature in these cyclic peptides is that they are very rich in
proline, taking into account the length of the peptide chain. Axinastatin 4, axinellin
A, hymenamide C, phakellistatin 13 (85) and stylissamide E (92) contain two,
stylisin 1 (86) and stylissamide A (88), C (90), D (91) and F (93) three proline
residues. In stylisin 2 (87) and stylissamide B (89) four out of the total of seven
amino acids are prolines.
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This makes the sequence assignment by mass spectrometric methods difficult
since proline-containing peptides preferentially fragment at a proline residue. [201]
In the case of stylissamide B (89), this results in four fragmentation pathways
with overlapping fragment masses. An additional challenge in mass spectrometric
experiments exhibited the simultaneous presence of isomeric amino acids like leucin
and isoleucin (bothm/z = 113.0841) in stylissamide D (91) as well as the coexistence
of tripeptide fragments of similar fragment mass in stylissamide C (90) and D (91)
(see publication 1).
Similarly, the dominant presence of one amino acid hampers evaluation of 2D NMR
experiments due to the resulting overlap in signals, especially in the Hα(i)/CO(i−1)
and NH(i)/CO(i−1) regions of the 1H,13C-HMBC spectrum used for assigning the
peptide sequence.
A combination of both methods, mass spectrometry with exact mass measurements
in the fragmentation mode and NMR spectroscopy with selective experiments,
finally led to the sequence assignment for all stylissamides. Both, the evaluation
of stylissamide mass spectra derived from different ionization and fragmentation
methods as well as extensive 2D NMR experiments are described in publication 1
(page 137).
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Material and Methods
Sponge material
Haliclona spp.
The sponges were collected by scuba divers in a depth range of 3-30m in the
Kongsfjord, Spitsbergen and around the Orkneys Islands, Great Britain. Sponges
sampled in the three areas before the year 2007 were collected by Michael Assmann
and other members of the AWI Scientific Diving Team.
The Orkney samples in 2007 were collected by G. Schmidt from different locations
around the islands whereas the samples in June 2008 and July 2009 were obtained
from the same diving locations by S. Fuhrmann, R. Lehmann and S. Bleck (AWI
Diving Team). In the Kongsfjord, sponges were collected by G. Schmidt in July
2008 and June/July 2009.
Sponges were cut off from the hard substrate and collected into diver’s mesh
bags. On board the diving boat, they were removed from the bag and maintained in
containers filled with ambient seawater. This was done to minimize stress or damage
to the animal by the net from beating waves during the transport back to land or
the research vessel.
In the laboratory, a small piece of each individual was conserved in 90% ethanol
and used for taxonomic identification, a second piece was removed for bacteria
isolation and stored at 4 °C in ambient seawater until further use, and the remaining
sponge material was individually packed into polypropylene zipper bags and frozen
at –20 °C. Later, this frozen sponge material was freeze-dried and again stored at
–20 °C.
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Stylissa caribica
Stylissa caribica was collected in Bahamian waters in a depth range of 10-30m in
2008 by Gesine Schmidt and before 2008 by Michael Assmann and other members
of the University of North Carolina Wilmington scientific diving team. On board,
the sponges were identified taxonomically by Prof. Sven Zea, then frozen at –20 °C.
Transport to Germany was performed on dry ice; subsequently the sponges were
freeze-dried and stored at –20 °C.
Taxonomic Identification
Taxonomic identification was carried out on a Zeiss Axioskop 40 equipped with a
10×/0.25 and a 40×/0.65Ph2 Achroplan achromatic system. A Neubauer Improved
Zählkammer1 with 1mm edge length in the major square, 0.2mm edge length in
the minor square and 0.4mm edge length in the smallest square was used for length
measurement. A digital camera with 3.5× internal zoom was mounted on the system
and pictures were taken of every specimen, with special focus on the choanosome
arrangement and the spicule size. For spicule size determination, 10 spicules of every
specimen were measured by applying the Zählkammer measure to the spicule photo.
Separation of Bacteria and Sponge Cells
The cell subdivision and extraction procedure followed a method described by
Laroche et al. (2007). [202] Briefly, approximately 2 cm3 of a fresh sponge individual
were pestled, the water-cell-suspension was transferred into a graduated cylinder
and filled to 4mL with salt water (3.4% NaCl). This solution which contained
compartmentalized or small aggregates of sponge- and bacteria cells was poured
over a 40µm sieve into a 15mL vial from which it was equally distributed into four
2mL vials and labelled SC (sponge cells). The SC-vials were then centrifuged at
1 500 rpm and 4 °C for 5 minutes. The supernatant of each of the four vials was
transferred to four 1.5mL vials labelled BC (bacteria cells). The 1.5mL BC-vials
were centrifuged at 13 000 rpm and 4 °C for 25 min. The supernatants were merged
in a storage vial and labelled SN (supernatant).
1 www.zaehlkammer.de/deutsch/neubauer.improved.html
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The procedure was repeated starting with addition of 1mL of salt water to each
of the SC-vials. The quality of the cell separation was inspected by observing the
cell size in light microscopy under oil: sponge cells 10-40 µm, bacteria cells 0.2-5µm.
Subsequently, all samples were frozen promptly in a steel cooling block at –80 °C and
shipped to Bremerhaven in a liquid nitrogen saturated dry shipper at a temperature
lower than –80 °C.
Sponge Tissue Extraction
Crude extracts were prepared by exhaustive extraction of one volume of freeze-
dried, homogenized sponge with the ten-fold volume of methanol : dichloromethane
(MeOH :DCM 1 : 1). Extracts were filtered (Schleicher & Schüll black ribbon paper,
Nr. 5891), then concentrated by rotaevaporation. For TLC and HPLC analyses, the
crude extract was redissolved in methanol.
Bacteria/Sponge Cell Extraction
The bacteria and sponge cell samples were thawed by adding 1mL methanol to each
vial. The cell pellet was suspended in a vortexer, treated with ultrasound for 15min,
then centrifuged. The sponge cell extract was filtered (Ederol, Nr. 53) into HPLC
vials whereas the bacteria cell extract was transferred without filtering. Of each
sample, 20µL of the dissolved extract were injected during HPLC instead of the
5µL used for crude extracts. This was done to account for the lower crude extract
concentration in the cell isolates. Each sample was subjected to the same HPLC
method as the sponge crude extracts to allow comparability.
Thin Layer Chromatography (TLC)
Glass plates precoated with a Merck RP-18 F254S stationary phase were used for
TLC. The mobile phase consisted of butanol saturated with acidic water. A mixture
of pure, synthetic haliclamines C and D (Rf ~0.8 ) and cyclostellettamines C, N, L,
and Q (Rf ~0.4 ) was used as a control, applied onto each TLC plate and run with
the crude extracts. Dragendorff’s reagent for staining alkaloids as well as vanillin
reagent and sulphuric acid (~5%) for a broader compound spectrum served as dye.
The plates were heated, then photographed immediately.
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Mobile phase — BuOH :CH3COOH (glacial) : H2O (4 : 1 : 5)
Dragendorff’s spray reagent — prefabricated, Merck 1.02035.0100
Vanillin spray reagent — 6g vanillin in 250mL EtOH and 2.5mL H2SO4 (95-97%)
Sulphuric acid spray solution — 10mL H2SO4 (95-97%) in 190mL H2O
High Performance Liquid Chromatography (HPLC)
High performance liquid chromatography (HPLC) used two different systems; an
analytical system and a preparative system. Both were fitted with a quarternary
pump to allow ternary or quarternary gradients and a diode array detector (DAD)
to record UV spectra. Analytical HPLC used an Agilent 1100 system equipped
with a Waters XTerra MS RP18 column (3.0× 150 mm, 3.5 µm) and a tempered
column compartment. The preparative system consisted of a Jasco 1500 series HPLC
equipped with a Prontosil Eurobond RP18 column (20× 250mm, 5mm), a tempered
column compartment and two simultaneously operating detector types, a DAD and
an evaporative light scattering detector (ELSD).
HPLC of Haliclona viscosa extracts
Analytical HPLC was run with a linear ACN/HCOOH (0.1% in H2O) gradient at
35 °C and a flow rate of 0.4mL min−1; 0min: 20% ACN/80% HCOOH; 25min:
55% ACN/45% HCOOH; 27min: 100% ACN.
During preparative HPLC, an ACN/H2O (both 0.1% TFA) gradient at 40 °C
and a flow rate of 8ml min−1 was used; 0-5min: 30% ACN/70% H2O isocratic;
35-40min: 60% ACN/40% H2O isocratic; 50min: 100% ACN.
HPLC of Stylissa caribica extracts
During analytical HPLC, the instrument supplied an ACN/HCOOH (0.1% in H2O)
gradient at 25 °C with a flow rate of 0.4mL min−1; 0min: 10% ACN/90% HCOOH;
30min: 60% ACN/40% HCOOH.
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High Resolution Mass Spectrometry (HRMS)
Accurate mass spectra were acquired using a Bruker microTOFLC mass spectrometer.
The instrument was equipped with an ESI source which operated in positive mode
and used the following conditions: dry gas flow 5L min−1, dry gas temperature
180 °C, nebulizer gas pressure 0.4 bar, capillary voltage 4500V (7 nA). The capillary
exit was set to 100V and the skimmer to 50V. For fragmentation experiments,
the voltage of the capillary exit voltage was raised to 150-200V while the skimmer
voltage remained the same. The instruments was externally calibrated prior to
every experiment using sodium formiate clusters of the following reference masses:
226.9515, 294.9389, 362.9263, 430.9138, 498.9012, 566.8886, 634.8760, 702.8635 and
770.8509. Calibration resulted in the standard deviation of the calibration curve
(quadratic calibration) being below 5 ppm.
For experiments that used liquid chromatography coupled to mass spectrometry
(LCMS), the gas flow into the instrument was increased to reach 4 bar nebulizer gas
pressure and 9L min−1 dry gas flow. The instrument was externally calibrated prior
to every LCMS experiment, with the exception of over-night recordings.
Matrix-Assisted Laser Desorption/Ionisation Mass Spectrometry
(MALDI-MS)
All MALDI-MS measurements were acquired at the GKSS Forschungszentrum
Geesthacht, Germany, using a Bruker ultraflex II TOF/TOF mass spectrometer. For
MALDI-MS measurements, approximately 10mg of freeze-dried and homogenised
sponge were weighed into a 1.5mL vial. Directly before the measurement, 100 µL
methanol (MeOH) were added to the vial, the mixture was treated with ultrasound
for 10min and then centrifuged. In a vial cap, 0.5 µL of the supernatant were
mixed with 0.5µL of matrix solution and of this mix, 0.5µL were pipetted onto an
Anchorchip™ target plate spot. Pure matrix solution pipetted onto a spot served as
a blank. All solutions were left to dry, then checked for adequate crystallisation and,
where necessary, re-crystallised.
After the drying was complete, the target plate was inserted into the machine,
the machine evacuated and the samples measured with adaptive laser power ("fuzzy
control") in positive mode. Peaks present in the blanks were regarded as background
in the sample measurements.
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Matrix solution — 5mg HCCA in 1mL ACN : 0.01% TFA (1 : 1)
Re-crystallisation solution — EtOH : acetone : 0.01% TFA (6 : 3 : 1)
134
6
Publications
Articles
1. G. Schmidt, A. Grube, M. Köck. Stylissamides A-D — New Proline-Containing
Cyclic Heptapeptides from the Marine Sponge Stylissa caribica. Eur. J. Org.
Chem., 2007, 4103-4110. DOI: 10.1002/ejoc.200700013. . . . . . . . . . . . . . . . . 137
2. G. Schmidt, C. Timm, M. Köck. New Haliclamines E and F from the Arctic
Sponge Haliclona viscosa. Org. Biomol. Chem. 2009, 7 (15), 3061-3064.
DOI: 10.1039/B904157E. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161
Poster Presentations
1. A. Grube, G. Schmidt, M. Köck. New Cyclic Heptapeptides and Pyrrole-
Imidazole Alkaloids from the Caribbean Sponge Stylissa caribica. 12th Inter-
national Symposium on Marine Natural Products, Queenstown, New Zealand
(2007). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 171
2. G. Schmidt, A. Grube, S. Frickenhaus, M. Köck. Conformational Studies
on Stylissamides, Cyclic Heptapeptides from Stylissa caribica. 5th European
Conference on Marine Natural Products, Ischia, Naples, Italy (2007). . . . 173
3. G. Schmidt, C. Cychon, M. Köck. Secondary Metabolites in Marine Sponges;
Qualitative and Quantitative Variation over Time. AWIPEV-Workshop Bre-
men, Germany (2008). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 175
135
6 Publications
4. G. Schmidt and M. Köck. Study of the MS-Fragmentation of the Haliclamines.
6th European Conference on Marine Natural Products, Porto, Portugal (2009).
177
5. C. Cychon, G. Schmidt, M. Köck. MALDI-TOF-MS, a Suitable Method for
Metabolite Screening? 6th European Conference on Marine Natural Products,
Porto, Portugal (2009). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 179
136
FULL PAPER
DOI: 10.1002/ejoc.200700013
Stylissamides A–D – New Proline-Containing Cyclic Heptapeptides from the
Marine Sponge Stylissa caribica
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Four new cyclic heptapeptides, stylissamides A–D (1–4),
were isolated from the Caribbean sponge Stylissa caribica.
The structures of these metabolites were elucidated by NMR
and MS/MS methods. The peptides contain three and, in one
case, four proline residues. The sequence assignment of 1–
4 by NMR was supported by fragmentations in HR-MS/MS
Introduction
Sponges of the order Halichondrida are a rich source of
non-ribosomal cyclic peptides containing seven to ten
amino acids.[1] Sponges of the genus Phakellia reveal the
substance class of phakellistatins whereas sponges of the
genus Hymeniacidon contain the hymenamides. The phakel-
listatins especially, such as phakellistatin 2 (5),[2] show cyto-
toxic effects against a variety of tumour cell lines.[3] Very
recently, two cyclic heptapeptides, stylisin 1 (6) and 2 (7),
were isolated from the Jamaican sponge Stylissa caribica
(see Scheme 1). In contrast to other cyclic peptides they are
inactive in antimicrobial, anti-malarial, anti-cancer, anti-
HIV-1, anti-Mtb, and anti-inflammatory assays.[4] The
Caribbean sponge Stylissa caribica (order Halichondrida)
was found to be a rich source of pyrrole-imidazole alka-
loids.[5] Using HPLC-HRMS screening of the crude extract
several new metabolites were isolated: 4-bromopyrrole-
2-carboxy-N(ε)-lysine,[6] 4-bromopyrrole-2-carboxyargi-
nine,[6] oxocyclostylidol,[7] and stylissadines A and B.[8] In
the course of this investigation a Sephadex LH-20 fraction
of the n-butanol phase was analyzed. This fraction con-
tained four non-brominated compounds with molecular
masses between m/z 800 and 900. A comparison of the ac-
curate molecular masses with the literature (MarinLIT®) re-
vealed four metabolites with a previously unobserved mass
which were separated by preparative HPLC. Herein, we re-
port the structure elucidation of these new compounds by
spectroscopic methods (NMR, MS, and MSn).
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measurements. The absolute configuration of all amino acid
residues was assigned as L using Marfey’s method and the
OPA method.
(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim,
Germany, 2007)
Scheme 1. Structural formulae of stylissamides A–D (1–4), phakel-
listatin 2 (5), stylisin 1 (6), and stylisin 2 (7).
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Results and Discussion
In our continuous search for new bioactive secondary
metabolites of marine sponges from tropical waters, Stylissa
caribica was collected by SCUBA at Little San Salvador in
the Bahamas (23 m depth, July 2000). The freeze-dried
sponge tissue was extracted with a 1:1 mixture of MeOH/
CH2Cl2 and the crude extract was partitioned by liquid/
liquid extraction between n-hexane, nBuOH and H2O.
The resulting nBuOH phase was purified by Sephadex
LH-20 chromatography. Final purification of the four me-
tabolites was achieved by preparative RP18 HPLC. The fact
that the metabolites were not halogenated, the characteris-
tic 1D NMR spectra and the occurrence of cyclic peptides
in other sponges of the order Halichondrida suggested the
compounds were peptides. The four compounds were eluci-
dated by 2D NMR and MS methods. The NMR spectro-
scopic data are summarized in Tables 1, 3, 5 and 6 respec-
tively.
For each of the four compounds 1–4 (see Scheme 1)
seven carbonyl carbons were observed in the 13C NMR
spectrum. The 1H NMR spectrum showed four amide pro-
tons for 1, 3, and 4 and three amide protons for 2. Together
with the results of the HPLC analysis of the hydrolysed
metabolites (Marfey’s method) which showed that proline
was a common amino acid in all four compounds, these
results indicated the assignment to the structural class of
heptapeptides. Due to the cyclic peptides found in other
sponges of the order Halichondrida the degrees of unsatu-
ration for the molecular formulae of 1–4 (HR-MS) were
compared to the sum of degrees of unsaturation in the
amino acids contained in each peptide. The molecular for-
mula of 1 resulted in 19 degrees while the amino acids ac-
counted for 18 degrees of unsaturation, indicating the cyclic
nature of this compound. The degrees of unsaturation were
compared in the same way for compounds 2 (20 vs. 19), 3
(23 vs. 22) and 4 (19 vs. 18), and suggested a cyclic structure
for these compounds as well.
The molecular weight of 1 (m/z 845.4555 [M + H]+) was
obtained from the ESI mass spectrum (HR-ESIMS) and
indicated the molecular formula C44H61N8O9. The 1H
NMR spectrum of 1 displayed four amide proton signals at
7.67, 7.62, 7.33 and 7.24 ppm in addition to seven carbonyl
signals at 171.5, 171.4, 2  170.5, 170.0, 169.1 and
167.9 ppm in the 13C NMR spectrum (see Table 1). All
amino acid residues were assigned by 2D NMR techniques
as 3  Pro, Val, Lys, and 2  Tyr, which was in accordance
with the carbonyl and amide proton signals and defined the
molecule as a heptapeptide. The amino acid sequence was
established by a combination of classical and semi-selective
1H,13C-HMBC experiments between the NH, Hα, and in
the case of proline, Hδ of one amino acid and the carbonyl
carbon of the preceding amino acid. The correlations Pro1-
Hα/Tyr7-CO and Pro1-Hδ/Tyr7-CO proved the fragment
Tyr7-Pro1. The correlations Lys3-Hα/Tyr2-CO, Pro4-Hα/
Lys3-CO, Pro5-Hα/Pro4-CO, Val6-Hα/Pro5-CO and Tyr7-
Hα/Val6-CO lengthened this fragment to give the final se-
quence Tyr2-Lys3-Pro4-Pro5-Val6-Tyr7-Pro1. In addition to
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Table 1. 1H, 13C and 15N NMR chemical shifts of stylissamide A
(1) in [D6]DMSO.[a]
Entry Residue Position δC/δN δH, mult. (J /Hz)
1 Pro1 N 135 –
2 CO 171.4 –
3 α 62.6 3.97, dd (7.3, 9.0)
4 β, β 28.3 2.02, m; 1.60, m
5 γ, γ 24.8 2.02, m
6 δ, δ 46.7 3.74, m
7 Tyr2 NH 108 7.67, d (8.1)
8 CO 170.5 –
9 α 54.2 4.32, m
10 β, β 34.2 3.17, dd (3.1, 14.0);
2.89, dd (11.8, 14.0)
11 1 128.2 –
12 2, 6 129.2 7.00, d (7.6)
13 3, 5 114.6 6.65, d (7.6)
14 4 155.6 –
15 OH – 9.18, s
16 Lys3 NH 115 7.33, d (7.0)
17 CO 167.9 –
18 α 50.4 4.40, d (8.4)
19 β, β 30.5 1.82, m; 1.50, m
20 γ, γ 22.0 1.32, m; 1.31, m
21 δ, δ 26.4 1.57, m
22 ε, ε 38.3 2.76, dd (7.0, 14.3)
23 NH2 34 7.76, s
24 Pro4 N 139 –
25 CO 170.0 –
26 α 58.6 4.30, m
27 β, β 27.7 2.17, m; 1.74, m
28 γ, γ 24.2 1.91, m, 1.85, m
29 δ, δ 46.6 3.44, m; 3.34, m
30 Pro5 N 126 –
31 CO 170.5 –
32 α 60.0 4.42, d (8.4)
33 β, β 30.9 2.17, m; 2.07, m
34 γ, γ 21.5 1.85, m; 1.51, m
35 δ, δ 46.1 3.42, m
36 Val6 NH 117 7.62, d (8.4)
37 CO 169.1 –
38 α 61.3 3.67, t (8.4)
39 β 29.5 1.77, m
40 γ 18.9 0.77, d (6.7)
41 γ 18.9 0.45, d (6.7)
42 Tyr7 NH 112.7 7.24, d (8.7)
43 CO 171.5 –
44 α 51.3 4.90, dt (3.4, 9.8)
45 β, β 37.0 3.28, m; 2.39, dd (10.7, 14.0)
46 1 126.4 –
47 2, 6 129.9 7.07, d (7.6)
48 3, 5 114.8 6.67, d (7.6)
49 4 155.8 –
50 OH – 9.23, s
[a] 1H and 13C chemical shifts were referenced to the [D6]DMSO
signal (2.50 ppm and 39.5 ppm, respectively). 15N NMR spectra
were not calibrated with an external standard. Therefore, the 15N
NMR shifts are given without decimals. The δ value has an accu-
racy of about 1 ppm in reference to NH3 (δ = 0 ppm).
the Hα(i)/CO(i–1) correlations the amide NH(i)/CO(i–1) corre-
lations were observed for Lys3-NH/Tyr2-CO, Val6-NH/
Pro5-CO and Tyr7-NH/Val6-CO. The ring closure in styliss-
amide A (1) was given by another 1H,13C-HMBC corre-
lation between Tyr2-NH and Pro1-CO and two NOE corre-
lations between Tyr2-NH and both, Pro1-Hα and Pro1-Hγ.
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Figure 1. HR-MS/MS spectrum of stylissamide A (1). The precursor ion is indicated by the filled square. Only the main fragmentation
pathway is indicated. Masses associated with this fragmentation pathway and the corresponding observed masses derived from CO loss
(28 amu) are given.
The sequence was supported by other NOE correlations be-
tween NH(i) and Hα(i–1) and in the case of proline Hδ(i) and
Hα(i–1) (see Figure 3 and Supporting Information).
The sequence of stylissamide A (1) was further supported
by the fragmentation pattern obtained through HR-MS/MS
and MSn measurements. Although, the cyclic structure of
the peptides 1–4 does not provide a definite position for
ring-opening reactions the protonated amide nitrogen may
be favoured in such reactions.[9] Mass spectrometric studies
on cyclic and linear peptides containing proline residues
showed a preferential protonation of the proline nitrogen
due to a high proton affinity.[10] For stylissamide A (1) there
are three proline residues which are preferred for ring-open-
ing reactions. The occurrence of at least three proline resi-
dues in the stylissamides and the resulting possibilities for
protonation and subsequent ring opening prevent the se-
quencing only by CID-MSn experiments. However, the
combined application of HR-MS/MS and MSn experiments
allows for sequencing the peptide fragments.[11]
For stylissamide A (1) the combination of these tech-
niques (see Supporting Information) confirmed the se-
quence assignments by NMR spectroscopy. After ring
opening at the Lys-Pro amide bond successive losses of Lys,
Tyr, Pro, Tyr and Val gave the corresponding acylium ions
(bn fragments) at m/z 717.3753, 554.3091, 457.2536,
294.1858 and 195.1175 (see Figure 1, Table 2). Other frag-
ments from ring openings at the Tyr-Pro and Pro-Pro amide
bonds are found as well and confirmed the results men-
tioned before. The main peak at m/z 457.2536 was deter-
mined to be the Pro-Pro-Val-Tyr and Pro-Val-Tyr-Pro frag-
ments.
The cis/trans configuration of the peptide bond preced-
ing the proline residues was determined on the basis of the
Cβ and Cγ shift difference (∆δβγ)[12] and upon the presence
of an NOE correlation between the proline Hα and the Hα
of the preceding amino acid, which is present in a cis con-
figuration but absent in trans-proline.[13] The ∆δβγ of Pro1
and Pro4 were both 3.5 ppm and that of Pro5 was 9.5 ppm.
This indicated a trans configuration for Pro1 and Pro4 and
a cis configuration for Pro5. The NOE correlation Pro4-Hα/
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Table 2. Fragments observed in HR-MS/MS and MSn experiments
of stylissamide A (1).
m/z Fragment Error Sequence MS3 loss
formula [ppm]
195.1175 C10H15N2O2 24.2 Pro-Pro –
197.1328 C10H17N2O2 22.2 Pro-Val –
261.1281 C14H17N2O3 18.1 Pro-Tyr –
294.1858 C15H24N3O3 15.5 Pro-Pro-Val Pro, Val
389.2243 C20H29N4O4 15.3 Pro-Tyr-Lys Lys
457.2536 C24H33N4O5 19.8 Pro-Pro-Val-Tyr Pro, Tyr
Pro-Val-Tyr-Pro
554.3091 C29H40N5O6 21.2 Pro-Pro-Val-Tyr-Pro –[a]
717.3753 C38H49N6O8 20.5 Pro-Pro-Val-Tyr-Pro-Tyr Pro, Tyr
[a] Due to the low intensity of this fragment it was not possible to
perform MS3 measurements.
Pro5-Hα was observed while the correlations Tyr7-Hα/Pro1-
Hα and Lys3-Hα/Pro4-Hα were not present. Thus, the
amino acid sequence of 1 was established as cyclo-(trans-
Pro1-Tyr2-Lys3-trans-Pro4-cis-Pro5-Val6-Tyr7).
The molecular weight of 2 (m/z 812.4311 [M + H]+) as
determined by HR-ESIMS indicated the molecular formula
C44H58N7O8. The 1H NMR spectrum of 2 showed three
amide proton signals at 8.65, 8.24 and 6.45 ppm while the
13C NMR spectrum showed four carbonyl carbons at 171.2,
170.2, 168.5, 167.6 ppm and three carbonyl carbon signals
at approximately 169.8 ppm, which could be differentiated
into two signals at 169.75 ppm and one at 169.81 ppm (see
Table 3). All amino acid residues were assigned by 2D
NMR techniques as 4Pro, Ile, Phe and Tyr which defined
the heptapeptide structure. Sequence assignments by
1H,13C-HMBC experiments were difficult due to the over-
lap of the carbonyl carbon chemical shifts of two prolines
(Pro1 and Pro4) and isoleucine. A semi-selective 1H,13C-
HMBC experiment allowed us to assign the three carbonyl
C atoms at 169.8 ppm to two prolines (169.75 ppm) and
isoleucine (169.81 ppm). The fragment Pro5-Ile6 was as-
signed from the correlations Ile6-NH/Pro5-CO and Ile6-Hα/
Pro5-CO as well as a weak correlation Ile6-Hγ/Pro5-CO and
the NOE correlation Ile6-NH/Pro5-Hα. The fragments Ile6-
Tyr7 and Tyr7-Pro1 were proven by the correlations Tyr7-
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NH/Ile6-CO, Tyr7-Hα/Ile6-CO, Pro1-Hα/Tyr7-CO, Pro1-Hδ/
Tyr7-CO and the NOE correlations Tyr7-NH/Ile6-Hα and
Pro1-Hα/Tyr7-Hα, thereby establishing the partial sequence
Pro5-Ile6-Tyr7-Pro1. Another fragment Pro3-Pro4 was given
by the correlation Pro4-Hα/Pro3-CO. Pro1 and Pro4 showed
the same carbonyl carbon shift at δ 169.75 ppm. Associated
with this shift were the correlations Phe2-NH/169.75 ppm,
Phe2-Hα/169.75 ppm, Pro5-Hα/169.75 ppm and Pro5-Hδ/
169.75 ppm which suggested the fragments Pro1-Tyr2 or
Pro4-Tyr2 and Pro1-Pro5 or Pro4-Pro5, respectively. Taking
into account the partial sequence Pro5-Ile6-Tyr7-Pro1 a seg-
ment Pro1-Pro5 was ruled out, therefore establishing the
segment Pro4-Pro5 and consequently Pro1-Phe2. Both seg-
ments were supported by the NOE correlations Pro4-Hα/
Pro5-Hα and Pro1-Hδ/Phe2-NH. This defined the final se-
quence as Pro3-Pro4-Pro5-Ile6-Tyr7-Pro1-Phe2. The ring clo-
sure was given by the two NOE correlations Phe2-Hα/Pro3-
Hα and Phe2-Hβ/Pro3-Hα as well as the two weak HMBC
correlations Pro3-Hα/Phe2-CO and Pro3-Hδ/Phe2-CO. The
configuration of the peptide bonds preceding the proline
residues was determined to be cis for Pro1, Pro3, and Pro5
and trans for Pro4 by the ∆δβγ values (9.4, 8.3, and 8.6 ppm
for Pro1, Pro3, and Pro5, respectively, and 2.6 ppm for Pro4).
The NOE correlations Tyr7-Hα/Pro1-Hα, Phe2-Hα/Pro3-Hα
and Pro4-Hα/Pro5-Hα were observed whereas Pro3-Hα/
Pro4-Hα was not present. This confirmed the configura-
tional assignment. The sequence of 2 was thus established
as cyclo-(cis-Pro1-Phe2-cis-Pro3-trans-Pro4-cis-Pro5-Ile6-
Tyr7) and confirmed on the basis of MSn data (see Figure 3
and Supporting Information). The fragment m/z 308.1979,
assigned as Pro-Pro-Ile, lost Ile and Pro under MS3 condi-
tions. The main fragment at m/z 405.2511 lost Pro to yield
the mass m/z 308.1979 and Ile to give the mass m/z 292.2
(Pro-Pro-Pro) under MS3 conditions. The fragment at m/z
568.3178 lost Tyr to give the mass m/z 405.2511 and lost
also Pro to give the fragment at m/z 471.2632 (see Figure 2,
Table 4). This fragmentation pathway is only possible for
the sequence Pro-Pro-Pro-Ile-Tyr which is in accordance
with the NMR spectroscopic data.
The molecular weight of 3 (m/z 862.4490 [M + H]+, HR-
ESIMS) indicated the molecular formula C48H60N7O8. The
1H NMR spectrum of 3 showed four amide proton signals
at 8.96, 8.89, 8.16 and 6.62 ppm while the 13C NMR spec-
trum displayed five carbonyls at 171.7, 171.5, 169.8, 169.0,
168.3 ppm and two carbonyl carbon signals at approxi-
mately 169.6 ppm, which could be differentiated into
169.66 ppm and 169.64 ppm (see Table 5). The amino acid
residues were identified by 2D NMR as 3Pro, Ile, 2Phe
and Tyr, which indicated a heptapeptide. Due to the over-
lapping carbonyl carbon signals a semi-selective 1H,13C-
HMBC experiment was needed for the sequence assign-
ment. The correlation Tyr2-Hα/Pro1-CO defined the seg-
ment Pro1-Tyr2. Pro1-Hα and Pro1-Hδ displayed corre-
lations to Ile7-CO. Along with the correlations Ile7-Hα/
Phe6-CO, Phe6-NH/Pro5-CO, Pro5-Hα/Phe4-CO and Phe4-
Hα/Pro3-CO the final sequence Pro3-Phe4-Pro5-Phe6-Ile7-
Pro1-Tyr2 was established. Additional 1H,13C-HMBC cor-
relations between the amide proton and the carbonyl car-
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Table 3. 1H, 13C and 15N NMR chemical shifts of stylissamide B
(2) in [D6]DMSO.[a]
Entry Residue Position δC/δN δH, mult. (J /Hz)
1 Pro1 N 131 –
2 CO 169.75[b] –
3 α 60.5 3.49, d (8.5)
4 β, β 30.4 1.68, m; 1.53, m
5 γ, γ 21.0 1.38, m; 1.29, m
6 δ, δ 45.4 3.22, m; 3.10, m
7 Phe2 NH 114 6.45, d (3.9)
8 CO 167.6 –
9 α 52.1 4.14, m
10 β, β 35.8 3.12, m
11 1 135.9 –
12 2, 6 127.6 7.22, m
13 3, 5 129.3 6.95, d (6.4)
14 4 126.3 7.19, m
15 Pro3 N 130 –
16 CO 168.5 –
17 α 56.1 4.45, m
18 β, β 29.1 2.03, m; 1.81, m
19 γ, γ 20.8 1.79, m
20 δ, δ 46.4 3.41, m; 3.31, m
21 Pro4 N 133 –
22 CO 169.75[b] –
23 α 58.3 4.30, t (7.8)
24 β, β 27.5 2.28, m; 1.66, m
25 γ, γ 24.9 2.06, m; 1.91, m
26 δ, δ 46.7 3.65, m; 3.42, m
27 Pro5 N 128 –
28 CO 170.2 –
29 α 60.3 4.41, t (8.1)
30 β, β 30.2 2.33, dd (6.4, 11.6); 1.90, m
31 γ, γ 21.6 1.82, m; 1.46, m
32 δ, δ 45.6 3.39, m; 3.21, m
33 Ile6 NH 122 8.65, d (9.2)
34 CO 169.81[b] –
35 α 56.8 4.01, m
36 β 34.8 1.83, m
37 β-Me 15.3 0.68, d (7.1)
38 γ, γ 24.6 1.23, m; 1.04, m
39 δ 10.6 0.72, t (7.4)
40 Tyr7 NH 122 8.24, d (8.5)
41 CO 171.2 –
42 α 50.9 4.43, m
43 β, β 37.2 2.78, dd (10.6, 13.0);
2.61, dd (6.7, 13.0)
44 1 126.2 –
45 2, 6 129.8 6.96, d (7.4)
46 3, 5 114.7 6.67, d (7.8)
47 4 155.9 –
48 OH – 9.28, s
[a] 1H and 13C chemical shifts are referenced to the [D6]DMSO
signal (2.50 ppm and 39.5 ppm, respectively). 15N NMR spectra
were not calibrated with an external standard. Therefore, the 15N
NMR shifts are given without decimals. The δ value has an accu-
racy of about 1 ppm in reference to NH3 (δ = 0 ppm). [b] 13C NMR
shifts of carbonyl carbons are given with two decimals if one deci-
mal did not allow for differentiation of two or three different car-
bonyl carbons.
bon of the preceding amino acid existed for Tyr2-NH/Pro1-
CO, Pro4-NH/Pro3-CO and Ile7-NH/Phe6-CO. A weak cor-
relation existed between Pro3-Hδ and Tyr2-CO which indi-
cated the ring closure. This weak correlation was supported
by an NOE correlation between Pro3-Hα and Tyr2-Hβ. The
∆δβγ values clearly indicated a cis configuration for all pep-
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Figure 2. HR-MS/MS spectrum of stylissamide B (2). The precursor ion is indicated by the filled square. Only the main fragmentation
pathway is indicated. Masses associated with this fragmentation pathway and the corresponding observed masses derived from CO loss
(28 amu) are given.
tide bonds preceding the proline residues in 3, with ∆δβγ
values of 9.6, 9.5 and 9.3 ppm for Pro1, Pro3, and Pro5,
respectively. The corresponding NOE correlations between
the proline Hα and the Hα of the preceding amino acid
were present for Pro3 and Pro5, but not for Pro1 due to
overlapping signals. The sequence of 3 was therefore estab-
lished as cyclo-(cis-Pro1-Tyr2-cis-Pro3-Phe4-cis-Pro5-Phe6-
Ile7) as shown in Figure 3.
Table 4. Fragments observed in HR-MS/MS and MSn experiments
on stylissamide B (2).
m/z Fragment Error Sequence MS3 loss
formula [ppm]
195.1150 C10H15N2O2 11.4 Pro-Pro –
292.1647 C15H22N3O3 2.8 Pro-Pro-Pro –[a]
308.1979 C16H26N3O3 3.3 Pro-Pro-Ile Pro, Ile
405.2511 C21H33N4O4 3.6 Pro-Pro-Pro-Ile Pro, Ile
471.2632 C25H35N4O5 6.5 Pro-Pro-Ile-Tyr Tyr, Ile
568.3178 C20H29N4O4 8.4 Pro-Pro-Pro-Ile-Tyr Tyr, Pro
[a] Due to the low intensity of this fragment it was not possible to
perform MS3 measurements.
The molecular weight of 4 (m/z 828.4657 [M + H]+, HR-
ESIMS) indicated the molecular formula C45H62N7O8. The
1H and 13C NMR spectra of 4 showed four amide signals
at 8.81, 8.70, 8.10 and 6.57 ppm and seven carbonyls at
171.6, 171.2, 170.7, 170.5, 169.5, 169.4 and 168.2 ppm,
respectively (see Table 6). The amino acid residues were de-
termined as 3Pro, Leu, Ile, Phe and Tyr. The HMBC cor-
relations between Ile7-Hα/Phe6-CO, Phe6-Hα/Pro5-CO and
Pro5-Hα/Leu4-CO determined a segment Leu4-Pro5-Phe6-
Ile7. Leu-Hα and Tyr-Hα showed the same 1H chemical
shift, and both correlated to Pro1-CO and Pro3-CO which
made it difficult to assign a partial sequence Pro1-Leu
rather than Pro3-Leu or Pro1-Tyr rather than Pro3-Tyr from
the Hα-correlations. However, a clear NH(i)/CO(i–1) HMBC
correlation established Pro3-Leu4 and consequently Pro1-
Tyr2, which defined two segments Pro3-Leu4-Pro5-Phe6-Ile7
and Pro1-Tyr2. A weak correlation between Pro3-Hδ and
Tyr2-CO connected both segments. Another weak corre-
lation Pro1-Hα/Ile7-CO indicated the ring closure. NOE
correlations supported the sequence; the correlations Ile7-
Eur. J. Org. Chem. 2007, 4103–4110 © 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.eurjoc.org 4107
CH3/Pro1-Hα and Phe6-Hα/Ile7-NH proved the sequence
Phe6-Ile7-Pro1 and the second segment Tyr2-Pro3-Leu4-Pro5
was given by the correlations Leu4-Hβ/Pro5-Hα, Pro3-Hα/
Leu4-NH and Tyr2-Hβ/Pro3-Hα. The ∆δβγ values (9.7, 8.7
and 10.0 ppm for Pro1, Pro3, and Pro5, respectively) clearly
indicated a cis configuration for all peptide bonds preceding
the proline residues in 4. The corresponding NOE corre-
lations between the proline Hα and the Hα of the preceding
amino acid were present only for Pro5, but were, if present,
overlapped for Pro1 and Pro3. The amino acid sequence of
7 was established as cyclo-(cis-Pro1-Tyr2-cis-Pro3-Lys4-cis-
Pro5-Phe6-Ile7).
The MSn analysis of stylissamides C (3) and D (4) was
complicated by the occurrence of the tripeptide fragments
Pro-Tyr-Pro and Pro-Phe-Ile (see Figure 4). Both fragments
have a similar molecular mass of m/z 358.1761 and m/z
358.2125, calculated for Pro-Tyr-Pro and Pro-Phe-Ile,
respectively, which prevent a differentiation of these frag-
ments under standard MSn conditions. However, the se-
quences of 3 and 4 could be followed by the HR-MS/MS
spectra of each compound. Both peptides successively lost
Ile, Phe and Pro to give the fragments at m/z 505.2484 (3)
and m/z 471.2645 (4). Starting from these fragments styliss-
amide C (3) lost Phe whereas stylissamide D (4) lost Leu to
give the fragment at m/z 358.20. An identical fragmentation
pattern for both molecules starting from this fragment indi-
cated the tripeptide sequence Pro-Tyr-Pro. These results
confirmed the different composition of 3 and 4 in only one
amino acid.
The absolute configuration of the amino acid residues of
stylissamide A-D (1–4) was determined by Marfey’s
method[14] and the OPA method[15] after hydrolysis of 1–4.
All amino acids were found to possess -configurations.
Conclusions
The isolated stylissamides A-D (1–4) extend the variety
of cyclic and proline-rich peptides from marine sponges. In
addition to the stylisins 1 (6) and 2 (7)[4] these metabolites
are the first examples of cyclic peptides from the sponge
G. Schmidt, A. Grube, M. KöckFULL PAPER
Table 5. 1H, 13C and 15N NMR chemical shifts of stylissamide C
(3) in [D6]DMSO.[a]
Entry Residue Position δC/δN δH, mult. (J /Hz)
1 Pro1 N 120 –
2 CO 169.8 –
3 α 61.0 4.36, m
4 β, β 30.9 2.22, m; 2.04, m
5 γ, γ 21.3 1.78, m; 1.45, m
6 δ, δ 45.7 3.38, m
7 Tyr2 NH 113 6.62, d
8 CO 168.3 –
9 α 52.0 4.33, m
10 β, β 34.5 3.22, dd (6.1, 13.8); 2.92, m
11 1 125.3 –
12 2, 6 130.3 6.73, d (8.5)
13 3, 5 114.5 6.62, d
14 4 155.9 –
15 OH – 9.21, s
16 Pro3 N 129 –
17 CO 171.5 –
18 α 57.3 4.60, d (8.1)
19 β, β 30.5 2.17, m; 2.01, m
20 γ, γ 21.0 2.00, m; 1.89, m
21 δ, δ 46.5 3.57, m; 3.32, m
22 Phe4 NH 124 8.96, d (1.6)
23 CO 169.0 –
24 α 53.3 4.32, m
25 β, β 35.8 3.10, m; 2.93, m
26 1 135.6 –
27 2, 6 128.9 7.25, m
28 3, 5 128.4 7.32, t (7.3)
29 4 126.7 7.25, t (7.3)
30 Pro5 N 132 –
31 CO 169.64[b] –
32 α 59.6 3.03, d (7.9)
33 β, β 29.8 1.61, m; 0.84, m
34 γ, γ 20.5 1.32, m; 0.47, m
35 δ, δ 45.5 3.09, m; 2.89, m
36 Phe6 NH 122 8.89, d (8.5)
37 CO 169.66[b] –
38 α 54.1 4.22, m
39 β, β 35.5 2.76, dd (3.5, 13.3);
2.68, t (12.9)
40 1 138.9 –
41 2, 6 128.6 7.23, m
42 3, 5 127.3 7.21, t (7.4)
43 4 125.4 7.12, t (7.4)
44 Ile7 NH 115 8.16, d (9.4)
45 CO 171.7 –
46 α 53.0 4.32, m
47 β 37.3 1.64, m
48 β-Me 14.5 0.79, d (6.9)
49 γ, γ 23.8 1.49, m; 1.02, m
50 δ 10.5 0.80, t (7.1)
[a] 1H and 13C chemical shifts are referenced to the [D6]DMSO signal
(2.50 ppm and 39.5 ppm, respectively). 15N NMR spectra were not cal-
ibrated with an external standard. Therefore, the 15N NMR shifts are
given without decimals. The δ value has an accuracy of about 1 ppm in
reference to NH3 (δ = 0 ppm). [b] 13C NMR shifts of carbonyl carbons
are given with two decimals if one decimal did not allow for differentia-
tion of two or three different carbonyl carbons.
Stylissa caribica. In fact, stylissamide B (2) is the first cyclic
heptapeptide from marine sponges of the order Halichond-
rida that includes the tripeptide fragment Pro-Pro-Pro.
The sequences of stylissamides C (3) and D (4) differ by
only one amino acid. Phenylalanine in stylissamide C (3) is
replaced by leucine in stylissamide D (7). In addition, 3
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Figure 3. Sequential 1H,13C-HMBC and 1H,1H-NOE correlations
in stylissamides A–D (1–4). Solid arrows above the sequence indi-
cate Hα(i)/CO(i–1) HMBC correlations, and dashed arrows show
Hδ(i)/CO(i–1) HMBC correlations. Arrows below indicate NH(i)/
CO(i–1) HMBC correlations. Standard bonds indicate that no NOE
correlation was observed. Bold bonds indicate NH(i)/Hα(i–1) and
Hδ(i)/Hα(i–1) NOE correlations between adjacent amino acids.
differs by only one amino acid from phakellistatin 2 (5),
isolated from the marine sponge Phakellia carteri.[2] Here,
the fragment Phe-Ile in 3 is replaced by Ile-Ile in 5. The
sequence of stylissamide D (4) shows a striking resemblance
to that of stylisin 1 (6) in that it is inverse to the sequence
of 6.
In contrast to members of the phakellistatin or hy-
menamide group no antimicrobial or cytotoxic effect was
found for stylissamide A (1). The biological activities of the
remaining metabolites are under investigation.
Experimental Section
General: 1H, 13C and 15N NMR spectra were recorded with Bruker
Avance 400 and 600 NMR spectrometers. All experiments were
measured at 298 K or 300 K. The DQF-1H,1H-COSY, 1H,13C-
HSQC, 1H,13C-HMBC, 1H,15N-HSQC, 1H,15N-HMBC, and
1H,1H-NOESY experiments were carried out using standard pa-
rameters. The mixing time for NOESY spectra was 200 ms, and the
delay for HMBC measurements was 80 ms. HPLC-MS analyses
were performed with an Agilent 1100 HPLC system and a Bruker
Daltonics microTOFLC mass spectrometer. Separation was
achieved by a Waters XTerra RP18 column (3.0150 mm, 3.5 µm)
applying a MeCN/H2O/HCOOH gradient [0 min: 10% MeCN/
90% HCOOH (0.01%); 30 min: 60% MeCN/40% HCOOH
(0.01%) with a flow rate of 0.4 mL/min]. UV spectra were recorded
during HPLC analysis with a DAD (Agilent). Accurate mass spec-
tra were acquired using a Bruker microTOFLC mass spectrometer.
Accurate MS/MS spectra were acquired using a Bruker micro-
TOFQ. Mass calibration was performed using sodium formiate
cluster. MS3 spectra were acquired using a Bruker Esquire 3000plus
ion trap. All mass spectrometers were equipped with an ESI-source.
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Table 6. 1H, 13C and 15N NMR chemical shifts of stylissamide D (4)
in [D6]DMSO.[a]
Entry Residue Position δC/δN δH, mult. (J /Hz)
1 Pro1 N 131 –
2 CO 169.4 –
3 α 60.9 4.31, m
4 β, β 31.0 2.20, m; 2.00, m
5 γ, γ 21.3 1.77, m; 1.48, m
6 δ, δ 45.7 3.37, m
7 Tyr2 NH 112 6.57, d (3.9)
8 CO 168.2 –
9 α 51.7 4.41, m
10 β, β 34.8 3.17, m; 2.91, dd (2.6, 14.3)
11 1 125.3 –
12 2, 6 130.2 6.72, d (7.8)
13 3, 5 114.6 6.61, d (7.5)
14 4 155.7 –
15 OH – 9.17, s
16 Pro3 N 130 –
17 CO 171.6 –
18 α 57.4 4.58, d (7.5)
19 β, β 30.1 2.11, m; 1.95, m
20 γ, γ 21.4 2.05, m; 1.86, m
21 δ, δ 46.6 3.54, m; 3.29, m
22 Leu4 NH 125 8.70, m
23 CO 170.5 –
24 α 51.1 4.42, m
25 β, β 37.9 1.53, t (11.7); 1.28, t (11.7)
26 γ 23.9 1.87, m
27 δ 23.2 0.94, d (6.4)
28 δ 20.3 0.86, d (6.4)
29 Pro5 N 127 –
30 CO 170.7 –
31 α 59.9 4.02, d (8.1)
32 β, β 31.0 1.99, m; 1.90, m
33 γ, γ 21.0 1.54, m; 0.82, m
34 δ, δ 46.1 3.23, m; 3.06, t (9.8)
35 Phe6 NH 122 8.81, d (8.4)
36 CO 169.5 –
37 α 54.6 4.25, m
38 β, β 35.2 2.74, m
39 1 139.2 –
40 2, 6 128.8 7.31, d (7.5)
41 3, 5 127.6 7.24, t (7.5)
42 4 125.7 7.14, t (7.5)
43 Ile7 NH 115 8.10, d (9.5)
44 CO 171.2 –
45 α 52.6 4.33, m
46 β 36.9 1.66, m
47 β-Me 14.4 0.77, d (7.4)
48 γ, γ 23.5 1.45, m; 1.10, m
49 δ 10.1 0.76, t (7.4)
[a] 1H and 13C chemical shifts are referenced to the [D6]DMSO signal
(2.50 ppm and 39.5 ppm, respectively). 15N NMR spectra were not cal-
ibrated with an external standard. Therefore, the 15N NMR shifts are
given without decimals. The δ value has an accuracy of about 1 ppm in
reference to NH3 (δ = 0 ppm).
Extraction and Isolation: The sponge Stylissa caribica was collected
by SCUBA at Little San Salvador in the Bahamas (23 m depth,
July 2000). The samples were immediately frozen after collection
and kept at –20 °C until extraction. The freeze dried sponge sam-
ples of Stylissa caribica (94.7 g) were crushed with a mill and ex-
tracted exhaustively at room temp. with a 1:1 mixture of CH2Cl2/
MeOH. The orange-colored crude extract of Stylissa caribica was
partitioned between n-hexane (4400 mL) and MeOH (300 mL).
The MeOH extract was then partitioned between n-BuOH
(3500 mL) and H2O (300 mL). The resulting n-BuOH (15.9 g)
Eur. J. Org. Chem. 2007, 4103–4110 © 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.eurjoc.org 4109
phase from the solvent-partitioning scheme was purified by gel
chromatography on Sephadex LH-20 (Pharmacia) using MeOH as
the mobile phase. The final purification of the isolated compounds
was achieved by preparative RP18 HPLC on a Kromasil RP18 col-
umn (16250 mm, 10 µm) applying a MeCN/TFA (0.1% in water)
gradient to afford 1 (35.3 mg, 0.037% of dry weight), 2 (8.7 mg,
0.009% of dry weight), 3 (12.5 mg, 0.013% of dry weight), and 4
(5.1 mg, 0.005% of dry weight).
Stylissamide A (1): was obtained as a light yellow powder. UV
(DAD): λmax = 224, 275 nm. [α]D20 = 86.8 (c = 0.46, MeOH); HPLC/
HR(+)ESI-MS: Rt = 11.0 min, m/z 845.4555 [M + H]+ (calcd. for
C44H61N8O9 845.4556), ∆m = 0.1 ppm.
Stylissamide B (2): was obtained as a light yellow powder. UV
(DAD): λmax = 275 nm; HPLC/HR(+)ESI-MS: Rt = 21.6 min,
m/z 812.4311 [M + H]+ (calcd. for C44H58N7O8 812.4341), ∆m =
3.7 ppm.
Stylissamide C (3): was obtained as a light yellow powder. UV
(DAD): λmax = 232, 275 nm; HPLC/HR(+)ESI-MS: Rt = 25.2 min,
m/z 862.4490 [M + H]+ (calcd. for C48H60N7O8 862.4498), ∆m =
0.9 ppm.
Stylissamide D (4): was obtained as a light yellow powder. UV
(DAD): λmax = 229, 275 nm; HPLC/HR(+)ESI-MS: Rt = 24.3 min,
m/z 828.4657 [M + H]+ (calcd. for C45H62N7O8 828.4654), ∆m =
0.3 ppm.
Determination of the Absolute Configuration of Proline by Marfey’s
Method: The analysis was performed using a modified Marfeys
method.[14] Stylissamides A–D (1–4, 700 µg each) were placed in
1 mL conical vials containing HCl (16%, 0.5 mL), and the sealed
vials were heated at 100 °C for 12 h. After evaporation of the sol-
vent under N2, H2O (100 µL) was added. A 40 µL aliquot of this
solution was used for the OPA method. To the remaining hydrolysis
solution (60 µL), NaHCO3 (0.1 , 100 µL) and 1-fluoro-2,4-dini-
trophenyl-5--alanine amide (-FDAA, 0.1%, 50 µL) in acetone
were added, and the sealed vials were heated at 80 °C for 5 min.
To the reaction mixture were added HCl (0.2 , 50 µL) and 50%
aqueous MeCN (containing 0.1% formic acid, 90 µL). The mixture
was subjected to HPLC analysis [Waters XTerra RP18 column
(3.0150 mm, 3.5 µm); MeCN/H2O/HCOOH gradient: 0 min:
30% MeCN/70% HCOOH (0.01%); 30 min: 60% MeCN/40 %
HCOOH (0.01%) with a flow rate of 0.4 mL/min]. UV detection
was performed at a wavelength of 340 nm.
Determination of the Absolute Configuration of Amino Acids by the
OPA Method: The analysis was performed using a modification of
a previously described method.[15] A 40 µL aliquot of the hydrolysis
solution was used for the OPA method. In an HPLC vial, 80 µL of
o-phthaldialdehyde (OPA) solution and 80 µL of N-isobutyryl-
cysteine (0.1%) were added to this solution, and after a reaction
time of 2 min 20 µL of the reaction mixture were subjected to
HPLC analysis [Phenomenex Hyperclone BDS C18 column
(4.0250 mm, 5 µm); MeOH/NaOAc gradient: solution A:
125 m NaOAc in water and 20 mL MeOH, adjusted to pH 6.8
using diluted HOAc; solution B: MeOH].
Supporting Information (see also the footnote on the first page of
this article): MS and 1D 1H NMR spectra of compounds 1–4, MSn
spectra of compounds 1 and 2, 1H,1H-COSY-, 1H,1H-NOESY-,
1H,13C-HMBC and semi-selective 1H,13C-HMBC data for com-
pounds 1–4, assigned 1H,13C-HMBC and 1H,1H-NOESY spectra
for compound 2, ∆δβγ values and NOE correlations used for the
cis/trans configuration assignments for compounds 1–4.
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Figure 4. HR-MS/MS spectra of stylissamide C (3, above) and stylissamide D (4). The precursor ions are indicated by the filled squares.
Only the main fragmentation pathways are given. Masses associated with this fragmentation pathway and the corresponding observed
masses derived from CO loss (28 amu) are given.
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Figure 6.1 MS spectrum of stylissamide A (1).
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Figure 6.2 Sections of MSn spectra of stylissamide A (1). Precursor ions are
marked with filled squares. The ion at m/z 845.7 lost Lys to give the fragment at
m/z 717.4. The fragment at m/z 717.4 lost Tyr to give the fragment at m/z 554.4
(Pro-Pro-Val-Tyr-Pro). By the loss of Pro from m/z 554.4 the fragment at m/z 457.2
(Pro-Pro-Val-Tyr) occurred. Due to the low intensity of the fragment at m/z 554.4
it was not possible to perform MS3 experiments on this ion. Finally the loss of Tyr
(m/z 294.2) and Val (m/z 195.1) defined the fragment at m/z 195.1 as Pro-Pro.
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Figure 6.3 1D 1H-NMR spectrum of stylissamide A (1) in DMSO-d6.
Table 6.1 1H,1H-COSY, sequential 1H,1H-NOESY and 1H,13C-HMBC correlations
of stylissamide A (1)
Pos δC/δN δH COSY (H–H) seq. NOESY (H–H) HMBC (H–C)
Pro1 N 135 -
CO 171.4 -
α 62.6 3.97 1-β,β’ 2-NH, 3-NH 1-CO, 7-CO, 1-α, 1-β
β 28.3 2.02a 1-α, 1-β’, 1-γ,γ′a
β’ 28.3 1.60 1-α, 1-βa, 1-γ,γ′a
γ, γ’ 24.8 2.02a 1-β,β’, 1-δ,δ’ 2-NH
δ, δ’ 46.7 3.74 1-γ,γ’ 7-α, 7-β, 7-2/6
Tyr2 NH 108 7.67 2-α 1-α, 1-γ,γ’, 3-NH, 3-δ,δ’ 1-CO, 2-β
CO 170.5 -
α 54.2 4.32 2-NH, 2-β,β’ 3-NH 2-1
β 34.2 3.17 2-α, 2-β’ 2-CO, 2-α, 2-2/6
β’ 34.2 2.89 2-α, 2-β 2-2/6
1 128.2 -
2,6 129.2 7.00 2-3/5 2-β, 2-2/6, 2-3/5, 2-4
3,5 114.6 6.65 2-2/6 2-1, 2-3/5, 2-4
4 155.6 -
OH - 9.18 2-2/6, 2-3/5, 2-4
Lys3 NH 115 7.33 3-α 1-α , 2-NH, 2-α, 4-α 2-CO, 3-CO
CO 167.9 -
α 50.4 4.40 3-NH, 3-β,β′a 4-α 2-CO, 3-CO, 3-α
β 30.5 1.82 3-α, 3-β′a, 3-γ,γ′a 3-CO, 3-α, 3-β
β’ 30.5 1.50a 3-α, 3-β, 3-γ,γ′a 3-CO, 3-α
γ 22 1.32a 3-β,β′a, 3-γ′a, 3-δ,δ’ 3-α, 3-β, 3-e
γ’ 22 1.31a 3-β,β′a, 3-γa, 3-δ,δ’
δ, δ’ 26.4 1.57 3-γ,γ′a, 3-ε,ε’ 2-NH, 4-δ,δ’ 3β, 3ε
ε, ε’ 38.3 2.76 3-δ,δ’, 3-NH2
NH2 34 7.76 3-ε,ε’
continued on next page
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continued from previous page
Pos δC/δN δH COSY (H–H) seq. NOESY (H–H) HMBC (H–C)
Pro4 N 139 -
CO 170 -
α 58.6 4.30 4-β,β’ 3-NH, 5-α 3-CO, 4-CO, 4-α, 4-β, 4-γ, 4-δ
β 27.7 2.17 4-α, 4-β’, 4-γ’ 4-CO, 4-α, 4-β, 4-γ, 4-δ
β’ 27.7 1.74 4-α, 4-β 5-α 4-CO, 4-γ, 4-δ
γ 24.2 1.91 4-γ’ 4-δ,δ’ 4-α, 4-β, 4-δ
γ’ 24.2 1.85 4-β, 4-γ, 4-δ,δ’ 4-α, 4-β, 4-δ
δ 46.6 3.44 4-γ,γ’, 4-δ’ 3-NH, 3-α, 3-δ,δ’ 4-CO, 4-α, 4-β, 4-γ
δ’ 46.6 3.34 4-γ,γ’, 4-δ 3-NH, 3-α, 3-δ,δ’ 4-α, 4-β, 4-γ
Pro5 N 126 -
CO 170.5 -
α 60 4.42 5-β,β’ 4-α, 4-β’, 6-NH 4-CO, 5-CO, 5-α, 5-β, 5-γ, 5-δ
β 30.9 2.17 5-α, 5-β’, 5-γ 5-γ, 5-δ
β’ 30.9 2.07 5-α, 5-β, 5-γ′a 5-CO, 5-α, 5-β, 5-γ
γ 21.5 1.85 5-β, 5-δ,δ’ 5-α, 5-β
γ’ 21.5 1.51a 5-β’, 5-δ,δ’ 6-NH
δ, δ’ 46.1 3.42 5-γ,γ′a 4-α, 4-β, 6-NH 5-β, 5-γ
Val6 NH 117 7.62 6-α 5-α, 5-γ’, 5-δ,δ’, 7-NH 5-CO, 6-α, 6-β
CO 169.1 -
α 61.3 3.67 6-NH, 6-β 7-NH, 7-α, 7-β, 7-2/6 5-CO, 6-CO, 6-α, 6-β, 6-γ
β 29.5 1.77 6-α, 6-γ,γ’ 7-NH 6-CO, 6-α, 6-β, 6-γ
γ 18.9 0.77 6-β 7-NH 6-α, 6-β, 6-γ
γ’ 18.9 0.45 6-β 7-NH 6-α, 6-β, 6-γ
Tyr7 NH 112.7 7.24 7-α 6-NH, 6-α, 6-β, 6-γ,γ’ 6-CO, 7-CO, 7-α
CO 171.5 -
α 51.3 4.90 7-NH, 7-β,β’ 1-δ,δ’, 6-α 6-CO, 7-CO, 7-β, 7-1
β 37 3.28 7-α, 7-β’ 1-δ,δ’, 6-α 7-1, 7-2/6
β’ 37 2.39 7-α, 7-β 7-CO, 7-α, 7-1, 7-2/6
1 126.4 -
2,6 129.9 7.07 7-3/5 1-δ,δ’, 6-α 7β, 7-2/6, 7-3/5, 7-4
3,5 114.8 6.67 7-2/6 7-1, 7-3/5, 7-4
4 155.8 -
OH - 9.23 7-2/6, 7-3/5, 7-4
a Signals are overlapped. Spins were established through 1H,13C- and 1H,15N-HSQC-TOCSY experiments.
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Figure 6.4 MS spectrum of stylissamide B (2).
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Figure 6.5 Sections of MSn spectra of stylissamide B (2). Precursor ions are marked
with filled squares. The fragment at m/z 568.0 lost Tyr to give the fragment at m/z
405.3 (Pro-Pro-Ile-Pro). By the loss of Pro from m/z 405.3 the fragment at m/z 308.2
occurred. Finally the loss of Ile (m/z 195.1) and Pro (m/z 212.1) defined the fragment
at m/z 308.2 as Pro-Pro-Ile. Additionally at m/z 86.2 the immonium fragment of
Ile and at m/z 126.0 the 1-Oxo-5,6,7,7a-tetrahydro-1H-pyrrolo[1,2-c]oxazol-4-ylium
fragment of Pro-Pro1 occurred.
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[ppm]24689 7 5 3 1
Figure 6.6 1D 1H-NMR spectrum of stylissamide B (2) in DMSO-d6.
Table 6.2 1H,1H-COSY, sequential 1H,1H-NOESY and 1H,13C-HMBC correlations
of stylissamide B (2)
Pos δC/δN δH COSY (H–H) seq. NOESY (H–H) HMBC (H–C)
Pro1 N 131.0 -
CO 169.75c -
α 60.5 3.49 1-β 7-α 1-CO/4-COc, 7-CO, 1-β, 1-γ, 1-γ
β 30.4 1.68 1-α, 1-γ,γ’ 1-γ, 1-γ
β’ 30.4 1.53 1-γ,γ’ 1-α
γ 21.0 1.38 1-β,β’, 1-γ’, 1-γ,γ’ 1-CO/4-CO, 1-α, 1-γ
γ’ 21.0 1.29 1-β,β’, 1-γ, 1-γ,γ’
γ 45.4 3.22 1-γ,γ’, 1-γ’ 2-NH, 6-NH 1-α, 1-β, 1-γ
γ’ 45.4 3.10 1-γ,γ’, 1-γ 2-NH, 6-NH 7-CO, 1-α, 1-β, 1-γ
Phe2 NH 114.0 6.45 2-α 1-γ,γ’ 1-CO/4-COc, 2-CO, 2-α, 2-β
CO 167.6 -
α 52.1 4.14 2-NH, 2-β,β’ 3-α 1-CO/4-COc, 2-CO, 2-β, 2-1
β, β’ 35.8 3.12 2-α 3-α 2-CO, 2-α
1 135.9 -
2/6 127.6 7.22 2-3/5 2-β, 2-1, 2-2/6, 2-3/5, 2-4
3/5 129.3 6.95 2-2/6 2-α, 2-β, 2-2/6, 2-3/5, 2-4
4 126.3 7.19 2-1, 2-2/6, 2-3/5
Pro3 N 130.0 -
CO 168.5 -
α 56.1 4.45 3-β 2-α, 2-β,β’, 4-γ,γ’ 2-CO, 3-β, 3-γ, 3-γ
β 29.1 2.03 3-α, 3-β’, 3-γ,γ’ 3-CO, 3-α, 3-γ, 3-γ
β’ 29.1 1.81 3-β 3-CO, 3-α, 3-γ, 3-γ
γ, γ’ 20.8 1.79 3-β, 3-γ,γ’ 3-α, 3-β, 3-γ
γ 46.4 3.41 3-γ,γ’, 3-γ’ 3-α, 3-β, 3-γ
γ’ 46.4 3.31 3-γ,γ’, 3-γ 2-CO, 3-α, 3-β, 3-γ
Pro4 N 133.0 -
CO 169.75c -
continued on next page
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Pos δC/δN δH COSY (H–H) seq. NOESY (H–H) HMBC (H–C)
α 58.3 4.30 4-β,β’ 5-α, 6-NH 1-CO/4-COc, 3-CO, 4-β, 4-γ, 4-γ
β 27.5 2.28 4-α, 4-β’, 4-γ,γ’ 1-CO/4-COc, 4-α, 4-γ, 4-γ
β’ 27.5 1.66 4-α, 4-β, 4-γ,γ’ 1-CO/4-COc, 4-α, 4-γ, 4-γ
γ 24.9 2.06 4-β,β’, 4-γ’, 4-γ,γ’ 4-α, 4-β, 4-γ
γ’ 24.9 1.91 4-β,β’, 4-γ, 4-γ,γ’ 4-α, 4-β, 4-γ
γ 46.7 3.65 4-γ,γ’, 4-γ’ 3-α 4-α, 4-β, 4-γ
γ’ 46.7 3.42 4-γ,γ’, 4-γ 3-α 4-α, 4-β, 4-γ
Pro5 N 128.0 -
CO 170.2 -
α 60.3 4.41 5-β’ 4-α, 6-NH 1-CO/4-COc, 5-CO, 5-β, 5-γ, 5-γ
β 30.2 2.33 5-β’, 5-γ’ 5-CO, 5-α, 5-γ, 5-γ
β’ 30.2 1.90 5-α, 5-β, 5-γ’ 5-CO, 5-α, 5-γ, 5-γ
γ 21.6 1.82 5-γ’, 5-γ,γ’ 5-α, 5-β
γ’ 21.6 1.46 5-β,β’, 5-γ, 5-γ,γ’ 5-β, 5-γ
γ 45.6 3.39 5-γ,γ’, 5-γ’ 5-α, 5-β, 5-γ
γ’ 45.6 3.21 5-γ,γ’, 5-γ 6-NH 1-CO/4-COc, 5-α, 5-β, 5-γ
Ile6 NH 122.0 8.65 6-α 4-α, 5-α, 5-γ,γ’, 7-NH 5-CO, 6-α, 6-β
CO 169.8 -
α 56.8 4.01 6-NH, 6-β 7-NH 5-CO, 6-CO, 6-β, 6-β-Me, 6-γ
β 34.8 1.83 6-α, 6-β-Me, 6-γ’ 7-NH 6-α, 6-β-Me, 6-γ, 6-γ
β-Me 15.3 0.68 6-β 6-α, 6-β, 6-γ
γ 24.6 1.23 6-γ’, 6-γ 6-α, 6-β, 6-β-Me, 6-γ
γ’ 24.6 1.04 6-β, 6-γ, 6-γ 6-α, 6-β, 6-β-Me, 6-γ
γ 10.6 0.72 6-γ,γ’ 7-NH 6-β, 6-γ
Tyr7 NH 122.0 8.24 7-α 6-NH, 6-α, 6-β, 6-γ 6-CO, 7-α, 7-β
CO 171.2 -
α 50.9 4.43 7-NH, 7-β,β’ 1-α 6-CO, 7-CO, 7-β, 7-1
β 37.2 2.78 7-α, 7-β’ 7-CO, 7-α, 7-1, 7-2/6
β’ 37.2 2.61 7-α, 7-β 7-CO, 7-α, 7-1, 7-2/6
1 126.2 -
2/6 129.8 6.96 7-3/5 7-α, 7-β, 7-2/6, 7-3/5, 7-4
3/5 114.7 6.67 7-2/6 7-β, 7-1, 7-2/6, 7-3/5, 7-4
4 155.9 -
OH - 9.28
a Signals are overlapped. Spin systems were established with the aid of 1H,13C- and 1H,15N-HSQC-TOCSY experiments.
b Intra-residual protons are overlapped.
c Carbonyl are overlapped.
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Figure 6.7 Section 1 (amide
proton area) of the semi-selective
1H,13C-HMBC spectrum of stylis-
samide B (2) in DMSO-d6.
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Figure 6.8 Section 2 (α- and δ-proton area) of the semi-selective 1H,13C-HMBC
spectrum of stylissamide B (2) in DMSO-d6.
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Figure 6.11 MS spectrum of stylissamide C (3).
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Figure 6.12 1D 1H-NMR spectrum of stylissamide C (3) in DMSO-d6.
Table 6.3 1H,1H-COSY, sequential 1H,1H-NOESY and 1H,13C-HMBC correlations
of stylissamide C (3).
Pos δC/δN δH COSY (H–H) seq. NOESY (H–H) HMBC (H–C)
Pro1 N 120.0 -
CO 169.8 -
α 61.0 4.36 1-β,β’ 7-δ, 7-β 7-CO, 1-CO, 1-β, 1-γ, 1-δ
β 30.9 2.22 1-α, 1-β’, 1-γ,γ’ 1-CO, 1-α
β’ 30.9 2.04 1-α, 1-β, 1-γ,γ’ 1-CO, 1-δ
γ 21.3 1.78 1-β,β’, 1-γ’, 1-δ,δ’
γ’ 21.3 1.45 1-β,β’, 1-γ’, 1-δ,δ’ 2-NH
continued on next page
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Pos δC/δN δH COSY (H–H) seq. NOESY (H–H) HMBC (H–C)
δ, δ’ 45.7 3.38 1-γ,γ’ 2-NH 7-CO, 1-α, 1-β, 1-γ
Tyr2 NH 113.0 6.62a,b 2-α 1-δ,δ’, 1-γ’ b 1-CO, 2-CO, 2-α, 2-1, 2-2/6, 2-3/5, 2-4
CO 168.3 -
α 52.0 4.33 2-NHa, 2-β,β’ 1-CO, 2-CO, 1-1, 1β
β 34.5 3.22 2-α, 2-β’ 3-α 2-CO, 2-α, 2-1, 2-2/6
β’ 34.5 2.92 2-α, 2-β 2-CO, 2-α, 2-1, 2-2/6
1 125.3 -
2/6 130.3 6.73 2-3/5a 2-α, 2-β, 2-2/6, 2-3/5, 2-4
3/5 114.5 6.62a,b 2-2/6 b 1-CO, 2-CO, 2-α, 2-1, 2-2/6, 2-3/5, 2-4
4 155.9 -
OH - 9.21
Pro3 N 129.0 -
CO 171.5 -
α 57.3 4.60 3-β,β’a, 4-NH, 4-α, 4-β’, 2-β 3-CO, 3-β, 3-γ, 3-δ
β 30.5 2.17 3-α, 3-β’a, 3-γa,γ’ 3-CO
β’ 30.5 2.01a,b 3-β, 3-γ’ b 3-CO, 3-δ
γ 21.0 2.00a,b 3-γ’, 3-β, 3-δ,δ’ b 3-CO, 3-δ
γ’ 21.0 1.89 3-β,β’a, 3-γ, 3-δ,δ’ 3-α
δ 46.5 3.57 3-γa,γ’, 3-δ’ 2-CO, 3-β, 3-γ
δ’ 46.5 3.32 3-γa,γ’, 3-δ 3-α, 3-β, 3-γ
Phe4 NH 124.0 8.96 4-αa 3-α 3-CO, 4-CO, 4-α, 4-β
CO 169.0 -
α 53.3 4.32a 4-β,β’ 3-α, 5-α 3-CO
β 35.8 3.10 4-αa, 4-β’ 4-CO, 4-α, 4-1, 4-2/6
β’ 35.8 2.93 4-αa, 4-β 3-α 4-CO, 4-α, 4-1, 4-2/6
1 135.6 -
2/6 128.9 7.25a,b 04.03.05 b 4-β, 4-1
3/5 128.4 7.32 4-2/6a, 4-4a 4-1, 4-2/6, 4-3,5
4 126.7 7.25a,b b 4-β, 4-1
Pro5 N 132.0 -
CO 169.6 -
α 59.6 3.03 5-β,β’ 4-α, 6-NH 4-CO, 5-CO, 5-β, 5-γ
β 29.8 1.61 5-α, 5-β’, 5-γ’ 5-CO, 5-γ, 5-δ
β’ 29.8 0.84 5-α, 5-β, 5-γ,γ’ 5-CO, 5-α, 5-γ
γ 20.5 1.32 5-β’, 5-γ’, 5-δ,δ’ 5-α, 5-β
γ’ 20.5 0.47 5-β,β’, 5-γ, 5-δ,δ’
δ 45.5 3.09 5-γ,γ’, 5-δ’ 4-β’ 5-γ
δ’ 45.5 2.89 5-γ,γ’, 5-δ 4-β’, 6-NH 5-β, 5-γ
Phe6 NH 122.0 8.89 6-α 5-α, 5-δ’ 5-CO, 6-β
CO 169.7 -
α 54.1 4.22 6-NH, 6-β,β’ 7-NH 6-CO, 6-β, 6-1
β 35.5 2.76 6-α, 6-β’ 7-α 6-CO, 6-1, 6-2/6
β’ 35.5 2.68 6-α, 6-β 6-CO, 6-1, 6-2/6
1 138.9 -
2/6 128.6 7.23 06.03.05 6-1, 6-2/6, 6-4
3/5 127.3 7.21 6-2/6, 6-4 6-1, 6-3/5
4 125.4 7.12 06.03.05 6-1, 6-2/6, 6-4
Ile7 NH 115.0 8.16 7-αa 6-CO, 7-α
CO 171.7 -
α 53.0 4.32a 7-NH, 7-β 6-α, 6-β 6-CO, 7-CO, 7-β, 7-β-Me, 7-γ
β 37.3 1.64 7-β-Me, 7-γ,γ’ 7-α, 7-β-Me, 7-γ, 7-δ
β-Me 14.5 0.79 7-β 7-α, 7-β, 7-γ
γ 23.8 1.49 7-β, 7-γ’, 7-δ 7-α, 7-β, 7-β-Me, 7-δ
γ’ 23.8 1.02 7-β, 7-γ, 7-δ 7-α, 7-β, 7-β-Me, 7-δ
δ 10.5 0.80 7-γ,γ’ 7-γ
a Signals are overlapped. Spin systems were established with the aid of 1H,13C- and 1H,15N-HSQC-TOCSY experiments.
b Intra-residual protons are overlapped.
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Figure 6.14 1D 1H-NMR spectrum of stylissamide D (4) in DMSO-d6.
Table 6.4 1H,1H-COSY, sequential 1H,1H-NOESY and 1H,13C-HMBC correlations
of stylissamide D (4)
Pos δC/δN δH COSY (H–H) seq. NOESY (H–H) HMBC (H–C)
Pro1 N 131.0 -
CO 169.4 -
α 60.9 4.31 1-β,β’ 7-δ 1-CO, 7-CO (weak), 1-β, 1-γ, 1-δ
β 31.0 2.20 1-α, 1-β’, 1-γ’ 1-CO, 1-α
β’ 31.0 2.00 1-α, 1-β, 1-γ’ 1-CO
γ 21.3 1.77 1-γ’, 1-δ,δ’
γ’ 21.3 1.48 1-β,β’, 1-γ, 1-δ,δ’
continued on next page
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Pos δC/δN δH COSY (H–H) seq. NOESY (H–H) HMBC (H–C)
δ, δ’ 45.7 3.37 1-γ,γ’ 1-β, 1-γ
Tyr2 NH 112.0 6.57 2-αa
CO 168.2 -
α 51.7 4.41a,c 2-NH, 2-β,β’ c 1-CO, 2-CO, 3-CO, 4-CO, 2-β, 2-1
β 34.8 3.17 2-αa, 2-β’ 2-CO, 2-α, 2-1, 2-2/6
β’ 34.8 2.91 2-αa, 2-β 3-α 2-CO, 2-1, 2-2/6
1 125.3 -
2/6 130.2 6.72 2-3/5 2-β, 2-2/6, 2-4
3/5 114.6 6.61 2-2/6 2-1, 2-3/5, 2-4
4 155.7 -
OH - 9.17
Pro3 N 130.0 -
CO 171.6 -
α 57.4 4.58 3-β,β’ 2-β’, 4-NH 2-CO (weak), 3-β, 3-γ, 3-δ
β 30.1 2.11 3-α, 3-β’, 3-γ,γ’
β’ 30.1 1.95 3-α, 3-β, 3-γ’
γ 21.4 2.05 3-β, 3-γ’, 3-δ,δ’
γ’ 21.4 1.86 3-β,β’, 3-γ, 3-δ,δ’
δ 46.6 3.54 3-γ,γ’, 3-δ’
δ’ 46.6 3.29 3-γ,γ’, 3-δ
Leu4 NH 125.0 8.70 4-αa 3-α 3-CO, 4-CO
CO 170.5 -
α 51.1 4.42a,c 4-NH, 4-β,β’ 5-α c 1-CO, 2-CO, 3-CO, 4-CO
β 37.9 1.53 4-αa, 4-β’, 4-γ
β’ 37.9 1.28 4-αa, 4-β, 4-γ 5-α
γ 23.9 1.87 4-β,β’, 4-δ,δ’
δ 23.2 0.94 4-γ 4-β, 4-γ, 4-δ’
δ’ 20.3 0.86 4-γ 4-β, 4-δ
Pro5 N 127.0 -
CO 170.7 -
α 59.9 4.02 5-β,β’ 4-α, 4-β’ 4-CO, 5-CO, 5-β, 5-γ, 5-δ
β 31.0 1.99 5-α, 5-β’, 5-γ,γ’ 5-CO, 5-δ
β’ 31.0 1.90 5-α, 5-β, 5-γ,γ’ 5-CO, 5-α
γ 21.0 1.54 5-β,β’, 5-γ’ 5-α
γ’ 21.0 0.82 5-β,β’, 5-γ, 5-δ,δ’
δ 46.1 3.23 5-γ’, 5-δ’ 5-γ
δ’ 46.1 3.06 5-γ’, 5-δ 5-β
Phe6 NH 122.0 8.81 6-α
CO 169.5 -
α 54.6 4.25 6-NH, 6-β,β’ 7-NH 5-CO, 6-CO, 6-β, 6-1
β, β’ 35.2 2.74 6-α 6-CO, 6-α, 6-1, 6-2/6
1 139.2 -
2/6 128.8 7.31 6-3/5 6-β, 6-2/6, 6-4
3/5 127.6 7.24 6-2/6, 6-4 6-1, 6-3/5
4 125.7 7.14 6-3/5 6-1, 6-2/6
Ile7 NH 115.0 8.10 7-α 6-α 6-CO
CO 171.2 -
α 52.6 4.33 7-NH, 7-β 6-CO, 7-CO, 7-β, 7-β-Me, 7-γ
β 36.9 1.66 7-α, 7-β-Mea, 7-γ’
β-Me 14.4 0.77a,b 7-β
γ 23.5 1.45 7-γ’, 7-δa 7-β
γ’ 23.5 1.10 7-β, 7-γ, 7-δa 7-α, 7-β, 7-β-Me, 7-δ
δ 10.1 0.76a,b 7-γ,γ’ 7-γ
a Signals are overlapped. Spin systems were established with the aid of 1H,13C- and 1H,15N-HSQC-TOCSY experiments.
b Intra-residual protons are overlapped.
c Carbonyls are overlapped.
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Table 6.5 Differential 13C values and NOESY correlations necessary to determine
the configuration of proline residues in the stylissamides A-D (1-4).
∆δβγ (ppm) Hα(i)-Hα(i−1) NOE correlation configuration
Stylissamide A (1) Pro1 3.5 invisible trans
Pro4 3.5 invisible trans
Pro5 9.4 visible cis
Stylissamide B (2) Pro1 9.4 visible cis
Pro3 8.3 visible cis
Pro4 2.6 invisible trans
Pro5 8.6 visible cis
Stylissamide C (3) Pro1 9.6 overlapped if present cis
Pro3 9.5 visible cis
Pro5 9.3 visible cis
Stylissamide D (4) Pro1 9.7 overlapped if present cis
Pro3 8.7 overlapped if present cis
Pro5 10 visible cis
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The Arctic sponge Haliclona viscosa is a rich source of 3-alkyl pyridinium alkaloids. Herein, we report
the identiﬁcation of two new haliclamines from the crude extract of this sponge. Due to the lack of
sponge material, identiﬁcation relied on HR-LCMS measurements and comparison with synthetic
compounds.
Introduction
The sponge genus Haliclona comprises more than 400 species
with a worldwide distribution and is a rich source of alkaloids,
many of them with cytotoxic properties. Examples include the
manzamines,1 papuamines,2 haliclonadiamines,3 haliclamines,4
halicyclamines,5 and haliclonacyclamines.6 The species Haliclona
viscosa contains several types of 3-alkyl pyridinium alkaloids
(3-APA) such as viscosaline,7 the trimeric viscosamine,8 the
dimeric cyclostellettamines and haliclamines9 and the ﬁrst cyclic
monomer of the 3-APA motif.10 In our continuous search for
bioactive compounds, we investigated the crude extract of a
H. viscosa specimen collected in 2003. It contained two new 3-alkyl
tetrahydropyridinium compounds, haliclamines E (1) and F (2),
in addition to the main metabolites, haliclamines C (3) and D
(4) (Scheme 1). Herein, we report the identiﬁcation of the new
compounds from the crude extract.
Scheme 1 Structural formulae of haliclamines E (1), F (2), C (3) and
D (4), and cyclostellettamines N, R, O and Q.
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† Electronic supplementary information (ESI) available: MS spectra of the
natural and the synthetic haliclamines; NMR spectra and shifts of the
synthetic haliclamines; synthetic pathway of compounds 1–4. See DOI:
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Results and discussion
A freeze-dried specimen of Haliclona viscosa, collected off
Blomstrandhalvøya in Kongsfjorden, Svalbard, by SCUBA div-
ing in 2003 was exhaustively extracted with a 1:1 mixture of
methanol/dichloromethane. The crude extractwas subjected to an
LCMS analysis. In addition to the main metabolites haliclamines
C (3) and D (4),9 it contained several unknown compounds.
Since the sponge material was sparse and only a small amount of
crude extract was available, further isolation of these compounds,
followed by NMR spectroscopy, was not possible. However, the
combined application of HPLC and HRMS indicated that two of
the secondary metabolites were related to the haliclamines and the
cyclostellettamines.
The high-resolution mass spectrum for compound 1 at a
retention time (tR, Fig. 1) of 27.2 min, obtained from ESI ion-
ization, suggested the molecular formula C29H52N2 (m/z 429.4217
[M + H]+). The molecular weight was 14 mass units less than that
of haliclamine C (3, m/z 443.4320 [M + H]+; tR = 28.7 min), indi-
cating that one alkyl chain of compound 1 was by one methylene
group shorter than haliclamine C (3). The atmospheric pressure
ionization-collision induced dissociation-MS/MS (API-CID-
MS/MS) spectrum of haliclamine C (3) showed two fragment
peaks of m/z 208.210 and m/z 236.240, which correspond to a
tetrahydropyridinium (THP)moiety connected to analkyl chainof
Fig. 1 Comparison of retention times of synthetic haliclamines E (1,
dashed line) and F (2, dotted line) with the crude extract of Haliclona
viscosa (continuous line).
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Table 1 Comparison of mass spectrometric data of the naturally occurring and the synthetic haliclamine E (1). Masses were acquired with a Bruker
micrOTOF mass spectrometer equipped with an ESI source
Iona Natural compound 1 Synthetic compound 1
[M + H]+ m/z = 429.4235, Dm = 7.5 ppm m/z = 429.4217, Dm = 3.3 ppm
[M + 2H]2+ n.a. m/z = 215.2160, Dm = 10.1 ppm
TFA salt [M + H]+ n.a. m/z = 543.4123, Dm = 1.7 ppm
fragment Cn m/z = 208.2118, Dm = 27.9 ppm m/z = 208.2071, Dm = 5.5 ppm
fragment Cm m/z = 222.2261, Dm = 20.1 ppm m/z = 222.2220, Dm = 1.8 ppm
a The doubly charged molecular ion originates from an experiment with a low voltage difference between capillary exit and skimmer. The singly charged
fragments Cn/Cm consists of a tetrahydropyridinium moiety and a side chain of nine/ten methylene groups.
9 and 11 carbons, respectively.9 Themass spectrum of compound 1
showed two similar fragments at m/z 208.2118 and m/z 222.2261,
which suggested that 1 contains side chains of 9 and 10 methylene
groups in addition to the two THP moieties. To add structural
proof to this suggestion, the proposed compound 1 was synthe-
sized by reduction of the corresponding cyclostellettamine.11 The
cyclostellettamine was prepared following a method described
by Baldwin et al.11 Subsequently, chromatographic and mass
spectrometric data of the synthetic product were compared to
those of the natural compound 1.
The synthetic and the natural compound 1 eluted at the same
retention time (Fig. 1). Both the molecular weight and the frag-
ments of the synthetic product agreed with the natural compound.
The synthetic product 1 showed a molecular mass of m/z 429.4217
([M + H]+), a doubly charged molecular ion at m/z 215.2160 and a
peak at m/z 543.4123 resulting from salt formation with the TFA
anion introduced during chromatographic puriﬁcation (Fig. 2,
Table 1). The mass spectrum of the synthetic compound also
contained two peaks of lower intensity at m/z 208.2071 and m/z
222.2220 which correspond to the two fragments expected from
Fig. 2 ESI-TOF-MS spectrum of synthetic haliclamine E (1). The section
shows a detail of the doubly charged molecular ion and the two singly
charged fragments.
THP moieties with C9 and C10 alkyl chains each. Under API-CID-
MS/MS (Skimmer-CID) conditions, these fragments became
more pronounced whereas the doubly charged molecular ion and
the TFA salt ion were eliminated (see Supporting Information for
details†).
Compound 2 (m/z 471.4664 [M + H]+; tR = 31.3 min) was 14
mass units larger than haliclamine D (4, m/z 457.4470 [M + H]+;
tR = 29.8 min) and suggested the molecular formula C32H58N2.
As haliclamine D (4) includes two chains of 10 and 11 methylene
groups, respectively,9 compound 2 was likely to contain chains of
either 10 and 12 or chains of equal length of 11 methylene groups.
Since the spectrum of the natural compound 2 also comprised a
singly charged fragment at m/z 236.2422 it was concluded that
the alkyl chains contained 11 methylene groups, and hence this
compound was synthesized and compared. The synthetic product
eluted at the same retention time (Fig. 1) and showeda similarmass
spectrum as the natural compound 2 (Fig. 3, Table 2). It showed
a molecular mass of m/z 471.4664 ([M + H]+), a doubly charged
molecular ion atm/z 236.2364 and a TFAadduct atm/z 585.4567.
An API-CID-MS/MS experiment eliminated the TFA salt ion
Fig. 3 TOF-MS spectrum of synthetic haliclamine F (2) under standard
ESI conditions. The section shows a detail of the doubly chargedmolecular
ion.
Table 2 Comparison of mass spectrometric data of the naturally occurring and the synthetic haliclamine F (2). Masses were acquired with a Bruker
micrOTOF mass spectrometer equipped with an ESI source
Iona Natural compound 2 Synthetic compound 2
[M + H]+ m/z = 471.4710, Dm = 7.9 ppm m/z = 471.4664, Dm = 1.8 ppm
[M + 2H]2+ n.a. m/z = 236.2364, Dm = 3.9 ppm
TFA salt [M + H]+ n.a. m/z = 585.4567, Dm = 5.8 ppm
fragment Cn = Cm m/z = 236.2422, Dm = 21.0 ppm m/z = 236.2355, Dm = 7.5 ppm
a The doubly charged molecular ion originates from an experiment with low voltage difference between capillary exit and skimmer. The singly charged
fragments Cn and Cm consist of a tetrahydropyridinium moiety and a side chain of 11 methylene groups, each.
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Fig. 4 ESI-TOF-MS spectrum of the synthetic haliclamine F (2) resulting from an API-CID-MS/MS experiment. The section shows a detail of the
doubly charged molecular ion which is superimposed by the singly charged fragment.
and resulted in a peak at m/z 236.2355 that contained the isotopic
pattern of the doubly charged molecular ion superimposed by the
singly charged fragment (THP + C11 alkyl chain, Fig. 4).
Conclusions
Our investigations proved again that Haliclona sponges from Arc-
tic waters are a rich source of interesting secondary metabolites.
The two new members of the haliclamine family, the haliclamines
E (1) andF (2), were directly identiﬁed from a sponge crude extract
using a HR-LCMS method. In this context the identiﬁcation
was supported by the known biosynthetic origin of the 3-alkyl
pyridinium alkaloids which are a common theme in sponges
of the order Haplosclerida. Furthermore, a direct comparison
was possible because the compounds were available through
synthesis.
Experimental
Animal material
A specimen of Haliclona viscosa was collected off Blomstrand-
halvøya by SCUBA diving in Kongsfjorden, Svalbard in June 2003.
A voucher specimen is deposited at the Zoo¨logisch Museum,
Amsterdam, The Netherlands (voucher reference MAK301, no
ZMA registration number available yet). Samples of H. viscosa
were divided into portions, immediately frozen after collection
and kept at -20 ◦C until extraction.
Extraction and analysis of the natural compounds
Freeze-dried sponge tissue (4.18 g) was exhaustively extracted
at room temperature with a 1:1 mixture of methanol and
dichloromethane (4 ¥ 80 mL). The resulting crude extract (1.22 g,
29.2%) was investigated by HR-LCMS on an Agilent 1100 series
instrument coupled to a micrOTOFLC mass spectrometer (Bruker
Daltonics). The HPLC was equipped with a Waters XTerra MS
C18 column (3 ¥ 150 mm, 3.5 mm, 30 ◦C) and a MeCN/H2O (5 mM
NH4OAc) gradient (30% MeCN/70% H2O to 50% MeCN/50%
H2O in 30 min) at a ﬂow rate of 0.4 mL min-1 was applied.
UV spectra were recorded with a DAD at 260 nm. The mass
spectrometer was equipped with an ESI source (capillary exit
100 V, skimmer 50 V).
Synthesis, puriﬁcation and analysis of the synthetic compounds
All solvents were puriﬁed by distillation, with the exception
of THF which was distilled from sodium/benzophenone under
argon. A solution of the respective cyclostellettamine (0.13 mmol,
cyclostellettamine N or R, Scheme 1) in 10 mL CH2Cl2/MeOH
(1:1) was cooled to -40 ◦C and NaBH4 (0.10 g, 2.63 mmol) was
added. After stirring for two hours in the cold, the mixture was
allowed to warm up to room temperature, 5 mL of 2 M NaOH
solutionwere added and it was stirred for an additional 15minutes.
It was then poured onto 15 mL water and extracted with CH2Cl2
(3 ¥ 10 mL). Drying of the combined organic extracts over MgSO4
and removal of the solvent yielded the crude product (47 mg of 1,
29 mg of 2). The crude product was puriﬁed via preparative HPLC
and yielded 32 mg (32%) of haliclamine E (1) and 20 mg (20%) of
haliclamine F (2) as TFA salts.
Puriﬁcation of the synthetic compounds was performed on a
Jasco 1500 series HPLC system. It was equipped with a Prontosil
Eurobond RP18 column (20 ¥ 250 mm, 5 mm, 40 ◦C) applying a
MeCN (0.1%TFA)/H2O (0.1% TFA) gradient (30% MeCN/70%
H2O isocratic for 5 min; to 60% MeCN/40% H2O in 30 min;
isocratic for 5 minutes; to 100% MeCN in 10 min) with a ﬂow
rate of 8 mL min-1. Analytical HPLC used a Kromasil RP18
column (4.6 ¥ 250 mm, 5 mm, 40 ◦C), as before with a MeCN
(0.1%TFA)/H2O (0.1% TFA) gradient (from 100% H2O to 80%
MeCN/20%H2O in 40min; to 100%MeCN in 5min) at a ﬂow rate
of 1 mL min-1. UV spectra were recorded during HPLC analyses
with a DAD (Jasco).
ESI mass spectra of the synthetic compounds were acquired
using the micrOTOFLC mass spectrometer (Bruker Daltonics) in
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direct injection mode and the same voltages as described for the
natural compounds. For API-CID-fragmentation, the voltage of
the capillary exit was raised to 180 V while the voltage of the
skimmer 1 remained at 50 V. The MS system was externally
calibrated in positive mode using sodium formiate cluster prior
to every analysis.
Columnchromatographywasperformedon silica gel 60 (Merck,
particle size 0.04–0.063 mm). Aluminium plates precoated with
Merck silica 60 were used for TLC. Compounds were visualized
by UV irradiation (254 nm) or dyeing with KMnO4 solution (1 g
KMnO4, 6.6 g K2CO3, 2 mL 5% NaOH solution in 100 mL H2O).
NMR spectra were recorded with a Bruker AM 300 (300 MHz)
spectrometer. All experiments were performed at 300 K. Chemical
shifts are quoted in ppm and are referenced to the appropriate
solvent signal. FT-IR spectra were recorded on a Perkin-Elmer
1600 series spectrometer. Absorptionmaxima are reported inwave
numbers and the following abbreviations are used: s strong, m
medium, w weak.
Haliclamine E (1). White amorphous powder. TLC Rf: 0.43
(9:1 CH2Cl2/MeOH (KMnO4)). IR (KBr, cm-1): n = 2932 m,
2860 m, 2623 w, 1685 s, 1465 w, 1406 w, 1198 s, 1162 s, 1133 s, 828
m, 797 m, 719 m. The compound does not show UV absorption.
HRMS ((+)-ESI): m/z= 429.4217 (calcd. 429.4203 for C29H53N2+
[M + H]+); m/z = 215.2160 (calcd. 215.2138 for C29H54N22+
[M + H]2+); m/z = 543.4123 (calcd. 543.4127 for C29H54N22+ ¥
C2F3O2- [M + H]+).
Haliclamine F (2). White amorphous powder. TLC Rf: 0.43
(9:1 CH2Cl2/MeOH (KMnO4)). IR (KBr, cm-1): n = 2928 s, 2856
m, 1675 s, 1465w, 1412w, 1197 s, 1170 s, 1132 s, 828w, 798w, 720m.
The compound does not show UV absorption. HRMS ((+)-ESI):
m/z = 471.4664 (calcd. 471.4673 for C32H59N2); m/z = 236.2364
(calcd. 236.2373 forC32H60N22+ [M+H]2+);m/z= 585.4567 (calcd.
585.4601 for C32H59N22+ ¥ C2F3O2- [M + H]+).
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Figure 6.15 Comparison of mass spectra of the natural and the synthetic compound
1. – (A). Mass trace obtained from an LCMS experiment of the crude extract of
Haliclona viscosa. – (B). Synthetic compound under standard ESI conditions. – (C).
Synthetic compound under API-CID-MS/MS conditions. The sections show details of
the doubly charged molecular ion and the singly charged fragments.
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Figure 6.16 Details and full scan (box) of a 1D 1H-NMR spectrum (300 MHz,
CDCl3) of the synthetic haliclamine E (1).
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Figure 6.17 Details and full scan (box) of a 1D 13C-NMR spectrum (75 MHz,
CDCl3) of the synthetic haliclamine E (1).
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Figure 6.18 Comparison of mass spectra of the natural and the synthetic compound
2. – (A). Mass trace obtained from an LCMS experiment of the crude extract of
Haliclona viscosa. – (B). Synthetic compound under standard ESI conditions. The
section shows a detail of the doubly charged molecular ion. – (C). Synthetic compound
under API-CID-MS/MS conditions. The section shows a detail of the doubly charged
molecular ion superimposed by the singly charged fragment.
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Figure 6.19 Details and full scan (box) of a 1D 1H-NMR spectrum (300 MHz,
CDCl3) of the synthetic haliclamine F (2).
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Figure 6.20 Details and full scan (box) of a 1D 13C-NMR spectrum (75 MHz,
CDCl3) of the synthetic haliclamine F (2).
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Table 6.6 1H- and 13C-NMR data of Haliclamines E (1) and F (2) in CDCl3. The
compounds in the solution were present as TFA salts.
Haliclamine E (1) Haliclamine F (2)
pos. δH δC pos. δH δC
NH, NH’ 12.62 (br. s, 2 H) NH, NH’ 12.62 (s, 2 H)
2 3.90 (d, 2 H, 15.7 Hz) 51.1 2 3.89 (d, 2 H, 15.8 Hz) 51.5
2’ 3.21-3.37 (m, 2 H) 50.8 2’ 3.25 (d, 2 H, 16.0 Hz) 51.4
3, 3’ 131,1 3, 3’ 131.1
4, 4’ 5.62 (s, 2 H) 119.1 4, 4’ 5.62 (s, 2 H) 119.1
5 2.51-2.69 (m, 2 H) 21.5 5 2.55-2.72 (m, 2 H) 21.6
5’ 2.27 (d, 2 H, 17.3 Hz) 21.8 5’ 2.26 (d, 2 H, 18.5 Hz) 21.5
6 3.34-3.55 (m, 2 H) 48.7 6 3.46-3.58 (m, 2 H) 48.3
6’ 2.87-3.16 (m, 6 H)a 47.9 6’ 2.85-3.11 (m, 6 H)b 48.1
7, 7’ 2.20 (t, 4 H, 6.6 Hz) 34.3, 34.7 7, 7’ 2.01 (t, 4 H, 7.1 Hz) 34.4, 34.6
8-13, 8’-14’ 1.18-1.49 (m, 26 H) 26.0, 26.4, 8-15, 8’-15’ 1.18-1.49 (m, 32 H) 26.4, 27.0,
27.0, 27.1, 27.1, 28.3–
27.2, 28.0– 29.0
28.7, 29.0
14, 15’ 1.72-1.89 (4 H, m) 23.5, 23.8 16, 16’ 1.70-1.85 (m, 4 H) 23.5
15, 16’ 2.87-3.16 (m, 6 H)a 54.8, 55.5 17, 17’ 2.85-3.11 (m, 6 H)b 55.2, 55.5
a Assignments are interchangeable. b Assignments are interchangeable.
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The marine sponge Stylissa caribica investigated by a MS-guided fractionation revealed several new secondary 
metabolites. The crude extract was analysed by HPLC-HRMS and the masses of the detected compounds were 
compared to literature (MarinLit
®
). This approach allowed the isolation of four new cyclic heptapeptides. 
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The heptapeptides stylissamides A to D are related to the phakellistatins, the hymenamides, and the stylisins.
[1]
 The 
structures were elucidated using HMBC and NOESY correlations as well as MS
n
 results.
[2]
 In addition to the cyclic 
heptapeptides, six new pyrrole-imidazole alkaloids, 4-bromopyrrole-2-carboxy-N(ε)-lysine[3], 4-bromopyrrole-2-
carboxyarginine
[3]
, oxocyclostylidol
[4]
, tetrabromostyloguanidine,
[5]
 and the first tetrameric derivatives stylissadines 
A and B
[6]
 were recently isolated from this sponge. Thus, the sponge Stylissa caribica was shown to be a rich source 
of new secondary metabolites of two different structure classes. 
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4. A. Grube, M. Köck, J. Nat. Prod. 2006, 69, 1212-1214. 
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The marine sponge Stylissa caribica investigated by a MS-guided fractionation revealed several 
new secondary metabolites. In addition to six new pyrrole-imidazole alkaloids
1
 (including the 
first tetrameric derivatives stylissadines A and B)
2
, four cyclic heptapeptides stylissamide A to D 
were isolated from this sponge.
3
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The structures of the stylissamides were elucidated using HMBC and NOESY correlations as 
well as MS
n
 results. The stylissamides A to D are related to the phakellistatins, the 
hymenamides, and the stylisins.
4
 NOESY experiments with mixing times of 100, 150, and 
200 ms formed the basis of studies on the conformation of the stylissamides. The NOE-derived 
interproton distances served as distance restraints in computation analyses to investigate the 
tertiary structure of the molecules.  
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In previous years, the composition and quantity of Haliclona viscosa metabolites changed with habitat 
and year, while a sympatric species, Haliclona rosea, did not show this variation (unpubl. data). This 
raises the question whether the variation in H. viscosa is due to an ability to adapt to varying 
environmental conditions (e.g. light, water temperature, different colonizing bacteria) or due to 
increased environmental pressure in some years that lowers the compound productivity of the sponge. 
 
The present study addresses the magnitude and quality of the metabolite variation in H. viscosa and 
H. rosea both between the polar habitat Spitsbergen and the temperate British Isles, and within each of 
the two habitats. To examine this, sponges are collected in three subsequent years by scuba diving at 
different sites and depth in Kongsfjorden, Spitsbergen and around the British Isles at times when 
metabolite production is highest.  
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Two new 3-alkyl-pyridinium alkaloids, haliclamines E and F, were identified in the crude extract 
of the Arctic sponge Haliclona viscosa using LC-MS methods. Due to the scarcity of sponge 
material available, the compounds were not isolated and the structure elucidation relied on the 
chromatographic comparison with synthetic compounds.
[1]
 
 
 
 
The MS fragmentation pattern of the haliclamines in general was examined on the basis of the 
synthetic compounds. Naturally occurring as well as to-date unreported haliclamines of (a) equal 
alkyl chain length and (b) chain length differences of one, two or three methylene groups were 
subject to extensive ion trap- and API-CID-MS/MS examinations.  
The MS fragmentation of these compounds is similar to the cyclostellettamines
[2]
 but strongly 
influenced by the tetrahydropyridine moiety and the ionization method applied in mass 
spectrometric analyses.
[3]
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Next to standard LC-MS applications, MALDI
[1]
-TOF mass spectrometry is a powerful method to 
analyze and characterize macromolecules like proteins
[2]
, carbohydrates
[3]
, oligonucleotides
[4]
 and 
synthetic polymers
[5]
. Research on small molecules did not, for traditional and technical reasons, 
focus on MALDI, but applications in the investigation of bacteria regarding their chemotaxonomy
[6]
 
and secondary metabolism
[7] 
are becoming more frequent. During our search for new natural 
products, we are applying MALDI-TOF-MS for a direct screening of secondary metabolites in 
sponge tissue.
[8]
 Due to the simple sample preparation, this method allows a broad insight into the 
compound spectrum at an early stage of investigation. Besides this, challenging questions regarding 
the qualitative and quantitative sample preparation, compound distribution and stability, etc. have 
emerged. Here, we want to discuss our experiences with this procedure using the sponge Stylissa 
caribica as an example. What are the possibilities and perspectives of MALDI-TOF-MS and where 
are the limits in natural products research? 
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Haliclamines take up an exceptional position in the large and diverse family of 3 -alkyl pyridinium 
alkaloids (3-APAs) isolated from natural sources. They are the only compounds among the 3-APAs 
that possess a tetrahydropyridine moiety and are only reported as macrocyclic dimers. We recently 
identified haliclamines E and F directly from the crude extract of a sponge. Since mass 
spectrometry plays an important role in the identification of these compounds, we initiated the  10 
present study on the MS-fragmentation of haliclamines as an extension of our study on the 
fragmentation of cyclostellettamines. Surprisingly, the singly charged molecular ion in 
haliclamines shows a distinctly different fragmentation in MS/MS experiments than the doubly 
charged molecular ion. 
Introduction 15 
The number of known 3-alkyl pyridinium and 3-alkyl piperi-
dine alkaloids (3-APAs) from sponges of the order Haplo-
sclerida is constantly growing.1 The main structural element 
of these alkaloids is a pyridine moiety connected in position 3 
and/or 1 to an alkyl chain of variable length. It can be 20 
arranged to cyclic or open monomers, dimers, trimers and 
polymers. A second structural element consists of a 
tetrahydropyridine moiety likewise connected to an alkyl 
chain of variable length. However, only macrocyclic 
tetrahydropyridine dimers are known, and to date only from 25 
sponges of the genus Haliclona. Hence, the number and 
diversity of 3-alkyl pyridinium compounds (cyclostellett-
amines,2 amphitoxin,3 cyclohaliclonamines,4 poly-alkyl-
pyridinium salts (Poly-APS),5 pachychalines,6 niphatoxines,7 
and many others) greatly exceeds the number of 3-alkyl tetra-30 
hydropyridine compounds known as haliclamines (Scheme 
1).8, 9 This suggests that the oxidation state of the six-
membered azacycle plays an important role in the occurrence 
of the compounds. 
 The repetitive 3-APA unit in cyclostellettamines and hali-35 
clamines cause NMR spectra to show only one structural unit 
of the molecule and the large number of similar methylene 
units results in a strong overlap of the aliphatic protons. NMR 
spectra are thus not ideally suited to distinguish large numbers 
of structurally very similar compounds present e.g. in 40 
Haliclona viscosa from Arctic waters. In these cases it makes 
sense to use LCMS and LCMS/MS methods to identify the 
natural compounds, e.g. directly from the crude extract.9 Mass 
spectrometric methods constitute a fast and easy way to 
identify haliclamines, cyclostellettamines and, potentially, 45 
also trimeric and polymeric 3-APAs.4, 6 They deliver insight 
into the size of the molecule as well as the length of the alkyl 
chains and number of double bonds therein. 
 For a confident identification of natural products by MS or 
MS/MS it is necessary to know the fragmentation pathways. 50 
As an expansion of our studies on the fragmentation of the  
 
Scheme 1 3-Alkyl pyridinium/pyridine- and 3-alkyl tetrahydropyridine 
alkaloids reported from sponges of the order Haplosclerida. 
cyclostellettamines10 we present the fragmentation of 55 
haliclamines. 
 Under certain fragmentation conditions, haliclamines pro-
duce fragments that are equal in mass to fragments known 
from cyclostellettamines that possess the same chain lengths. 
Since the kind of fragments derived depend very much on the 60 
fragmentation mode and the molecular ion selected for 
fragmentation, these typical fragments can be used during 
identification studies. The survey comprises haliclamines with 
equal alkyl chain length and chain length differences of one, 
two and three methylene groups, respectively. We include 65 
haliclamines that have not yet been isolated from natural 
sources, i.e. haliclamines with alkyl chains of 12/12, 13/13 
and 11/14 methylene groups. 
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Table 1 MS and in-source CID-MS/MS results for haliclamines C–I (1-7). 
Haliclamine  HRMS [M+H]+ HRMS [M+2H]2+ in-source CID-MS/MS Frag. 1 in-source CID-MS/MS Frag. 2 
C (1, 9/11) calcd. 
exper. 
443.4360, C30H55N2 
443.4364, Δm = 0.9 ppm 
FWHM: 0.0567 
222.2216, C30H56N2 
222.2216, Δm = 0.1 ppm 
FWHM: 0.0380 
208.2059, C14H26N (C9) 
208.2050, Δm = 4.8 ppm 
FWHM: 0.0329 
236.2373, C16H30N (C11) 
236.2359, Δm = 5.8 ppm 
FWHM: 0.0359 
D (2, 10/11) calcd. 
exper. 
457.4516, C31H57N2 
457.4522, Δm = 1.2 ppm 
FWHM: 0.0581 
229.2295, C31H58N2 
229.2301, Δm = 3.0 ppm 
FWHM: 0.0388 
222.2216, C15H28N (C10) 
222.2214, Δm = 1.0 ppm 
FWHM: 0.0351 
236.2373, C16H30N (C11) 
236.2370, Δm = 1.1 ppm 
FWHM: 0.0365 
E (3, 9/10) calcd. 
exper. 
429.4203, C29H53N2 
429.4217, Δm = 3.3 ppm 
FWHM: 0.0571 
215.2138, C29H54N2 
215.2160, Δm = 10.1 ppm 
FWHM: 0.0401 
208.2060, C14H26N (C9) 
208.2067, Δm = 3.3 ppm 
FWHM: 0.0326 
222.2216, C15H28N (C10) 
222.2219, Δm = 1.2 ppm 
FWHM: 0.0346 
F (4, 11/11) calcd. 
exper. 
471.4673, C32H59N2 
471.4664, Δm = 1.8 ppm 
FWHM: 0.0557 
236.2373, C32H60N2 
236.2364, Δm = 3.9 ppm 
FWHM: 0.0373 
236.2373, C16H30N (2 × C11) 
236.2355, Δm = 7.5 ppm 
FWHM: 0.0366 
 
G (5, 12/12) calcd. 
exper. 
499.4986, C34H63N2 
499.4967, Δm = 3.8 ppm 
FWHM: 0.0598 
250.2529, C34H64N2 
250.2527, Δm = 1.0 ppm 
FWHM: 0.0383 
250.2529, C17H32N (2 × C12) 
250.2524, Δm = 2.0 ppm 
FWHM: 0.0376 
 
H (6, 13/13) calcd. 
exper. 
527.5299, C36H67N2 
527.5283, Δm = 3.1 ppm 
FWHM: 0.0643 
264.2686, C36H68N2 
264.2690, Δm = 1.6 ppm 
FWHM: 0.0400 
264.2686, C18H34N (2 × C13) 
264.2685, Δm = 0.3 ppm 
FWHM: 0.0393 
 
I (7, 11/14) calcd. 
exper. 
513.5142, C35H65N2 
513.5121, Δm = 4.2 ppm 
FWHM: 0.0632 
257.2608, C35H66N2 
257.2610, Δm = 0.8 ppm 
FWHM: 0.0406 
236.2373, C16H30N (C11) 
236.2630, Δm = 5.5 ppm 
FWHM: 0.0368 
278.2842, C19H36N (C14) 
278.2833, Δm = 3.3 ppm 
FWHM: 0.0413 
 
 
Fig. 1 High resolution mass spectrum (A) and HR-in-source-CID-MS/MS spectrum (B) of haliclamine C (1) (THP = tetrahydropyridine). 5 
Results and Discussion 
The synthetic haliclamines used within this investigation 
originate from reduction of synthetic cyclostellettamines that 
contain the desired chain lengths. This reduction provides 
haliclamines C (1, m = 4, n = 6), D (2, m = 5, n = 6), E (3, m = 10 
4, n = 5), F (4, m = n = 6), G (5, m = n = 7), H (6, m = n = 8) 
and I (7, m = 6, n = 9)9 and follows a procedure described by 
Baldwin et al.11 Haliclamines G (5), H (6) and I (7) are not yet 
reported from natural sources but are purposely synthesized 
for this study. Since all haliclamines show the same 15 
fragmentation pattern under equal MS conditions, haliclamine 
C (1) serves as a general representative during the discussion 
of the fragmentation pattern. 
 The high resolution mass spectrum of haliclamine C (1) 
displays three major peaks: the singly charged molecular ion 20 
at m/z 443.4364, the doubly charged molecular ion at m/z 
222.2216 and the TFA12 adduct of haliclamine C (1) at m/z 
557.4269 (Figure 1). 
 Two additional minor peaks at m/z 208.2050 and 236.2359 
are visible in HR-MS of haliclamine C (1) and represent mass 25 
equivalents of fragments composed of e.g. a tetrahydro-
pyridine (THP) moiety connected to a chain of 9 or 11 
methylene groups, respectively (Table 1). 
 For fragmentation studies, the compounds receive two 
different treatments: (a) in-source CID-MS/MS (on a TOF 30 
mass spectrometer equipped with an ESI-source) as an omni-
directional fragmentation method, and (b) CID-MSn (on an 
Ion-trap mass spectrometer, likewise equipped with an ESI 
source) as a possibility to select different precursor ions for 
fragmentation.  35 
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Fig. 2 CID-MS/MS spectra of haliclamine C (1) during fragmentation of the singly charged molecular ion. Diamonds mark the respective precursor ions 
(Pyr = pyridine). 
 
Scheme 2 Possible fragments derived from different fragmentation 5 
reactions of haliclamine C (1) assuming two equal simultaneous 
fragmentation reactions. 
Fragmentation by in-source CID 
Application of in-source CID-MS/MS conditions results in 
increased intensity of the singly charged molecular ion, a 10 
considerable decrease in intensity of the doubly charged 
molecular ion and the loss of the TFA adduct ion. At the same 
time, the intensity of the THP + alkyl chain type fragments, 
m/z 208.2 and m/z 236.2, increases slightly. A number of 
reactions are supposable for the formation of fragments with 15 
the mass m/z 208.2 and m/z 236.2; onium and retro-Diels-
Alder reactions as well as McLafferty rearrangement (Scheme 
2). However, with in-source CID-MS/MS being omni-
directional, it is not possible in this step to distinguish or 
argue which reaction is more probable. A combination of 20 
them is most likely. Since fragments of the same mass also 
form under MSn conditions, a suggestion for the predominant 
fragmentation reaction is discussed below. 
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Fig. 3 CID-MS/MS spectra of haliclamine C (1) during fragmentation of the doubly charged molecular ion. The section shows a detail of the m/z 44 
region during MS2. Diamonds mark the respective precursor ions (THP = tetrahydropyridine). 
Fragmentation by CID 5 
Under CID-MS conditions on the Ion trap mass spectrometer, 
the two minor fragments that represent the THP + alkyl chain 
type fragments are not visible at considerable intensities 
which is probably due to slight differences in source geometry 
or other instrument parameters. For CID-MSn experiments, 10 
both the singly and the doubly charged molecular ion serve as 
precursors for fragmentation experiments and result in two 
distinctly different fragmentation patterns. 
 
Fragmentation of the singly charged molecular ion 15 
The first pattern originates from isolation and fragmentation 
of the singly charged molecular ion. Here, a stepwise loss of 2 
mass units at a time occurs in MS2 and subsequently also in 
MS3, resulting in a total of 4 mass units difference to the 
molecular ion (Figure 2). It is the result of a progressive 20 
oxidation of the THP rings in which each of the rings can be 
oxidized independently or one ring is fully oxidized to the 
pyridinium. 
 From the MSn spectra it is clear that complete oxidation of 
one THP to the pyridinium is preferred (Scheme 3A). There 25 
are two indications for this: one is the appearance of two 
strong fragments at m/z 204.2 and 232.2 which stand for the 
mass equivalent of a pyridinium (Pyr) moiety connected to 
either alkyl chain [Pyr + (CH2)9 or Pyr + (CH2)11]; the other is 
the absence of a continued oxidation after the loss of four 30 
mass units which would be expected if neither ring was 
completely oxidized in this step. However, no pronounced 
mass peak at m/z 437.4 is present in the MS4 experiment. 
 The oxidation of only one of the THP rings might be 
explained by considering that the fully unsaturated pyridine 35 
lends structural stability to the molecule while the THP easily 
fractures, e.g. in a retro-Diels-Alder reaction. With one ring 
existing as a pyridine and the other as THP, the compound can 
follow a fragmentation pattern as described for the cyclo-
stellettamines. An onium reaction and McLafferty rearrange-40 
ment both provide the fragments m/z 204.2 and 232.2 (Scheme 
3B). 
 The phenomenon of oxidation to the pyridine also occurs 
during a high temperature NMR experiment in DMSO-d6  
under air. From approximately 353 K, four distinct signals 45 
appear in the range 8.0 to 9.5 ppm and a fifth signal at 4.6 
ppm. They become increasingly stronger with higher tempera-
ture. The signals correspond in multiplicity and chemical shift 
to the cyclostellettamine aromatic protons and the methylene 
group attached to the pyridine nitrogen. Thus, the tetrahydro-50 
pyridine ring in haliclamine is oxidized to a pyridine and the 
amount of pyridine increases with increasing temperature. The 
reaction does not happen under a protective gas or in CDCl3-
d1. 
 In mass spectrometry, this oxidation happens in two steps 55 
under generation of a dihydropyridine. Dihydropyridines are 
known to decompose into pyridines and tetrahydropyridines 
when heated or on exposure to air.13 However, in NMR there 
seems to be a direct oxidation from the THP to the pyridine 
60 
 This journal is © The Royal Society of Chemistry [year] Journal Name, [year], [vol], 00–00  |  5 
 
Scheme 3 Fragmentation of the singly charged molecular ion of haliclamine C (1). A: stepwise oxidation; B: fragmentation into the Pyr + alkyl chain type 
fragments. 
 
Scheme 4 Proposed fragmentation pathway of the doubly charged 5 
molecular ion of haliclamine C (1). 
since none of the NMR signals correspond to a dihydro-
pyridine. A ring opening as proposed for MS experiments 
does not seem to occur since the signals that correspond to a 
terminal methylene or imine group are missing. While it is not 10 
possible from the NMR spectrum to determine whether only 
one or possibly both THP rings in the molecule are oxidized, 
it is still clear that the THP ring is completely oxidized to the 
pyridinium. This strengthens the conclusion on complete 
oxidation of one THP ring instead of a partial oxidation to 15 
dihydropyridines in both THP rings made above for the MS 
fragmentation. 
 There are also some indications that the macro-cycle opens 
up, possibly during the ionization or in a multi-fragmentation 
process during MS2; though at low intensity, MS2 and MS3 20 
provide fragments that derive from a loss of m/z 17, corres-
pondent to ammonia elimination, and m/z 31, the elimination 
of methanamine. To achieve this loss, the macro-cyclic and 
tetrahydropyridine ring structures must be open early. 
Ammonia loss from methylenediamines is described by Boss-25 
hardt and Hesse14, but it seems to be a minor process in com-
parison to the formation of the Pyr + (CH2)9/11 fragments. 
 
Fragmentation of the doubly charged molecular ion  
The second fragmentation pattern under CID-MSn conditions 30 
evolves when fragmenting the doubly charged molecular ion. 
Most obvious is the immediate loss of a charged fragment that 
includes one of the nitrogen atoms since all emerging 
fragments are singly charged and even numbered (Figure 3). 
For the loss of such a charged fragment a ring opening of both 35 
the macro-cycle and the THP ring has to occur. The loss of the 
charged fragment strongly indicates a retro-Diels-Alder 
(RDA) reaction for the initial ring opening which leads to a 
doubly charged methylene iminium ion (m/z 222.2, Scheme 
4). Other reactions like α-cleavage and onium reactions open 40 
the macro-cycle but leave the THP intact, and therefore do not 
lead to an intermediate from which this charged fragment can 
be split. 
 The most pronounced fragment in MS2 emerging from 
doubly charged haliclamine C (1) is m/z 400.5 (Δ m/z 44 to 45 
the precursor). Since both nitrogen atoms are protonated in the 
doubly charged compound, an onium reaction would lead to a 
charged fragment m/z 30 (Figure 3) and a second charged 
fragment at m/z 414. The latter is detected at low intensity 
while m/z 30 cannot be detected due to instrument limitations. 50 
A McLafferty-type rearrangement would result in the two 
charged fragments m/z 44 and m/z 400 (Scheme 4). Several 
authors have investigated the fragmentation of aliphatic 
iminium ions;15 they conclude that the fragmentation 
mechanism, i.e. whether an onium reaction or a McLafferty 55 
rearrangement dominate the process, strongly depends on the 
length of the alkyl chain. Taking into account the length of the 
aliphatic chain in haliclamines, McLafferty rearrangement 
would be the prominent reaction. However, the authors 
examined aliphatic iminium ions that carried a single charge 60 
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while the haliclamine in the present fragmentation carries a 
double charge. Added to this, McLafferty rearrangement is 
defined as leading to a charged and a neutral particle. Since 
both fragments, m/z 44 and 400, retain their charge and are 
visible in MS2 (Figure 3), with m/z 400 present at highest 5 
intensity, we must conclude that the underlying reaction is not 
a McLafferty rearrangement. If however the aliphatic chain of 
considerable length in haliclamines can be seen a pseudo-
neutral isolator against the second charge present in the 
molecule, McLafferty rearrangement would be possible. 10 
 At the same time, THP + alkyl chain type fragments m/z 
208.2 and 236.2 emerge during MS2. This is in contrast to the 
Pyr + alkyl chain type fragments generated during fragmen-
tation of the singly charged molecular ion but comparative to 
results from in-source CID-MS/MS experiments. A suitable 15 
explanation for the THP type fragments seems to be a second 
RDA reaction at the remaining THP ring leading to two long 
chain aliphatic methylene iminium ions that are the mass 
equivalent of a THP ring connected to an alkyl chain of 9 or 
11 methylene groups in the case of haliclamine C (1). 20 
 During fragmentation of the m/z 400.5 ion in MS3, we again 
observe the loss of m/z 2, correspondent to the generation of a 
double bond, along with the characteristic stepwise cleavage 
of the alkyl chain with mass differences of m/z 14 (Figure 4). 
However, this fragment m/z 398.4 is of low intensity and 25 
cannot be compared to the stepwise oxidation of the singly 
charged molecular ion as only one oxidation step can be 
observed. 
Conclusions 
The systematic investigation of the MS spectra of hali-30 
clamines expands the analysis of the fragmentation pathways 
of 3-alkyl pyridinium alkaloids which was initiated by our 
work on the cyclostellettamines. Most astonishingly in this 
respect are the different fragmentation patterns of singly and 
doubly charged haliclamine molecular ions. Whereas the frag-35 
mentation of the singly charged molecular ion leads to frag-
ments corresponding in mass to a pyridinium moiety 
connected to an alkyl chain, the fragmentation of the doubly 
charged molecular ion results in tetrahydropyridine-type 
fragments. Fragmentation of the doubly charged molecular ion 40 
results in a similar fragmentation as reported from ESI-in-
source-CID-MS/MS fragmentation. The presented 
investigation serves as a reference for future studies of these 
molecules. 
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Synthetic pathway towards the haliclamines
N
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O
N
OH
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N
O
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N
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N
N
2.
C (1-7)
Cyclostellettamines Haliclamines C-I (1-7)
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n
m
n
n
m
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Figure 7.1 Pathway for synthesis of the haliclamines.
1. Synthesis of N-oxide dimers A mixture of 1.0 mmol N -oxide (A), 1.0 mmol alcohol
(B), and 1.2 mmol NaI was dissolved in 25 mL butan-2-one and refluxed for
48 h. After cooling the solvent was removed and the residue was adsorbed
on silica and purified via column chromatography. The starting material was
synthesized following literature procedures.
2./3. Synthesis of Cyclostellettamines Within 10 minutes PBr3 (0.39 mL, 4.0 mmol)
was added to a cooled (0 °C) suspension of dimer C in 15 mL of CHCl3 under
an atmosphere of Argon. The mixture was stirred for 15 minutes at that
temperature and then heated to reflux for 1 h. After cooling it was poured
onto 50 mL of an ice/water mixture. The layers were separated and the water
layer was extracted with CH2Cl2 (3 × 15 mL). The combined organic extracts
were neutralized with 2 m Na2CO3 (3 × 15 mL), dried over MgSO4, and the
solvent was removed leaving about 1 mL bromide-containing solution. After
diluting with 10 mL of butan-2-one it was added to a refluxing solution of NaI
(0.33 g, 2.2 mmol) in 200 mL butan-2-one via a syringe pump at a rate of 0.5
mL h−1. The mixture was refluxed for 4 days. Removal of the solvent yielded
an oily residue which solidified upon trituration with Et2O. The resulting solid
was purified via recrystallisation.
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4. Synthesis of Haliclamines A solution of the cyclostellettamine (D, 0.13 mmol) in
10 mL CH2Cl2/MeOH (1:1) was cooled to –40 °C and NaBH4 (0.10 g, 2.63
mmol) was added. After stirring for two hours in the cold, the mixture was
allowed to warm to room temperature, 5 mL of 2 m NaOH solution were added
and it was stirred for an additional 15 minutes. It was then poured onto 15
mL water and extracted with CH2Cl2 (3 × 10 mL). Drying of the combined
organic extracts over MgSO4 and removal of the solvent yielded the crude
product (1-7). The crude product was purified via preparative HPLC.
Experimental conditions
All solvents were purified by distillation, with the exception of THF which was
distilled from sodium/benzophenone under argon. Column chromatography was
performed on silica gel 60 (Merck, particle size 0.04–0.063 mm). Aluminum plates
pre-coated with Merck silica 60 were used for TLC. Compounds were visualized
by UV irradiation (254 nm) or dying with KMnO4 solution (1 g KMnO4, 6.6 g
K2CO3, 2 mL 5 % NaOH solution in 100 mL H2O). Purification of the synthetic
compounds was performed on a Jasco 1500 series HPLC system. It was equipped
with a Prontosil Eurobond RP18 column (20 × 250 mm, 5 µm, 40 °C) applying a
MeCN/H2O (0.1 % TFA) gradient [30 % MeCN / 70 % H2O isocratic for 5 min;
to 60 % MeCN / 40 % H2O in 30 min; isocratic for 5 minutes; to 100 % MeCN in
10 min] with a flow rate of 8 mL min−1. Analytical HPLC used a Kromasil RP18
column (4.6 × 250 mm, 5 µm, 40 °C), as before with a MeCN/H2O (0.1 % TFA)
gradient [from 100 % H2O to 80 % MeCN / 20 % H2O in 40 min; to 100 % MeCN
in 5 min] at a flow rate of 1 mL min−1. UV spectra were recorded during HPLC
analyses with a DAD (Jasco). Melting points were obtained with a Kofler melting
point apparatus and are uncorrected. NMR spectra were recorded with Bruker AM
250 (250 MHz), Bruker AM 300 (300 MHz), and Bruker Avance 400 (400 MHz)
spectrometers. All experiments were performed at 300 K, with the exception of the
high-temperature NMR experiment for which the temperatures are given in Figure
SI 4. Chemical shifts are quoted in ppm and are referenced to the appropriate solvent
signal. FT-IR spectra were recorded on a Perkin-Elmer 1600 series spectrometer.
Absorption maxima are reported in wave numbers and the following abbreviations
are used: s strong, m medium, w weak. Elemental analysis was performed on a
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Heraeus CHN Rapid. Mass spectra were acquired in positive mode after external
calibration with sodium formiate cluster. HRMS and in-source CID-MS/MS spectra
were recorded on a micrOTOF spectrometer (Bruker Daltonics) equipped with an
ESI source (capillary exit = 100 V, skimmer 1 = 50 V). For in-source CID-conditions,
the capillary exit voltage was set to 180 V while skimmer 1 remained at 50 V. MSn
spectra were recorded on an Esquire 3000plus Ion-trap (Bruker Daltonics) equipped
with an ESI source.
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Haliclamine C (1), 9/11
Compound data
3-(9hydroxynonyl)-1-[11-(N-oxidopyridine-3-yl)-undecyl]-pyridinium iodide (1C). 3-(11-
chloroundecyl)-pyridine-N -oxide (1A, 1.50 g, 5.28 mmol), 9-(pyridine-3-yl)-nonane-
1-ol (1B, 1.17 g, 5.28 mmol), and NaI (0.95 g, 6.34 mmol) were treated as described
above (procedure 1.). Chromatography on silica (9:1 CH2Cl2/MeOH) yielded 1.83
g (58%) of the dimer as a yellow solid. — TLC Rf : 0.3 (9:1 CH2Cl2/MeOH). —
1H-NMR (250 MHz, DMSO-d6): δ = 1.09-1.73 (m, 30 H, 15 × CH2), 1.93 (m, 2 H,
NCH2CH 2), 2.52 (t, J = 7.4 Hz, 2 H, 3-CH 2), 2.79 (t, J = 7.6 Hz, 2 H, 3’-CH 2),
3.36 (dt, J = 6.1 Hz, J = 4.8 Hz, 2 H, CH 2OH), 4.30 (t, J = 4.9 Hz, 1 H, OH),
4.56 (t, J = 7.3 Hz, 2 H, NCH 2), 7.19 (d, J = 7.9 Hz, 1 H, H4), 7.32 (dd, J =
7.8 Hz, J = 6.4 Hz, 1 H, H5), 7.99-8.18 (m, 3 H, H2, H6 and H5’) 8.49 (d, J =
8.1 Hz, 1 H, H4’), 8.95 (d, J = 6.0 Hz, 1 H, H6’), 9.05 (s, 1 H, H2’). — 13C-NMR
(62.5 MHz, DMSO-d6): δ = 25.2, 25.4, 28.2-28.8 (12 × CH2), 29.6 (3’-CH2CH2),
29.8 (3-CH2CH2), 31.4 (3’-CH2), 31.5 (3-CH2), 32.4 (CH2CH2OH), 60.5 (NCH2),
60.6 (CH2OH), 125.3 (C4), 125.9 (C5), 127.4 (C5’), 136.1 (C6), 138.1 (C2), 141.3
(C3’), 142.1 (C6’), 142.9 (C3) 143.8 (C2’) 145.0 (C4’). — IR (KBr, cm−1): ν˜ =
3416 s, 3096 m, 2924 s, 2851 s, 1630 w, 1604 w, 1568 w, 1505 m, 1467 s, 1438 m,
1370 w, 1308 w 1266 s, 1159 s, 1063 m, 1019 m, 962 m, 793 m, 760 m, 719 w, 679
s. — HRMS ((+)-ESI): m/z = 469.3761 (calcd. 469.3789 for C30H49N2O2+ [M+H]+).
Cyclostellettamine O (1D). Following the procedure 2./3., cyclostellettamine O
(1D) was prepared from 3-(9-hydroxynonyl)-1-[11-(N -oxidopyridine-3-yl)-undecyl]-
pyridinium iodide (1C) (1.50 g, 2.51 mmol), PBr3 (0.97 mL, 10.06 mmol) and NaI
(0.83 g, 5.53 mmol). Recrystallisation from MeOH/Et2O yielded 1.24 g (71%) of a
brown solid. — TLC bromide: Rf : 0.55 (free base, 9:1 CH2Cl2/MeOH); cyclostellett-
amine O (1D): Rf : 0.23 (9:1 CH2Cl2/MeOH). — 1H-NMR (250 MHz, DMSO-d6): δ
= 0.84-1.43 (m, 24 H, 12 × CH2), 1.43-1.79 (m, 4 H, 3-CH2CH 2), 1.84-1.97 (m, 4 H,
NCH2CH 2), 2.81 (t, J = 6.9 Hz, 4 H, 3-CH 2), 4.60 (t, J = 5.8 Hz, 4 H, NCH 2), 8.10
(dd, J = 8.0 Hz, J = 6.0 Hz, 2 H, H5), 8.50 (d, J = 8.0 Hz, 2 H, H4), 8.96 (d, J =
6.0 Hz, 2 H, H6), 9.09 (s, 2 H, H2). — 13C-NMR (62.5 MHz, DMSO-d6): δ = 24.6,
25.0, 27.2, 27.6, 27.7, 28.1-28.9 and 29.3 (14 × CH2), 29.8 and 30.1 (3-CH2CH2),
31.1 and 31.2 (3-CH2), 60.3 and 60.5 (NCH2), 127.7 (C5), 142.1 (C6), 142.6 (C3),
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143.8 (C2), 145.3 (C4). — IR (KBr, cm−1): ν˜ = 3017 m, 2924 s, 2850 s, 1626 m,
1584 w, 1504 s, 1468 s, 1368 w, 1318 w, 1240 w, 1153 w, 920 w, 830 w, 807 w, 722
w, 694 m. — EA calcd. for C30H48N2I2 (690.52): C 52.18, H 7.01, N 4.06; calc. for
C30H48N2I2 × 0.5 H2O: C 51.51, H 7.06, N 4.00; found C 51.73, H 7.04, N 3.75. —
UV (DAD): λmax = 218, 270 nm; λmin = 242 nm. — HRMS ((+)-ESI): m/z =
218.1903 (calcd. 218.1904 for C30H48N22+ [M+H]2+).
Haliclamine C (1). In the manner described above (procedure 4.), 100 mg of cyclo-
stellettamine O (1D) were treated with 100 mg of NaBH4. Purification of 58 mg of
the crude product via HPLC yielded 27 mg (29%) haliclamine C (1) as TFA-salt. —
TLC Rf : 0.43 (9:1 CH2Cl2/MeOH). — 1H-NMR (400 MHz, CDCl3): δ = 1.19-1.46
(m, 28 H, 14 × CH2), 1.72-1.85 (m, 4 H, NCH2CH 2), 2.01 (t, J = 6.4 Hz, 4 H,
3-CH 2), 2.14-2.37 (m, 2 H, H5’), 2.56-2.76 (m, 2 H, H5), 2.83-3.17 (m, 6 H, H6’ and
NCH 2), 3.30 (d, J = 15.6 Hz, 2 H, H2’), 3.41-3.62 (m, 2 H, H6), 3.83-3.97 (m, 2 H,
H2), 5.62 (s, 2 H, H4), 11.95-12.30 (m, 2 H, NH). — 13C-NMR (75.0 MHz, CDCl3):
δ = 21.5 and 21.8 (C5), 23.4 (NCH2CH2), 26.0, 26.2, 27.0, 27.1 and 28.0-29.0 (14 ×
CH2), 34.5 and 34.6 (3-CH2), 48.2 and 48.7 (C6), 51.4 and 51.8 (C2), 55.4 and 55.8
(CH2N), 119.2 (C4), 131.1 (C3). — IR (KBr, cm−1): ν˜ = 2931 s, 2858 m, 1735 w,
1671 s, 1560 w, 1466 m, 1199 s, 1137 s, 798 w, 720 m. — HRMS ((+)-ESI): m/z =
443.4334 (calcd. 443.4360 for C30H55N+2 [M+H]+); m/z = 222.2210 (calcd. 222.2217
for C30H56N22+ [M+H]2+).
Mass spectra
0.0
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Figure 7.2 High-resolution mass spectrum of haliclamine C (1) under standard
(top) and in-source CID-MS/MS condition (below). THP = tetrahydropyridine.
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Figure 7.3 MS/MS-fragmentation of the singly charged molecular ion of haliclamine
C (1) under ion trap conditions. Pyr = pyridine. Precursor ions for fragmentation
are marked with a yellow diamond.
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Figure 7.4 MS/MS-fragmentation of the doubly charged molecular ion of haliclamine
C (1) under ion trap conditions. THP = tetrahydropyridine. Precursor ions for
fragmentation are marked with a yellow diamond.
Figure 7.5 Details of the 1H-NMR spectrum of haliclamine C (1)
at different temperatures. Spectra are equally scaled.
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Haliclamine D (2), 10/11
Compound data
3-(10-hydroxydecyl)-1-[11-(N-oxidopyridine-3-yl)-undecyl]-pyridinium iodide (2C). For
preparation and compound data refer to Grube et al. [117]
Cyclostellettamine Q (2D). For preparation and compound data refer to Grube
et al. [117]
Haliclamine D (2). In the manner described above (procedure 4.), 100 mg of
cyclostellettamine Q (2D) were treated with 100 mg of NaBH4. Purification of
56 mg of the crude product via HPLC yielded 31 mg (32%) haliclamine D (2) as
TFA-salt. — TLC Rf : 0.43 (9:1 CH2Cl2/MeOH). — 1H-NMR (300 MHz, CDCl3):
δ = 1.18-1.50 (m, 30 H, 15 × CH2), 1.71-1.88 (m, 4 H, NCH2CH 2), 1.97-2.09 (m,
4 H, 3-CH2), 2.29 (d, J = 18.6 Hz, 2 H, H5’), 2.54-2.73 (m, 2 H, H5), 2.85-3.17
(m, 6 H, H6’ and NCH 2), 3.27 (d, J = 15.5 Hz, 2 H, H2’), 3.46-3.60 (m, 2 H, H6),
3.85-3.99 (m, 2 H, H2), 5.63 (s, 2 H, H4), 12.34 (s, 2 H, NH). — 13C-NMR (75.0
MHz, CDCl3): δ = 21.5 and 21.7 (C5), 23.4 and 23.7 (NCH2CH2), 26.1, 26.3, 27.0,
27.1, 28.2, 28.3, 28.4, 28.6-28.8, 28.9 and 29.2 (15 × CH2), 34.5 and 34.7 (3-CH2),
48.4 and 48.8 (C6), 51.4 and 51.5 (C2), 55.4 and 55.9 (NCH2), 119.2 (C4), 131.2
(C3). — IR (KBr, cm−1): ν˜ = 2929 s, 2857 m, 1672 s, 1531 w, 1465 w, 1414 w,
1308 w, 1198 s, 1135 s, 828 w, 798 w, 720 m. — The compound does not show UV
absorption. — HRMS ((+)-ESI): m/z = 457.4508 (calcd. 457.4516 for C31H57N2+
[M+H]+); m/z = 229.2287 (calcd. 229.2295 for C31H58N22+ [M+H]2+).
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Mass spectra
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Figure 7.6 High-resolution mass spectrum of haliclamine D (2) under standard
(top) and in-source CID-MS/MS condition (below). THP = tetrahydropyridine.
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Figure 7.7 MS/MS-fragmentation of the singly charged molecular ion of haliclamine
D (2) under ion trap conditions. Pyr = pyridine. Precursor ions for fragmentation
are marked with a yellow diamond.
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Figure 7.8 MS/MS-fragmentation of the doubly charged molecular ion of haliclamine
D (2) under ion trap conditions. THP = tetrahydropyridine. Precursor ions for
fragmentation are marked with a yellow diamond.
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Haliclamine E (3), 9/10
Compound data
3-(10-hydroxydecyl)-1-[9-(N-oxidopyridine-3-yl)-nonyl]-pyridinium iodide (3C). 3-(9-
chlorononyl)-pyridine-N -oxide (3A, 0.80 g, 3.13 mmol), 10-(pyridine-3-yl)-decane-1-
ol (3B, 0.74 g, 3.13 mmol), and NaI (0.56 g, 3.76 mmol) were treated as described
above (procedure 1.). Chromatography on silica (9:1 CH2Cl2/MeOH) yielded 0.59
g (33%) of the dimer as a brown solid. — TLC Rf : 0.22 (9:1 CH2Cl2/MeOH). —
1H-NMR (250 MHz, DMSO-d6): δ = 1.07-1.72 (m, 28 H, 14 × CH2), 1.83-1.98 (m,
2 H, NCH2CH 2), 2.45-2.59 (m, 2 H, 3-CH 2), 2.79 (t, J = 7.6 Hz, 2 H, 3’-CH 2),
3.29-3.44 (m, 2 H, CH 2OH), 4.33 (t, J = 5.1 Hz, 1 H, OH), 4.55 (t, J = 7.3 Hz, 2 H,
NCH 2), 7.20 (d, J = 8.0 Hz, 1 H, H4), 7.32 (dd, J = 7.7 Hz, J = 6.5 Hz, 1 H, H5),
8.02-8.13 (m, 3 H, H2, H6 and H5’), 8.48 (d, J = 8.1 Hz, 1 H, H4’), 8.94 (d, J =
6.0 Hz, 1 H, H6’), 9.04 (s, 1 H, H2’). — 13C-NMR (62.5 MHz, DMSO-d6): δ = 25.3,
25.4, 28.2, 28.5-28.9 and 29.0 (11 × CH2), 29.7 (3’-CH2CH2), 29.9 (3-CH2CH2),
30.5 (NCH2CH2), 31.5 (3-CH2 and 3’-CH2), 32.4 CH2CH2OH), 60.6 (NCH2), 62.7
(CH2OH), 125.5 (C4), 126.0 (C5), 127.5 (C5’), 136.2 (C6), 138.1 (C2), 141.4 (C3’),
142.1 (C6’), 143.0 (C3), 143.9 (C2’), 145.0 (C4’). — IR (NaCl, cm−1): ν˜ = 3416 s,
3027 w, 2926 s, 2854 s, 1734 w, 1630 m, 1503 m, 1443 s, 1355 w, 1260 m, 1163 s,
1052 w, 965 w, 802 w, 762 w, 722 w, 685 s. — HRMS ((+)-ESI): m/z = 455.3591
(calcd. 455.3632 for C29H47N2O2+ [M+H]+).
Cyclostellettamine N (3D). Following procedure 2./3., cyclostellettamine N (3D) was
prepared from 3-(10-hydroxydecyl)-1-[9-(N -oxidopyridine-3-yl)-nonyl]-pyridinium
iodide (3C) (0.50 g, 0.86 mmol), PBr3 (0.32 mL, 3.44 mmol) and NaI (0.28 g, 1.19
mmol). Recrystallisation from MeOH/Et2O gave 0.39 g (67%) of a yellow solid.
TLC bromide: Rf : 0.65 (free base, 9:1 CH2Cl2/MeOH); cyclostellettamine N (3D):
Rf : 0.41 (9:1 CH2Cl2/MeOH). — 1H-NMR (250 MHz, DMSO-d6): δ = 0.96-1.40
(m, 22 H, 11 × CH2), 1.55-1.72 (m, 4 H, 3-CH2CH 2), 1.82-1.99 (m, 4 H, NCH2CH 2),
2.81 (t, J = 6.4 Hz, 4 H, 3-CH 2), 4.60 (t, J = 6.1 Hz, 4 H, NCH 2), 8.10 (dd, J =
7.8, J = 6.1 Hz, 2 H, H5), 8.50 (d, J = 7.9 Hz, 2 H, H4), 8.97 (d, J = 5.9 Hz, 2 H,
H6), 9.11 (s, 2 H, H2). — 13C-NMR (62.5 MHz, DMSO-d6): δ = 24.5, 24.9, 27.0,
27.5, 27.8, 28.1-28.6, 29.0 and 29.2 (13 × CH2), 29.9 and 30.0 (3-CH2CH2), 31.0 and
31.3 (3-CH2), 60.4 and 60.5 (NCH2), 127.7 (C5), 142.3 (C6), 142.6 (C3), 143.9 (C2),
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145.3 (C4). — IR (KBr, cm−1): ν˜ = 3011 s, 2922 s, 2851 s, 1624 m, 1501 s, 1467
m, 1444 m, 1364 w, 1238 w, 1205 w, 1153 w, 930 w, 828 w, 697 s, 618 w. — UV
(DAD): λmax = 218, 270 nm; λmin = 242 nm. — HRMS ((+)-ESI): m/z = 549.2682
(calcd. 549.2700 for C29H46N2I+ [M+H]+); m/z = 211.1824 (calcd. 211.1825 for
C29H46N22+ [M+H]2+).
Haliclamine E (3). In the manner described above (procedure 4.), 100 mg of cyclo-
stellettamine N (3D) were treated with 100 mg of NaBH4. Purification of 47 mg of
the crude product via HPLC yielded 32 mg (35%) haliclamine (3) as TFA-salt. —
TLC Rf : 0.43 (9:1 CH2Cl2/MeOH). — 1H-NMR (300 MHz, CDCl3): δ = 1.18-1.49
(m, 26 H, 13 × CH2), 1.72-1.89 (m, 4 H, NCH2CH 2), 2.20 (t, J = 6.6 Hz, 4 H,
3-CH 2), 2.27 (d, J = 17.3 Hz, 2 H, H5’), 2.51-2.69 (m, 2 H, H5), 2.87-3.16 (m, 6
H, NCH 2 and H6), 3.21-3.37 (m, 2 H, H2’), 3.43-3.55 (m, 2 H, H6), 3.90 (d, J =
15.7 Hz, 2 H, H2), 5.62 (s, 2 H, H4), 12.69 (br. s, 2 H, NH). — 13C-NMR (75.0
MHz, CDCl3): δ = 21.5 and 21.8 (C5), 23.5 and 23.8 (NCH2CH2), 26.0, 26.4, 27.0,
27.1, 27.2, 28.0-28.7 and 29.0 (13 × CH2), 34.3 and 34.7 (3-CH2), 47.9 and 48.7
(C6), 50.8 and 51.1 (C2), 54.8 and 55.5 (NCH2), 119.1 (C4), 131.1 (C3). — IR
(KBr, cm−1): ν˜ = 2932 m, 2860 m, 2623 w, 1685 s, 1465 w, 1406 w, 1198 s, 1162 s,
1133 s, 828 m, 797 m, 719 m. — The compound does not show UV absorption. —
HRMS ((+)-ESI): m/z = 429.4161 (calcd. 429.4203 for C29H53N2+ [M+H]+); m/z
= 215.2129 (calcd. 215.2138 for C29H54N22+ [M+H]2+); m/z = 543.4057 (calcd.
543.4127 for C29H54N22+ × C2F3O2− [M+H]+).
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Mass spectra
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Figure 7.9 High-resolution mass spectrum of haliclamine E (3) under standard
(top) and in-source CID-MS/MS condition (below). THP = tetrahydropyridine.
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Figure 7.10 MS/MS-fragmentation of the singly charged molecular ion of halicla-
mine E (3) under ion trap conditions. Pyr = pyridine. Precursor ions for fragmentation
are marked with a yellow diamond.
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Figure 7.11 MS/MS-fragmentation of the doubly charged molecular ion of halicla-
mine E (3) under ion trap conditions. THP = tetrahydropyridine. Precursor ions for
fragmentation are marked with a yellow diamond.
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Haliclamine F (4), 11/11
Compound data
3-(11-hydroxyundecyl)-1-[11-(N-oxidopyridine-3-yl)-undecyl]-pyridinium iodide (4C). 3-
(11-chloroundecyl)-pyridine-N -oxide (4A, 0.90 g, 3.17 mmol), 11-(pyridine-3-yl)-
undecane-1-ol (4B, 0.79 g, 3.17 mmol), and NaI (0.57 g, 3.80 mmol) were treated
as described above (procedure 1.). Chromatography on silica (9:1 CH2Cl2/MeOH)
yielded 1.38 g (70%) of the dimer as a yellow solid. — TLC Rf : 0.42 (9:1
CH2Cl2/MeOH). — 1H-NMR (250 MHz, DMSO-d6): δ = 1.11-1.73 (m, 34 H,
17 × CH2), 1.82-2.03 (m, 2 H, NCH2CH 2), 2.53 (t, J = 7.8 Hz, 2 H, 3-CH 2), 2.79
(t, J = 7.6 Hz, 2 H, 3’-CH 2), 3.36 (dt, J = 6.6 Hz, J = 5.4 Hz, 2 H, CH 2OH), 4.30
(t, J = 5.1 Hz, 1 H, OH), 4.55 (t, J = 7.3 Hz, 2 H, NCH 2), 7.19 (d, J = 7.9 Hz, 1 H,
H4), 7.31 (dd, J = 7.3 Hz, J = 6.7 Hz, 1 H, H5), 8.02-8.12 (m, 3 H, H2, H6, H5’),
8.48 (d, J = 8.0 Hz, 1 H, H4’), 8.93 (d, J = 6.0 Hz, 1 H, H6’), 9.02 (s, 1H, H2’). —
13C-NMR (62.5 MHz, DMSO-d6): δ = 25.2, 25.4 and 28.1-28.9 (14 × CH2), 29.6
(3’-CH2CH2), 29.8 (3-CH2CH2), 30.5 (NCH2CH2), 31.4 (3’-CH2), 31.5 (3-CH2),
32.4 (CH2CH2OH), 60.6 (CH2OH and NCH2), 125.3 (C4), 125.9 (C5), 127.4 (C5’),
136.1 (C6), 138.1 (C2), 141.3 (C3’), 142.1 (C6’), 142.9 (C3), 143.8 (C2’), 145.0 (C4’).
— IR (KBr, cm−1): ν˜ = 3405 m, 3059 w, 2922 s, 2849 s, 1735 w, 1628 w, 1600 w,
1560 w, 1468 m, 1430 w, 1268 w, 1156 m, 1049 w, 1014 w, 963 w, 802 w, 758 w, 720
w, 682 m. — HRMS ((+)-ESI): m/z = 497.4065 (calcd. 497.4102 for C32H53N2O2+
[M+H]+).
Cyclostellettamine R (4D). Following procedure 2./3., cyclostellettamine R (4D)
was prepared from 3-(11-hydroxyundecyl)-1-[11-(N -oxidopyridine-3-yl)-undecyl]-
pyridinium iodide (4C) (1.00 g, 1.60 mmol), PBr3 (0.62 mL, 6.40 mmol) and NaI
(0.53 g, 3.52 mmol). Recrystallisation from H2O yielded 598 mg (52%) as a yellow
solid. — TLC bromide: Rf : 0.6 (free base, 9:1 CH2Cl2/MeOH); cyclostellettamine
R (4D): Rf : 0.15 (9:1 CH2Cl2/MeOH). — M. p. 228 ï¿½C. — 1H-NMR (250 MHz,
DMSO-d6): δ = 0.96-1.33 (m, 28 H, 14 × CH2), 1.51-1.76 (m, 4 H, 3-CH2CH 2),
1.80-2.00 (m, 4 H, NCH2CH 2), 2.81 (t, J = 6.7 Hz, 4 H, 3-CH 2), 4.64 (t, J = 6.2
Hz, 2 H, NCH 2), 8.10 (dd, J = 7.8 Hz, J = 6.1 Hz, 2 H, H5), 8.51 (d, J = 7.9 Hz,
2 H, H4), 9.05 (d, J = 5.8 Hz, 2 H, H6), 9.18 (s, 2 H, H2). — 13C-NMR (75.0 MHz,
DMSO-d6): δ = 25.0, 27.5, 28.4, 28.7-29.0 and 29.3 (16 × CH2), 30.1 (3-CH2CH2),
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31.2 (3-CH2), 60.4 (NCH2), 127.7 (C5), 142.3 (C6), 142.5 (C3), 144.0 (C2), 145.3
(C4). — IR (KBr, cm−1): ν˜ = 3012 s, 2921 s, 2852 s, 1627 m, 1582 w, 1502 s, 1469
s, 1445 m, 1371 w, 1241 w, 1207 w, 1171 w, 1152 w, 953 w, 924 w, 846 w, 820 m,
759 w, 697 s. — EA calcd. for C32H52N2I2 (718.58): C 53.49, H 7.29, N 3.90; found
C 53.34, H 7.29, N 3.73. — UV (DAD): λmax = 218, 270 nm; λmin = 242 nm. —
HRMS ((+)-ESI): m/z = 232.2042 (calcd. 232.2060 for C32H52N22+ [M+H]2+).
Haliclamine F (4). In the manner described above (procedure 4.), 100 mg of cyclo-
stellettamine R (4D) were treated with 100 mg of NaBH4. Purification of 29 mg of
the crude product via HPLC yielded 20 mg (20%) haliclamine F (4) as TFA-salt. —
TLC Rf : 0.43 (9:1 CH2Cl2/MeOH). — 1H-NMR (300 MHz, CDCl3): δ = 1.18-1.49
(m, 32 H, 16 × CH2), 1.70-1.85 (m, 4 H, NCH2CH 2), 2.01 (t, J = 7.1 Hz, 4 H,
3-CH 2), 2.26 (d, J = 18.5 Hz, 2 H, H5’), 2.55-2.72 (m, 2 H, H5), 2.85-3.11 (m, 6 H,
H6’ and NCH 2), 3.25 (d, J = 16.0 Hz, 2 H, H2’), 3.46-3.58 (m, 2 H, H6), 3.89 (d, J
= 15.8 Hz, 2 H, H2), 5.62 (s, 2 H, H4), 12.62 (s, 2 H, NH). — 13C-NMR (75.0 MHz,
CDCl3): δ = 21.5 and 21.6 (C5), 23.5 (NCH2CH2), 26.4, 27.0, 27.1, and 28.3-29.0
(16 × CH2), 34.4 and 34.6 (3-CH2), 48.1 and 48.3 (C6), 51.4 and 51.5 (C2), 55.2
and 55.5 (NCH2), 119.1 (C4), 131.1 (C3). — IR (KBr, cm−1): ν˜ = 2928 s, 2856
m, 1675 s, 1465 w, 1412 w, 1197 s, 1170 s, 1132 s, 828 w, 798 w, 720 m. — The
compound does not show UV absorption. — HRMS ((+)-ESI): m/z = 236.2371
(calcd. 236.2373 for C32H60N22+ [M+H]2+).
Mass spectra
TFA adduct ion
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Figure 7.12 High-resolution mass spectrum of haliclamine F (4) under standard
(top) and in-source CID-MS/MS condition (below). THP = tetrahydropyridine.
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Figure 7.13 MS/MS-fragmentation of the singly charged molecular ion of halicla-
mine F (4) under ion trap conditions. Pyr = pyridine. Precursor ions for fragmentation
are marked with a yellow diamond.
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Figure 7.14 MS/MS-fragmentation of the doubly charged molecular ion of halicla-
mine F (4) under ion trap conditions. THP = tetrahydropyridine. Precursor ions for
fragmentation are marked with a yellow diamond.
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Haliclamine G (5), 12/12
Compound data
3-(12-hydroxydodecyl)-1-[12-(N-oxidopyridine-3-yl)-dodecyl]-pyridinium iodide (5C). 3-
(12-chlorododecyl)-pyridine-N -oxide (5A, 0.89 g, 3.35 mmol), 12-(pyridine-3-yl)-
dodecane-1-ol (5B, 1.00 g, 3.35 mmol), and NaI (0.60 g, 4.00 mmol) were treated
as described above (procedure 1.). Chromatography on silica (9:1 CH2Cl2/MeOH)
yielded 1.99 g (91%) of the dimer as a light yellow solid. — TLC Rf : 0.34 (9:1
CH2Cl2/MeOH) — 1H-NMR (250 MHz, DMSO-d6): δ = 1.13-1.72 (m, 38 H, 19 ×
CH2), 1.82-2.00 (m, 2 H, NCH2CH 2), 2.50-2.56 (m, 2 H, 3-CH 2), 2.80 (t, J = 7.5
Hz, 2 H, 3’-CH 2), 3.33-3.40 (m, 2 H, CH 2OH), 4.37 (t, J = 5.0 Hz, 1 H, OH), 4.59
(t, J = 7.3 Hz, 2 H, NCH 2), 7.20 (d, J = 8.2 Hz, 1 H, H4), 7.29-7.37 (m, 1 H, H5),
8.02-8.14 (m, 3 H, H2, H6, H5’), 8.49 (d, J = 8.3 Hz, 1 H, H4’), 8.99 (d, J = 6.0 Hz,
1 H, H6’), 9.10 (s, 1 H, H2’) — 13C-NMR (62.5 MHz, DMSO-d6): δ = 25.3, 25.5 and
28.2-29.1 (16 × CH2), 29.7 (3’-CH2CH2), 29.9 (3-CH2CH2), 30.6 (NCH2CH2), 31.5
(3’-CH2 and 3-CH2), 32.5 (CH2CH2OH), 60.6 (CH2OH and NCH2), 125.5 (C4),
126.1 (C5), 127.6 C5’), 136.3 (C6), 138.1 (C2), 141.5 (C3’), 142.1 (C6’), 143.0 (C3),
143.9 (C2’), 145.1 (C4’) — IR (KBr, cm−1): ν˜ = 3346 s, 3041 m, 2916 s, 2850 s,
1654 w, 1630 w, 1599 w, 1560 w, 1501 w, 1481 w, 1470 s, 1438 m, 1325 w, 1270 s,
1203 w, 1157 s, 1048 m, 1014 m, 940 w, 885 w, 855 w, 811 m, 760 w, 716 w, 680
m — HRMS ((+)-ESI): m/z = 525.4368 (calcd. 525.4415 for C34H57N2O2+ [M+H]+).
Cyclostellettamine A (5D). For preparation and compound data refer to Baldwin et
al. [203]
Haliclamine G (5). In the manner described above (procedure 4.), 100 mg of cyclo-
stellettamine A (5D) were treated with 100 mg of NaBH4. Purification of 45 mg of
the crude product via HPLC yielded 31.1 mg (32%) haliclamine G (5) as TFA-salt.
— TLC Rf : 0.51 (9:1 CH2Cl2/MeOH) — 1H-NMR (250 MHz, CDCl3): δ = 1.14-1.48
(m, 40 H, 20 × CH2), 1.70-1.89 (m, 4 H, NCH2CH 2), 2.01 (t, J = 7.1 Hz, 4 H,
3-CH 2), 2.26 (d, J = 18.3 Hz, 2 H, H5’), 2.55-2.69 (m, 2 H, H5), 2.87-3.12 (m, 6
H, H6’ and NCH 2), 3.23 (d, J = 16.0 Hz, 2 H, H2’), 3.43-3.56 (m, 2 H, H6), 3.89
(d, J = 15.8 Hz, 2 H, H2), 5.62 (s, 2 H, H4), 12.87 (s, 2 H, NH) — 13C-NMR (150
MHz, CDCl3): δ = 21.2 and 21.3 (C5), 23.8(NCH2CH2), 26.5, 27.0 and 27.2, 28.6,
208
7.1 Systematic Investigation on the MS-fragmentation of the Haliclamines
28.8-29.1 and 29.2 (20 × CH2), 34.6 (3-CH2), 48.1 (C6), 51.3 (C2), 55.3 (NCH2),
119.0 (C4), 131.1 (C3) — IR (KBr, cm−1): ν˜ = 2929 s, 2855 m, 2593 w, 1735
w, 1670 s, 1467 m, 1420 w, 1194 s, 1175 s, 1149 s, 831 m, 799 m, 719 m — The
compound does not show UV absorption. — HRMS ((+)-ESI): m/z = 264.2676
(calcd. 264.2686 for C36H68N22+ [M+2H]2+).
Mass spectra
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Figure 7.15 High-resolution mass spectrum of haliclamine G (5) under standard
(top) and in-source CID-MS/MS condition (below). THP = tetrahydropyridine.
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Figure 7.16 MS/MS-fragmentation of the singly charged molecular ion of halicla-
mine G (5) under ion trap conditions. Pyr = pyridine. Precursor ions for fragmentation
are marked with a yellow diamond.
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Figure 7.17 MS/MS-fragmentation of the doubly charged molecular ion of halicla-
mine G (5) under ion trap conditions. THP = tetrahydropyridine. Precursor ions for
fragmentation are marked with a yellow diamond.
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Haliclamine H (6), 13/13
Compound data
3-(13-hydroxytridecyl)-1-[13-(N-oxidopyridine-3-yl)-tridecyl]-pyridinium iodide (6C). 3-
(13-chlorotridecyl)-pyridine-N -oxide (6A, 0.30 g, 1.08 mmol), 13-(pyridine-3-yl)-
tridecane-1-ol (6B, 0.34 g, 1.08 mmol), and NaI (0.19 g, 1.30 mmol) were treated
as described above (procedure 1.). Chromatography on silica (9:1 CH2Cl2/MeOH)
yielded 475 mg (65%) of the dimer as a light yellow solid. — TLC Rf : 0.44 (5:1
CH2Cl2/MeOH) — 1H-NMR (250 MHz, MeOD-d4): δ = 1.13-1.83 (m, 42 H, 21 ×
CH2), 1.96-2.11 (m, 2 H, NCH2CH 2), 2.68 (t, J = 7.6 Hz, 2 H, 3-CH 2), 2.90 (t, J
= 7.6 Hz, 2 H, 3’-CH 2), 3.53 (t, J = 6.5 Hz, 2 H, CH 2OH), 4.64 (t, J = 7.3 Hz,
2 H, NCH 2), 7.44-7.58 (m, 2 H, H4 and H5), 8.03 (dd, J = 7.4 Hz, J = 6.3 Hz 1
H, H5’), 8.15-8.27 (m, 2 H, H2 and H6), 8.47 (d, J = 7.9 Hz, 1 H, H4’), 8.87 (d,
J = 5.7 Hz, 1 H, H6’), 8.98 (s, 1 H, H2’) — 13C-NMR (62.5 MHz, MeOD-d4): δ
= 27.0, 27.2, 30.1 and 30.4-30.8 (18 × CH2), 31.6 (3’-CH2CH2), 31.7 (3-CH2CH2),
32.5 (NCH2CH2), 33.5 (3’-CH2) 33.6 (3-CH2), 33.7 (CH2CH2OH), 63.0 (CH2OH
and NCH2), 127.7 (C4), 129.0 (C5), 131.6 (C5’), 137.9 (C6), 140.0 (C2), 143.4 (C3’),
144.4 (C6’), 145.3 (C3), 145.8 (C2’), 146.7 (C4’) — IR (KBr, cm−1): ν˜ = 3396 s,
3075 m, 2919 s, 2848 s, 1702 w, 1627 m, 1601 m, 1560 m, 1498 w, 1469 s, 1436 s,
1371 w, 1298 m, 1269 s, 1217 m, 1155 s, 1052 s, 1013 s, 962 s, 905 w, 865 w, 810 m,
793 m, 759 m, 718 s, 682 s — HRMS ((+)-ESI): m/z = 553.4711 (calcd. 553.4728
for C36H61N2O2+ [M+H]+).
Cyclostellettamine C (6D). For preparation and compound data refer to Baldwin et
al. [203]
Haliclamine H (6). In the manner described above (procedure 4.), 100 mg of
cyclostellettamine C (6D) were treated with 100 mg of NaBH4. Purification of 44
mg of the crude product via HPLC yielded 27.8 mg (29%) haliclamine H (6) as
TFA-salt. — TLC Rf : 0.51 (9:1 CH2Cl2/MeOH) — 1H-NMR (250 MHz, CDCl3): δ
= 1.21-1.45 (m, 36 H, 18 × CH2), 1.71-1.84 (m, 4 H, NCH2CH 2), 2.01 (t, J = 7.0
Hz, 4 H, 3-CH 2), 2.27 (d, J = 18.4 Hz, 2 H, H5’), 2.51-2.69 (m, 2 H, H5), 2.89-3.12
(m, 6 H, H6’ and NCH 2), 3.24 (d, J = 16.3 Hz, 2 H, H2’), 3.44-3.56 (m, 2 H, H6),
3.90 (d, J = 16.1 Hz, 2 H, H2), 5.62 (s, 2 H, H4), 12.75 (s, 2 H, NH) — 13C-NMR
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(150 MHz, CDCl3): δ = 21.3 (C5), 23.9 (NCH2CH2), 26.3, 27.2, 28.6, 28.7-29.0, 29.1
(18 × CH2), 34.5 (3-CH2), 48.1 (C6), 51.4 (C2), 55.0 (NCH2), 118.9 (C4), 131.1
(C3) — IR (KBr, cm−1): ν˜ = 2928 s, 2854 s, 2579 w, 1671 s, 1467 m, 1414 w, 1196 s,
1173 s, 1143 s, 830 m, 800 w, 720 m — The compound does not show UV absorption.
— HRMS ((+)-ESI): m/z = 250.2519 (calcd. 250.2530 for C34H64N22+ [M+2H]2+).
Mass spectra
264.2690
527.5283
264.2690
527.5283
[M+2H]2+
100 200 300 400 500 600 mz/
TFA adduct ion
[M+H]+
[M+H]+
[M+2H]2+
Figure 7.18 High-resolution mass spectrum of haliclamine H (6) under standard
(top) and in-source CID-MS/MS condition (below). THP = tetrahydropyridine.
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Figure 7.19 MS/MS-fragmentation of the singly charged molecular ion of halicla-
mine H (6) under ion trap conditions. Pyr = pyridine. Precursor ions for fragmentation
are marked with a yellow diamond.
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Figure 7.20 MS/MS-fragmentation of the doubly charged molecular ion of halicla-
mine H (6) under ion trap conditions. THP = tetrahydropyridine. Precursor ions for
fragmentation are marked with a yellow diamond.
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Haliclamine I (7), 11/14
Compound data
3-(14-hydroxytetradecyl)-1-[11-(N-oxidopyridine-3-yl)-undecyl]-pyridinium iodide (7C).
For preparation and compound data refer to Grube et al. [117]
Cyclostellettamine L (7D). For preparation and compound data refer to Grube
et al. [117]
Haliclamine I (7). In the manner described above (procedure 4.), 100 mg of cyclo-
stellettamine L (6D) were treated with 100 mg of NaBH4. Purification of 67 mg of
the crude product via HPLC yielded 37 mg (39%) haliclamine I (7) as TFA-salt. —
TLC Rf : 0.51 (9:1 CH2Cl2/MeOH) — 1H-NMR (250 MHz, CDCl3): δ = 1.21-1.48
(m, 38 H, 19 × CH2), 1.69-1.88 (m, 4 H, NCH2CH 2), 1.96-2.10 (m, 4 H, 3-CH 2),
2.27 (d, J = 18.1 Hz, 2 H, H5’), 2.51-2.70 (m, 2 H, H5), 2.88-3.11 (m, 6 H, H6’
and NCH 2), 3.24 (d, J = 16.1 Hz, 2 H, H2’), 3.44-3.57 (m, 2 H, H6), 3.90 (d, J =
16.0 Hz, 2 H, H2), 5.62 (s, 2 H, H4), 12.73 (s, 2 H, NH) — 13C-NMR (150 MHz,
CDCl3): δ = 21.3 and 21.4 (C5), 23.7 and 23.8 (NCH2CH2), 26.4, 27.1, 28.6-29.1
(19 × CH2), 34.5 and 34.6 (3-CH2), 48.1 and 48.2 (C6), 51.4 and 51.5 (C2), 55.0
and 55.1 (NCH2), 118.9 and 119.0 (C4), 131.0 (C3) — IR (KBr, cm−1): ν˜ = 2929 s,
2855 s, 2441 w, 1670 s, 1468 m, 1418 w, 1196 s, 1142 s, 830 m, 800 m, 720 s — The
compound does not show UV absorption. — HRMS ((+)-ESI): m/z = 257.2590
(calcd. 257.2608 for C35H66N22+ [M+2H]2+).
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Mass spectra
257.2610
513.5121236.2365 279.1047
THP+C11 THP+C14
[M+2H]2+
[M+H]+
100 200 300 400 500 600 mz/
257.2601
513.5113 [M+H]+
236.2360 278.2833
THP+C11 THP+C14
[M+2H]2+
TFA adduct ion
Figure 7.21 High-resolution mass spectrum of haliclamine I (7) under standard
(top) and in-source CID-MS/MS condition (below). THP = tetrahydropyridine.
Figure 7.22 MS/MS-fragmentation of the singly charged molecular ion of halicla-
mine I (7) under ion trap conditions. Pyr = pyridine. Precursor ions for fragmentation
are marked with a yellow diamond.
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Figure 7.23 MS/MS-fragmentation of the doubly charged molecular ion of halicla-
mine I (7) under ion trap conditions. Pyr = pyridine, THP = tetrahydropyridine.
Precursor ions for fragmentation are marked with a yellow diamond.
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For the first time, the macrocyclic monomeric 3-alkyl pyridinium alkaloid with an alkyl chain of 
13 methylene groups, haliclocyclin C (1) could be identified from a natural source in the crude 
extract of the Arctic sponge Haliclona viscosa. Structure elucidation based on the comparison of 
the natural product with the corresponding synthetic compound. 10 
In recent years, a number of novel 3-alkyl pyridinium 
alkaloids were identified from the crude extract of the Arctic 
marine sponge Haliclona viscosa.1-2, 3 The material available 
from this sponge is limited by the small size of the 
individuals, their slow growth rate and the effort to sample 15 
substainably in the Arctic ecosystem. A new refinement of the 
spectroscopic methods led to improved resolution of the 
compound peaks in HPLC experiments and consequently also 
in the coupled mass spectrometric analyses. As a result, we 
were able to identify a new monomeric 3-alkyl pyridinium 20 
alkaloid (1, Scheme 1) by HPLC-HRMS experiments. The 
compound could not be isolated in sufficient quantity and 
purity to allow NMR studies. 
 
Scheme 1 Cyclic monomeric, dimeric and trimeric and a linear 3-alkyl 25 
pyridinium alkaloid isolated from the Arctic sponge Haliclona viscosa. 
 Compound 1 elutes at a retention time of 15.5 min in the 
crude extract of H. viscosa. It shows a singly charged 
molecular ion of m/z = 260.2368 which suggests a molecular 
formula of C18H30N (Δm = 1.8 ppm, Fig. 1). Apart from a 30 
partly overlapping, unidentified compound, the mass spectrum 
of the natural compound does not show other molecular-, 
fragment- or adduct-ions. The molecular mass is by 14 mass 
units smaller than the mass of the known cyclic monomeric 3-
alkyl pyridinium compound 23 which elutes at 17.9 min in the 35 
same sponge extract and also shows only a singly charged 
molecular ion. The crude extract of H. viscosa contains a 
number of compounds that are structurally very similar but 
differ in the length of the alkyl chains and the degree of 
oligomerisation. Cyclostellettamine C (3) at a retention time 40 
of 16.5 min also shows a molecular ion at m/z = 260, but it 
can be differentiated from the molecular ion of 1 by being 
doubly charged. Another molecular ion of m/z = 260 is found 
for viscosamine C (4)4 which elutes at 17.1 min, but the 
molecular ion of 4 is triply charged, and the spectrum shows 45 
additional fragment and adduct masses.1 
 Therefore, it seems reasonable to propose that 1 is the 
structural analogue of 2 and contains an alkyl chain that is 
shortened by one methylene group in comparison to 2. 
Compound 1 has previously been synthesized during the 50 
development of the total synthesis of cyclostellettamine C (3)5 
as well as for cytotoxicity studies3 and is therefore available 
for chromatographic comparisons between the natural 
compound and the synthetic compound. 
 55 
Fig. 1. High-resolution mass spectrum of natural haliclocyclin C (1) 
resulting from a chromatographic separation of the crude extract. 
 The synthetic compound 1 elutes at the same retention time 
as the natural compound 1 in the crude extract. The HPLC-
HRMS analysis of the synthetic compound 1 yields the mass 60 
m/z = 260.2360 (Fig. 2) which corresponds to the molecular 
formula C18H30N with a mass accuracy of 4.9 ppm and fits 
very well to the observed mass of the natural compound 1. As 
before in the natural compound 1, the mass spectrum of the 
synthetic compound 1 does not show additional fragment- or 65 
adduct-ions. The chromatographic analysis of a mixture of the 
crude extract and the synthetic 1 results in increased intensity 
of the compound peak in the crude extract (Fig. 3). It can 
therefore be concluded that the natural compound 1 has the 
same structure as the synthetic 1.  70 
 
Fig. 2. High-resolution mass spectrum (direct injection) of synthetic 
haliclocyclin C (1). 
  
Fig.3 Overlay of the HPLC-HRMS base peak chromatogram of the crude 
extract of a Haliclona viscosa sample from 2000 (black), the synthetic 
haliclocyclin C (1, dashed line), and a mixture of both (dotted line). The 
chromatogram peaks of haliclocyclin F (2), cyclostellettamine C (3), and 5 
viscosamine C (4) are indicated by the appropriate number. 
 Although Schmitz et al. (1978)6 and Davies-Coleman et al. 
(1993)7 describe chloride as the predominant, if not exclusive 
natural counterion of halitoxin and the cyclostellettamines, we 
do not find evidence for chloride as the counterion in the 3-10 
alkyl pyridinium alkaloids contained in the crude extract of 
the Arctic Haliclona viscosa. Instead, MALDI-TOF 
investigations of the crude extract show a different ion of yet 
unknown structure (unpublished results). This first report of 
haliclocyclin C (1) from a natural source completes the set of 15 
oligomers with equidistant alkyl chains (C13) isolated or 
identified in the Arctic sponge Haliclona viscosa. An 
interesting aspect is the progression of the bioactivity between 
the monomeric haliclocyclin C (1), dimeric cyclostellettamine 
C (3) and trimeric viscosamine (4).8 The monomeric 20 
compound shows the highest whereas the trimeric compound 
shows the lowest antimicrobial activity.9 The cytotoxic 
activity in volumetric concentrations is almost identical for all 
three while in molar concentrations viscosamine C (4) shows 
the strongest and haliclocyclin C (1) the lowest cytotoxic 25 
activity.10 While the monomer with a C14 alkyl chain, 
haliclocyclin F (2), also exists in the crude extract, the 
corresponding dimer and trimer with C14 alkyl chains, 
cyclostellettamine F and viscosamine F, have not been 
identified yet. On the other hand, a viscosamine in which at 30 
least one C14 alkyl chain is present was recently identified in 
Haliclona viscosa (unpublished results). 
 With the appearance of additional cyclic monomeric 3-
alkyl pyridinium alkaloids we suggest that the to-date 
unnamed compound 2 should be renamed to haliclocyclin F; 35 
this suggestions follows the nomenclature of 
cyclostellettamines, where cyclostellettamine F contains two 
C14 alkyl chains.
11 Accordingly, compound 1 should be named 
haliclocyclin C (1) in analogy to cyclostellettamine C (3) and 
viscosamine C (4) both of which contain alkyl chains with 13 40 
methylene groups. 
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Extraction and analysis of the natural compound 1
The sponge was collected in summer 2003 by the AWI scientific diving team using
scuba in the Kongsfjord, Spitsbergen, at a depth of aproximately 15m. One part
of the sponge was conserved in ethanol for taxonomic identification, which was
performed by Wallie H. de Weerdt at the Zoölogisch Museum Amsterdam (voucher
MAK301). The remaining sponge tissue was frozen at –20 °C and transported back
to Bremerhaven where it was freeze-dried. Freeze-dried sponge tissue (4.18 g) was
exhaustively extracted at room temperature with a 1:1 mixture of methanol and
dichloromethane (4 × 80 mL).
The resulting crude extract was investigated by HR-LCMS on an Agilent 1100
HPLC system equipped with a Waters XTerra RP18 column (3.0 × 150mm, 3.5µm)
applying an ACN/H2O (0.1% HCOOH) gradient at 35 °C; 0min and a flow rate of
0.4 mL min−1: 20% ACN/80% H2O; 25min: 55% ACN/45% H2O; 27min: 100%
ACN. UV spectra were recorded during HPLC analysis with a DAD (Agilent). Mass
spectra were acquired on-line with a coupled Bruker Daltonics microTOFLC mass
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spectrometer. The instrument was externally calibrated using sodium formiate
cluster. TLC used prefabricated, silica coated aluminum sheets (Merck, silica 60)
and a liquid phase of CH2Cl2/MeOH (9:1). NMR spectra were recorded on a
Bruker Avance 250 MHz spectrometer at 298K in DMSO-d6. Melting points were
determined using a Kofler melting point apparatus and are uncorrected. Chemical
shifts are quoted in ppm and are referenced to the appropriate solvent signal. FT-IR
spectra were recorded on a Perkin-Elmer 1600 series spectrometer. Absorption
maxima are reported in wave numbers and the following abbreviations are used: s
strong, m medium, w weak.
Experimental data for the synthetic Haliclocyclin C (1)
Synthesis followed the method described by Timm & Köck (2008)1 and produced a
yellow solid (60% synthesis yield). TLC: Rf = 0.25 (9:1 CH2Cl2/MeOH on Merck
silica 60) — mp: 151 °C — 1H-NMR (250 MHz, DMSO-d6): δ = 0.97-1.34 (m, 18 H,
9 × CH2), 1.67-1.82 (m, 2 H, 3-CH2CH2), 1.90-2.06 (m, 2 H, pyCH2CH2), 2.87 (t,
J = 6.3 Hz, 2 H, 3-CH2), 4.64 (t, J = 6.0 Hz, 2 H, pyCH2), 8.12 (dd, J = 7.9 Hz, J
= 6.2 Hz, 1 H, H5), 8.53 (d, J = 8.0 Hz, 1 H, H4), 8.98 (d, J = 6.0 Hz, 1 H, H6),
9.14 (s, 1 H, H2) — 13C-NMR (62.5 MHz, DMSO-d6): δ = 23.4, 25.5, 25.6, 25.8,
25.9, 26.2, 26.4, 26.6, 28.1, 28.8 (10 × CH2), 29.3 (3-CH2CH2), 30.5 (3-CH2), 60.3
(CH2N), 127.6 (C5), 142.3 (C6), 142.6 (C3), 143.8 (C2), 145.5 (C4) — IR (NaCl,
cm−1): 3018 m, 2927 s, 2857 s, 1624 m, 1508 m, 1463 m, 1442 m, 1383 w, 1229 w,
1154 w, 931 w, 842 w, 814 w, 793 w, 717 w, 690 w — HRMS (ESI, direct injection):
m/z = 260.2332 (calcd. for C18H30N+ m/z = 260.2373).
1 C. Timm, C. Volk, F. Sasse and M. Köck, Org. Biomol. Chem., 2008, 6, 4036-4040.
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ppm12345678910
Figure 7.24 1H-NMR spectrum of the synthetic Haliclocyclin C (1) in DMSO-d6.
150 140 130 120 110 90 80 70 60 50 40 30 20 10 ppm160
Figure 7.25 13C-NMR spectrum of the synthetic Haliclocyclin C (1) in DMSO-d6.
221
7 Manuscripts
150 200 250 300 350 400 450 m z/
260.2368 [M]+
unidentified compound
Figure 7.26 HRMS spectrum of the natural compound 1 obtained from LC-MS
analysis of the crude extract.
150 200 250 300 350 400 450 m z/
260.2360 [M]+
Figure 7.27 HRMS spectrum of the synthetic compound 1 obtained from LC-MS
analysis of the pure, synthetic compound.
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Refined spectroscopic methods and a detailed knowledge about 
the behaviour of haliclamines during mass spectrometric 
experiments led to the identification of two new haliclamines, 
haliclamine J (1) with two equal alkyl chains of 10 methylene 10 
groups and haliclamine K (2) with alkyl chains of 10 and 12 
methylene groups, directly from the crude extract of the sponge 
Haliclona viscosa. 
Haliclamines are cyclic dimeric 3-alkyl tetrahydropyridine 
alkaloids where two tetradydropyridine moieties (THP) are 15 
interconnected in 1- and 3-position1 by alkyl chains of 
variable length. They are integrated into the large and diverse 
group of 3-alkyl pyridinium alkaloids (3-APAs).2 Mono-, di-, 
tri-, and polymeric 3-alkyl pyridinium compounds have been 
identified in six different sponge families of the order 20 
Haplosclerida from around the world. In contrast, only 
dimeric haliclamines have to date only been reported from 
two locations, Hiburi-jima, Japan, and the Svalbard 
archipelago, and only from the sponge genus Haliclona.3, 4 As 
such they take up an exceptional position within the 3-APA 25 
compound class. 
 Only recently, the comparison of the crude extract of the 
Arctic sponge Haliclona viscosa with retention times and 
spectrometric data of two synthetic haliclamines led to the 
identification of the two new haliclamines E and F.4 The 30 
subsequent systematic investigation of the MS-fragmentation 
of haliclamines5 laid the basis for further detailed HPLC-
HRMS examinations of crude extracts of H. viscosa. 
 
Fig. 1 Haliclamine J (1) and K (2) 35 
 The knowledge about haliclamine behavior in mass 
spectrometry now enabled us to identify two more 
haliclamines, haliclamine J (1, 10/10) and K (2, 10/12), from 
the same crude extract that had yielded the haliclamines E and 
F. Isolation of the compounds was not possible due to the 40 
limited amount of sponge material available. The two new 
compounds were not recognized in earlier HPLC-HRMS 
analyses since they co-eluted with haliclamines C and F. A 
refinement of the spectroscopic method split both the 
haliclamine C and the haliclamine F peak into two and thus 45 
allowed to distinguish the known and the new compound. 
 Compound 1 at a retention time of 13.8-14.0 min shows a 
singly charged pseudomolecular ion [M+H]+ at m/z = 
443.4370 and a doubly charged pseudomolecular ion 
[M+2H]2+ at m/z = 222.2225 corresponding to the molecular 50 
formula C30H55N2 The same molecular formula and similar 
masses are assigned to haliclamine C (3), but 3 elutes at a 
retention time of 14.0-14.2 min. Haliclamine C (3) contains 
two alkyl chains of 9 and 11 methylene groups, respectively. 
The high resolution mass spectrum of haliclamine C shows 55 
mass peaks of two fragments at m/z = 208.2090 and m/z = 
236.2331 which represent the mass equivalent of a THP 
moitey connected to either alkyl chain. In constrast, the mass 
spectrum of compound 1 does not show obvious fragments. 
The different retention time to haliclamine C (3) and the 60 
absence of fragment masses suggests the alkyl chains to be of 
equal length of 10 methylene groups. This is supported by the 
isotope peak intensity of the doubly charged molecular ion 
and the observed isotope pattern that indicates a superimposed 
singly charged mass. While the calculated peak intensity (PI) 65 
is 100 : 33.3 : 5.5, the observed PI is 100 : 31.1 : 10.4 (Figure 
A). The X+2 isotope peak of an overlying singly charged 
fragment lies at m/z = 224.2244. Both results suggest that 
compound 1 should be a haliclamine with saturated alkyl 
chains of ten methylene groups, each. Evidence by 70 
comparison to synthetic compounds is in progress. 
 
Fig 2 Base peak chromatogram of a crude extract of Haliclona viscosa. 
Known haliclamines are marked  
 Compound 2 which elutes at 17.0–17.3 min shows a singly 75 
charged pseudomolecular ion [M+H]+ at m/z = 471.4699 and a 
doubly charged pseudomolecular ion [M+2H]2+ at m/z = 
236.2385. This corresponds to a molecular formula of 
C32H60N2 (Δm = 5.5 ppm for [M+H]
+ and Δm = 5.2 ppm for 
[M+2H]2+), the same as has been established for haliclamine F 80 
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which elutes at a retention time of 16.8–17.0 min. With the 
alkyl chains of haliclamine F being of equal length of 11 
methylene groups the fragments that represent the THP 
moiety connected to an alkyl chain concur with the doubly 
charged molecular ion. In the mass spectrum of compound 2 5 
however, two fragment peaks are visible at m/z = 222.2218 
and m/z = 250.2538. They correspond to fragments that carry 
alkyl chains of 10 and 12 methylene groups, respectively. 
Evidence by comparison to synthetic compounds is in 
progress. 10 
Conclusions 
The resolution obtained by spectroscopic methods has a large 
impact on the resolution of coupled spectrometric analyses. 
The detailed knowledge about the behavior of haliclamines in 
different mass spectrometric experiments yielded relevant 15 
information for the identification of new compounds directly 
from the crude extract as is required by the small sample sizes 
of Arctic sponges. 
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A
Haliclona
Haliclona viscosa
The species descriptions is taken from the book "Sponges of Britain and Ireland - A
colour guide and working document" [204]
Form Variable, depending on microhabitat, but typically from spreading cushions
with mamillate oscular chimneys, to massive lobose forms with tall, rugose,
volcano-like oscular chimneys. These oscular chimneys tend to be arranged
in irregular rows in cushion forms. The rows can become ill-defined ridges,
caused by the oscular chimneys anastomosing for up to 3/4 of their height. In
large forms the oscular projections can be mammiform, or chimneys, which
become bulbous for the first 2/3 of their height, narrowing more sharply in
the upper 1/3. The oscular rows may appear as tassels, or as repent branches.
More information is required on growth forms, and their relationships with
habitat types. Specimens may be large, with a spread of up to 30 cm, and
height to 5 cm.
Colour Typically purple, but can verge to pink or brown in some specimens. The
colour is normally deeper on the higher portions of the sponge (i.e. oscular
chimneys), becoming a washed-out fawn/grey away from the extremities. The
depth of colour probably reduces.
Smell None.
Slime May be present in considerable amounts, especially when crushed or torn
apart.
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Consistency Firm, compressible, friable.
Surface Smooth and punctate (from the inhalant pores). Large specimens become
rugose, caused by irregular tuberculate projections of variable size and position,
giving a distinctive warty appearance. The projections can form surface ridges,
giving the sponge an "angular" appearance. Some specimens display an initially
moderate friction, but quickly become slimy as pressure is applied.
Apertures The oscules are formed on chimneys, as described under ’Form’. The
openings are large, up to 1cm in diameter, and remain open after collection
and preservation. Inhalant pores show through the surface, and are closely
packed and conspicuous.
Contraction None.
Skeleton Primary tracts are 3 to 6 spicules in diameter, with single inter-connecting
spicules which are not differentiated into secondary tracts. There is no ectoso-
mal skeleton. Spongin is scarce, nodal.
Spicules Oxea, typically slightly curved, but varying from straight to fairly abruptly
bent in the middle. 140-160 × 4.5-7µm. Larger oxea (up to 170µm?) are
rare. Oxea in the range 95-140 × 1-5.5 µm are occasionally found.
Habitat This sponge is typically found from the upper circalittoral downwards,
but less well developed specimens occur in shallower water and on the shore.
It mainly occurs on vertical rock faces, in silt free areas of considerable water
movement, e.g. gullies and/or areas exposed to wave action and tidal currents.
Distribution Recently known from W. coast of Ireland; Northern Ireland (Antrim;
Strangford Lough); W. coast of Scotland (Mull; Coll; Tiree; Oban; Lewis); SW
Britain (Salcombe, Devon, Eddystone, Hard Deeps; Scilly Isles; Lundy).
Similar Species
Key Identification Features The purplish colour, giant volcano-like oscules, ru-
gose appearance and slime are characteristic. Less well developed specimens
could be confused with other Chalinids. This description is compiled largely
from 11 specimens in the collection of G. Ackers. Other specimens may differ
slightly in detail.
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Samples
Table A.1 Haliclona viscosa samples obtained from the Kongsfjord between 1999
and 2009. Spgn. = Spitsbergen, KFN = Kongsfjordneset, HNC = Hansneset Cave,
Sec.Met. = secondary metabolites.
Year 1999 2000 2001 2003 2009
ID HAVI 025 CV 217 CV 218 MAK 301 09/23 09/27
Origin Kongsfjord Kongsfjord Kongsfjord KFN KFN HNC
Depth 15-25m 15-25m 15-25m 12m 16m 2m
Date/Season May-June Summer Summer 20 June June June
Vouchera 16591 17008 17009 in Bremerhaven
published Chalinasterol 43 43 29, 30 61, 62
Cholesterol 18 18 61, 62
27, 28
a Reference number of vouchers deposited at the Zoölogisch Museum Amsterdam
Table A.2 Key parameters of the type descriptions of different Haliclona sponges.
H. = Haliclona, R. = Reniera, prim. = primary, sec. = secondary, paucisp. =
paucispicular, unisp. = unispicular, ↓ = away from the extremities.
H. viscosa H. rosea H. indistincta R. laxa
Topsent 1888 [205] Bowerbank 1866 Bowerbank Lundbeck 1902 [206]
Consistency firm, friable soft, fragile soft, friable soft, fragile
looser than tubulosa
Slime very slimy
Ectoskeleton none none none none
Surface shiny, smooth
Oscula 1-5mm 0.5-2mm 1.5-3mm 2-4mm
0.5-1mm
on ridges few, scattered sharp edges round, flush
Prim. tracts paucisp. paucisp., wavy paucisp. paucisp.
Sec. tracts unisp. unisp. unisp. unisp.
Spongin little scarce, at nodes little, at nodes some, at nodes
Oxea length 110-150 µm 150-220 µm 110-150 µm 180-205µm
Oxea width 3-8 µm 4-12 µm 3-8 µm 11µm
Choanosome disorderly ↓ orderly many spicules orderly
confused confused
Collected 0-50m 0-200m intertidal 80-180m
Shetlands- Arctic-Boreal Britain, France, Iceland
Mediterranean USA
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Table A.3 Key parameters of the type descriptions of different Haliclona sponges.
R. = Reniera, prim. = primary, sec. = secondary, paucisp. = paucispicular, unisp. =
unispicular, polysp. = polyspicular, ↓ = away from the extremities.
R. heterofibrosa R. glacialis R. mollis R. rufescens
Lundbeck 1902 [206] Hentschel 1916 [207] Lambe 1893 [208] Lambe 1892 [143]
Consistency
Slime
Ectoskeleton none none none none
Surface
Oscula 1-2mm 4mm 5mm 2mm
Prim. tracts paucisp. paucisp. paucisp. unisp.
Sec. tracts polysp. unisp. unisp. unisp.
Spongin some, at nodes copious, at nodes
Oxea lenght 160-178 µm 144-168 µm 196-262 µm 144 µm
Oxea width 5-10 µm 6-8 µm 13 µm 13µm
Choanosome disorderly ↓ disorderly ↓
Collected 12m 15-45m 36-45m
Iceland Svalbard Vancouver Is. Kamtchatka
Table A.4 Key parameters of the type descriptions of different Haliclona sponges.
H. = Haliclona, R. = Reniera, prim. = primary, sec. = secondary, paucisp. =
paucispicular, unisp. = unispicular, ↑ = towards the extremities.
R. tubulosa H. cinerea R. calamus
Fristedt 1902 Grant 1826 Lundbeck 1902 [206]
Consistency soft, firm soft, fragile, hard, firm
compressible
Slime slime strands
Ectoskeleton none present, unisp. none
Surface
Oscula 2-4mm not always present
Prim. tracts polysp. unisp. polysp.
Sec. tracts unisp. unisp. unisp.
Oxea length 170-208 µm 80-140µm 235-268 µm (straight)
107-150 µm (curved)
Oxea width 5-8 µm 3-8µm 11/7 µm (straight/curved)
varying ends hastate, stylote
Choanosome disorderly ↑ rather irregular
Collected 18-55m inter-, subtidal 1 000-1 600m
Greenland, Iceland NE Atlantic (Orkney- Iceland
Farøer W Mediterranean)
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3-APAs from Haplosclerid sponges (except Haliclona)
Table A.5 3-Alkyl pyridinium and 3-alkyl tetrahydropyridine alkaloids isolated
from different sponge genera.
Nr Geographic region Compound Sponge
1 JPN, Shishi-shima Cyclostellettamine A, G [209] Xestospongia sp.
Dehydrocyclostellettamine D, E [209] Xestospongia sp.
2 JPN, Hachijo-jima Cribrochalinamin oxide A, B [210] Cribrochalina sp.
3 JPN, Sata, Shikoku Is. Cyclostellettamine A–F [211] Stelletta maxima
JPN, Unten Bay Theonelladins A–D [212] Theonella swinhoei
JPN, Kerama Is. Manzamine A, B [213] Pellina sp.
Niphatesines A–D [214] Niphates sp.
Niphatesines E–H [215] Niphates sp.
Keramaphidine C [216] Amphimedon sp.
Keramamine C [216] Amphimedon sp.
Ircinol A, B [217] Amphimedon sp.
Manzamine A–C [217] Amphimedon sp.
Ircinal A, B [217] Amphimedon sp.
6-Hydoxymanzamine A [218] Amphimedon sp.
3,4-Dihydroxymanzamine A [218] Amphimedon sp.
Manzamine L [219] Amphimedon sp.
Ma’eganedin A [220] Amphimedon sp.
JPN, Miyako Is. Manzamine E, F [221] Xestospongia sp.
JPN, Seragaki Is. Zamamides A, B [222] Amphimedon sp.
JPN, Kise Is. Ircinal A, B [223] Ircinia sp.
JPN, Aragusuku-jima Araguspongines A–H, J [224] Xestospongia sp.
Aragupetrosine A [225] Xestospongia sp.
JPN, Iriomote Is. Manzamine A, E, F, X [104] Xestospongia sp.
Xestomanzamine A, B [104] Xestospongia sp.
5 FSM, Ant Atoll Ikimines A–D [226] unidentified sponge
FSM, Pohnpei Halitoxin, unbranched [125] Callyspongia fibrosa
6 IDN, Sangihe Is. Halicyclamine B [227] Xestospongia sp.
7 IDN, Derawan Is. Upenamide [228] Echinochalina sp.
8 PNG, Laing Is. Petrosin [81] Petrosia seriata
Petrosin A, B [229] Petrosia seriata
PNG, Madang Ingamine A, B [230] Xestospongia ingens
Ingenamine [231] Xestospongia ingens
Mandangamine A [232] Xestospongia ingens
Ingenamine B–F [233] Xestospongia ingens
9 PNG, Milne Bay Xestocyclamine A [234] Xestospongia sp.
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Xestocyclamine B [235] Xestospongia sp.
PNG, Motupore Is. Motuporamine A–C [236] Xestospongia exigua
10 FJI, Vitu Levu Niphatynes A, B [237] Niphates sp.
11 NCL, Baie de Prony Xestospongin B, D [238] Xestospongia sp.
Araguspongine F [238] Xestospongia sp.
Demethylxestospongin B [238] Xestospongia sp.
12 AUS, Capricorn Is. Niphatoxin C [239] Callyspongia sp.
13 AUS Xestospongin A–D [82] Xestospongia exigua
14 BHS, San Salvador Is. Amphitoxin [240] Amphimedon compressa
BHS, Acklin Is. Xestamines A–C [241] X. wiedenmayeri
Xestamines A, B, D–H [242] Calyx podatypa
15 PRI, Isla Maguayez Halitoxin, branched [80] Amphimedon compressa
16 MTQ Pachychalines A–C [121] Pachychalina sp.
17 BRA, Ilha do Pai Ingenamine G [116] Pachychalina sp.
Cyclostellettamine G–I, K, L [116] Pachychalina sp.
BRA, Búzios Haliclonacyclamine E [243] Arenosclera brasiliensis
Arenosclerin A–C [243] Arenosclera brasiliensis
18 ISR, Gulf of Eilat Niphatoxin A, B [244] Niphates sp.
19 IND, Andaman Is. Araguspongin C, D, E [245] Xestospongia exigua
Xestospongin D [245] Xestospongia exigua
3α-Methylaraguspongin [245] Xestospongia exigua
Country Codes: AUS = Australia, BRA = Brasil, BHS = Bahamas, FJI = Fiji, FSM = Micro-
nesia, IDN = Indonesia, ISR = Israel, IND = India, JPN = Japan, MTQ = Martinique,
NCL = New Caledonia, PNG = Papua New Guinea, PRI = Puerto Rico.
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